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LIST OF ABBREVIATIONS 
 
aa   amino acids 
ACE2   angiotensin-converting enzyme 2 
AEBSF   4-(2-aminoethyl)benzenesulfonyl fluoride hydrochloride 
AP   adaptor protein 
APN   aminopeptidase N 
CALM   clathrin-assembly lymphoid-myeloid leukaemia 
cav   caveolin 
CCoV    canine coronavirus 
CEACAM  carcinoembryonic antigen-related cell adhesion molecule 
CHO (cells)  Chinese hamster ovary (cells) 
CHO-DC-SIGN  CHO cells stably expressing DC-SIGN 
Chol tox B  Cholera toxin B 
c-lig   control ligand 
CME   clathrin-mediated endocytosis 
CPE   cytopathogenic effect 
CrFK (cells)  Crandell feline kidney (cells) 
DC   dendritic cell 
DC-SIGN dendritic cell-specific intercellular adhesion molecule (ICAM3) grabbing  
nonintegrin 
DC-SIGNR  DC-SIGN related 
dip  dynamin inhibitory peptide 
DN  dominant-negative 
dyn  dynamin 
E   envelop (protein) 
E-64   trans-epoxysuccinyl-L-leucylamido-(4-guanidino)butane 
eFCoV   enteric feline coronavirus 
ERGIC   ER tot Golgi intermediate compartment 
fAPN   feline aminopeptidase N 
FCoV   feline coronavirus 
fDC-SIGN  feline DC-SIGN 
FCS   foetal calf serum 
Fcwf (cells)  Felis catus whole foetus 
FIPV   feline infectious peritonitis virus 
8 
FIV   feline immunodeficiency virus 
GEEC   GPI-anchored protein enriched endocytic compartments 
GPI    glycosylphosphatidylinositol 
hAPN   human aminopeptidase N 
HCoV   human coronavirus 
hDC-SIGN  human DC-SIGN 
HIV1   human immunodeficiency virus 1 
HR   heptad repeat 
IBV   infectious bronchitis virus 
IL-2R   interleukin-2 receptor 
irr   irrelevant 
L-SIGN  liver/lymph node specific ICAM3 nonintegrin 
M   membrane (protein) 
mAb   monoclonal antibody 
MDCK (cells)  Madin-Darby canine kidney (cells) 
MHV   mouse hepatitis virus 
moi   multiplicity of infection 
N   nucleocapsid (protein) 
ORF   open reading frame 
PAK   p21-activated kinase 
pAPN   porcine aminopeptidase N 
PBS   phosphate buffered saline 
PBS-G   PBS supplemented with gelatine 
PEDV   porcine epidemic diarrhoea virus 
PI3K   phosphatidyl inositol 3-kinase 
PRCoV   porcine respiratory coronavirus 
PRRSV   porcine reproductive and respiratory syndrome virus 
RdRp   RNA-dependent RNA-polymerase 
Rec X   unknown receptor ‘X’ 
RTC   replication-transcription complex 
SARS   severe acute respiratory syndrome 
TBS   Tris-buffered saline 
TBS-GS  TBS supplemented with sucrose and inactivated goat serum 
Tfn   transferrin 
TGEV   transmissible gastroenteritis virus 
9 
TNF-α   tumour necrosis factor α 
TRS   transcription-regulatory sequence 
S   spike (protein) 
WT   wild type 
γc   common cytokine receptor γ
  
 
Chapter 1  _________________________________________________ 
 
 
 
 
 
 
 
 
INTRODUCTION 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Chapter 1 
 
 12 
1.1 THE FELINE INFECTIOUS PERITONITIS VIRUS 
 
1.1.1 Introduction - taxonomy 
 
Nidoviruses, members of the order Nidovirales, are one evolutionary lineage among the 
positive stranded RNA viruses. Their genome organization and the relatedness of their 
proteins involved in RNA replication and transcription ties them together and distinguishes 
them from other viruses (Siddell & Snijder, 2008). The Nidovirales enclose three families: the 
Coronaviridae, the Arteriviridae and the Roniviridae, found to be evolutionary distinct based 
on sequence analysis of their RNA-dependent RNA-polymerase (RdRp) (Gorbalenya et al., 
2006). The Coronaviridae consist of two genera: Coronavirus and Torovirus. The coronavirus 
genus is further divided in three groups. Coronavirus species are grouped based on genetic 
and antigenic criteria (Gonzalez et al., 2003). Table 1 lists all recently accepted species of 
coronaviruses and situates them within one of the three groups. Further, the strains or 
biotypes of species often referred to in literature, are also mentioned. These coronaviruses 
are associated with either respiratory or enteric diseases (Siddell & Snijder, 2008).   
 
Feline coronaviruses are found in group 1. Based on neutralization reactivity with specific 
antibodies, they are divided in two serotypes: I and II (Fiscus & Teramoto, 1987). Type I 
grows poorly in cell culture, while type II grows easily in many different cell lines (Pedersen 
et al., 1984). Type II has arisen from double recombination events between type I FCoVs 
and CCoV (Herrewegh et al., 1998). FCoV type I is the most prevalent serotype with a 
prevalence of approximately 85 % in Switzerland and Austria (Benetka et al., 2004; 
Kummrow et al., 2005).  
Apart from the different serotypes, there are also two pathotypes or virulence variants. First 
there is the mild, mostly unapparent enteric feline coronavirus (eFCoV). Almost all Swiss cats 
and 17 % of the British cats are seropositive. Second, there is the systemic, highly lethal 
feline infectious peritonitis virus (FIPV). Approximately 5 % of the seropositive cats 
eventually develop FIPV (personal communication Dr Addie). This implies that 1 to 5 % of 
the European cat population is a potential victim of this infection.  
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Table 1: List of the currently known coronaviruses (adapted from Siddell & Snijder, 2008). 
 
CoV group  species strains or biotypes abbreviation 
Group 1  Canine coronavirus Canine coronavirus CCoV 
 Feline coronavirus (Enteric) feline coronavirus  (e)FCoV 
  Feline infectious peritonitis virus FIPV 
 Human coronavirus 229E Human coronavirus 229E HCoV-229E 
  Human coronavirus NL63 HCoV-NL63 
 Porcine epidemic diarrhea virus Porcine epidemic diarrhea virus PEDV 
 Transmissible gastroenteritis virus Transmissible gastroenteritis virus TGEV 
  Porcine respiratory coronavirus PRCoV 
 Bat coronavirus Bat coronavirus BtCoV 
 Rabbit coronavirus Rabbit coronavirus RbCoV 
Group 2a Canine respiratory coronavirus  Canine respiratory coronavirus 4182 CRCoV-4182 
 Bovine coronavirus Bovine coronavirus  BCoV 
 Human coronavirus OC43 Human coronavirus OC43 HCoV-OC43 
  Human coronavirus HKU1 HCoV-HKU1 
 Human enteric coronavirus Human enteric coronavirus HECoV 
 Murine hepatitis virus Murine hepatitis virus JHM MHV-JHM 
  Murine hepatitis virus A59 MHV-A59 
 Porcine hemagglutinating 
encephalomyelitis virus 
Porcine hemagglutinating 
encephalomyelitis virus 
HEV 
 Puffinosis coronavirus Puffinosis coronavirus PCoV 
 Rat coronavirus Rat coronavirus RtCoV 
  Sialodacryoadenitis SDAV 
Group 2b Severe acute respiratory syndrome 
virus 
Severe acute respiratory syndrome 
virus 
SARS-CoV 
 Bat coronavirus Bat coronavirus 133/2005 BtCoV-133/2005 
Group 3  Infectious bronchitis virus Infectious bronchitis virus  IBV 
 Pheasant coronavirus  Pheasant coronavirus PhCoV 
 Turkey coronavirus  Turkey coronavirus TCoV 
 
 
1.1.2 Pathogenesis of the feline coronaviruses 
 
Feline enteric coronavirus (eFCoV) 
Feline enteric coronavirus is a ubiquitous, worldwide intestinal virus (Pedersen et al., 1981; 
2004). The importance of eFCoV as a primary intestinal pathogen is however minimal as the 
infection is usually unapparent or manifested by a transient gastroenteritis (Pedersen et al., 
1981; Hayashi et al., 1982; Pedersen et al., 2008). 
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The virus is spread by fecal-oral route. eFCoV has a tropism for enterocytes in the epithelium 
of intestinal villi (Pedersen et al., 1981). During the course of a natural infection some 
eFCoVs may be detected in the blood, but much less than seen with FIPV (Meli et al., 2004). 
Further, virus can also be detected in mesenteric lymph nodes, spleen, bone marrow, tonsils 
and thymus (Pedersen et al., 1984; Herrewegh et al., 1995; Gunn-Moore et al., 1998). 
Obviously, infection leads to systemic disease. Virus shedding occurs within a week after 
exposure and remains at high levels for 2 to 10 months. Then, it evolves into one of three 
excretion patterns: some cats shed the virus persistently, some have periods of shedding 
interlaced with periods of non-shedding (recurrent shedders) and some just cease shedding 
(Pedersen et al., 2008). Immunity generated upon infection is slow to develop, variable in 
strength and duration and lacks memory explaining why reinfection can occur easily (Addie 
et al., 2003; Pedersen et al., 2008).  
The importance of eFCoV lies in its potential to mutate in vivo into a biotype that causes the 
highly fatal disease, feline infectious peritonitis (Poland et al., 1996; Vennema et al., 1998). 
Mutations that might be responsible for the FIPV biotype were identified in the 3c gene 
and/or to a lesser extent in the 7b gene (Vennema et al., 1998). Pedersen claims that 
eFCoVs and FIPVs can be discriminated based on the 3c gene (Pedersen, 2009). The 
acquisition of an enhanced macrophage tropism is also essential for the development of FIP. 
Rottier et al. showed that the C-terminal domain of the spike protein is the determinant for 
efficient macrophage infection and that it distinguishes eFCoV strains from FIPV strains 
(2005). Taken together, these results suggest that the mutational transition between eFCoV 
and FIPV requires mutations in both the spike and the accessory gene(s). The higher the 
level of eFCoV replication, the more chance a mutation occurs and the cat develops FIP. 
Therefore, FIPV arises mostly during primary eFCoV infection and in kittens (Pedersen et al., 
2008).  
 
Feline infectious peritonitis virus (FIPV) 
The evolution from eFCoV to FIPV is accompanied by the acquisition of an enhanced 
macrophage tropism (Stoddart & Scott, 1989; Rottier et al., 2005). Circulating blood 
monocytes are the predominate target cells for FIPV. These are migratory cells and after 
infection, they may pass through the endothelium of small vessels and initiate infection in 
various parts of the body (Fenner et al., 1974; Weiss & Scott, 1981). Targets are the 
mesenteric lymph nodes, serosal surfaces of the gut and organs, and to a lesser extent the 
pleura, and the omentum. Some virus also appears to reach the meninges, the ependyma 
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surrounding the ventricles, the spinal cord, and the uveal tract and retina of the eyes 
(Pedersen, 2009).  
Subsequent inflammatory reactions at these locations can lead to intravascular coagulation 
and vasculitis (Weiss et al., 1980). Circulating immune complexes sediment in small vessels 
leading to complement activation. This triggers vasodilatation and the release of chemotactic 
mediators which attract monocytes. Therefore, inflammation is associated with expanding 
cycles of monocyte/macrophage infection, virus replication and release. Released virions in 
turn infect the attracted macrophages and the infection site expands dramatically. This 
reaction is centered on small venules and the result is a lesion called pyogranuloma 
(Pedersen & Boyle, 1980; Jacobse-Geels et al., 1980; 1982). Further, FIPV-induced vasculitis 
is characterized by macrophage-dominated circular infiltrates in small veins and focal 
infiltrates in larger veins. Activated monocyte attachment to endothelial cells, subsequent 
emigration and perivenous macrophage accumulation cause the destruction of the vascular 
basal lamina through the secretion of matrix metalloproteinase B. This results in vasculitis 
and possible leakage (Kipar et al., 2005).  
There are two forms of FIPV: wet/effusive FIPV and dry/non-effusive FIPV. Wet/effusive 
FIPV is characterized by leakage of protein-rich fluid into the peritoneal cavity or (less 
frequent) the pleural or cardiac cavity. Effusion in the peritoneal cavity leads to the typical 
physiology of a skinny FIP cat with a swollen abdomen. Often dry FIPV eventually evolves to 
wet FIPV when the immune system totally collapses. When a cat develops dry FIPV, it is 
believed that the animal is partially protected against infection by the cellular immune 
system. 
Virus specific antibodies fail to control or clear the infection despite the presence of high 
titers (Paltrinieri et al., 1998). They even seem to facilitate infection. First, this may be 
explained by the occurrence, at least in vitro, of antibody-dependent enhancement (ADE) of 
infection of macrophages (Hohdatsu et al., 1991; Olsen et al., 1992). The in vivo relevance 
of ADE of infection is questioned as in natural infections of seropositive animals no 
enhancement of infectivity seems present. Seropositive cats showed a normal FIP 
progression and did not die more rapidly (Addie et al., 1995). Second, antibodies mediate 
internalization of surface expressed viral proteins on infected cells, making the infected 
monocyte invisible for the immune system (Dewerchin et al., 2007; Cornelissen et al., 2007). 
Further, despite the presence of antibodies and complement, there is no antibody-dependent 
complement-mediated lyses of infected monocytes (Cornelissen et al., 2009). 
The humoral immune response is obviously not capable of successfully fighting the infection. 
Protection or partial protection against FIPV is therefore supposed to be cell-mediated. It is 
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suggested that the efficacy of early T-cell responses critically determines the outcome of 
infection (de Groot-Mijnes et al., 2005). Nevertheless, the cell-mediated immune system is 
also targeted by the FIP virus. In FIPV infected cats, T-cell depletion occurs in both lymphoid 
tissues and in the blood (Kipar et al., 2001; Paltrinieri et al., 2003; de Groot-Mijnes et al., 
2005). This T-cell depletion is caused by a soluble factor, possibly glycoprotein 7b (see 
further in 1.1.3.2), present in the supernatant of infected cells, through apoptosis 
(Haagmans et al., 1996). Much remains to be learned on cell-mediated immunity in FIPV 
infection. This knowledge is indispensible for a better understanding of the pathogenesis of 
FIPV.  
 
1.1.3 Structure of the virion 
 
1.1.3.1 Genomic organization 
 
FIPV contains an extremely large positive-stranded RNA genome of 29 125 nt in length 
excluding the poly(A) tail, with a 5’ cap (Fig. 1) (Dye & Siddell, 2005). The replicase gene 
encompasses two thirds of the genome and consists of 2 open reading frames (ORFs), ORF 
1a and 1b. ORF 1a encodes polyprotein pp1a, while ORF 1a and 1b together encode pp1ab 
through a ribosomal frameshift during translation of genomic RNA (Brierley, 1995). The 
polyproteins are processed by viral proteinases to 16 non-structural proteins (Ziebuhr et al., 
2000). These replicase proteins assemble to form the membrane-bound replication-
transcription complex (RTC) in the cytoplasm of the cell (Gosert et al., 2002). ORFs 2, 4, 5 
and 6 encode the structural proteins that are incorporated in the virion. ORFs 3 and 7 
encode the accessory proteins. Expression of genes 2-7 occurs from a nested set of 
subgenomic mRNAs with a common leader sequence (Fig. 1). mRNA synthesis is controlled 
by a transcription-regulatory sequence (TRS) (Haijema et al., 2007). 
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Figure 1: Genomic organization of FIPV with the leader sequence, 8 ORFs and the poly(A) tail. The 
nested set of 7 subgenomic mRNAs is also depicted. 
 
1.1.3.2 Viral proteins 
 
 
 
 
 
 
 
 
 
 
Figure 2: Schematic representation of a FIPV virion (Dewerchin, 2008). 
 
Spike protein  
The large petal-shaped spikes determine the characteristic morphology of the coronavirus 
virion. These protrusions of approximately 20 nm are formed by trimers of the monomeric 
spike (S-) protein (Fig. 2). The nascent S polypeptide is directed to the ER by a signal 
peptide (Masters, 2006). During maturation in the ER, S is heavily glycosylated and the 
~150-200 kDa monomers form trimers. S-trimers are incorporated in virions by associating 
with the membrane protein during the budding process in the ER-to-Golgi intermediate 
compartment (ERGIC).  
slippery sequenceleader sequence poly(A) tail
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The spike protein is responsible for diverse interactions that are critical for establishing and 
maintaining infection in the host. First, the spike protein determines host range by inducing 
viral entry after specific interaction with its receptor (Dye et al., 2007). Second, the spike 
protein contains epitopes important for antibody neutralization and on the other hand for 
various immune evasion processes, namely antibody-mediated enhancement of infection and 
antibody-induced internalization of viral proteins expressed in the plasma membrane 
(Hohdatsu et al., 1991; Hohdatsu et al., 1994; Dewerchin et al., 2006).  
Coronavirus spike proteins are class I fusion proteins and they are primed for fusion through 
cleavage with furin (Bosch et al., 2003). However, the group 1 coronaviruses, including FIPV, 
are generally considered to carry uncleaved S-proteins. Regan et al. claim that the FCoV S-
protein is cleaved by cathepsins (2008), while de Haan et al. state that cathepsin cleavage 
does not occur (2008). Instead, they showed that some specific group 1 coronavirus spikes 
carried a furin enzyme recognition motif that could be lost by a single mutation upon culture 
adaptation resulting in a heparin binding motif (de Haan et al., 2008). 
 
Envelope protein 
The envelope (E-) or small membrane protein is a small protein of approximately 10 kDa that 
is expressed in virions and infected cells in small amounts. E-protein is an integral membrane 
protein whose highly hydrophobic N-terminal two thirds region is a transmembrane domain 
that spans the bilayer twice (Fig. 2) (Maeda et al., 2001). The C-terminal region extends into 
the virion interior. Through its interaction with M-protein, E-protein is necessary for envelope 
formation and budding (Lim & Liu, 2001). To fulfil its task, E-protein is retained in the pre-
Golgi membranes of the intermediate compartment, prior to virus budding in the ERGIC. 
 
Membrane protein 
The coronavirus membrane or M-protein is a protein, ranging from 20-38 kDa according to 
glycosylations, that spans the viral envelope three times, leaving only small parts ‘hanging 
out’ on either site of the membrane (Fig. 2) (Rottier et al., 1986). M is supposed to be the 
determinant for the intracellular budding site. It is localized in the Golgi region which 
correlates with the ER to Golgi intermediate compartment (ERGIC) being the budding site 
(Rottier & Rose, 1987). By associating with the S-protein, the M-protein retains it at the 
budding site and prevents transport of S to the plasma membrane (Opstelten et al., 1995). 
Probably the M-protein may be involved in viral entry in monocytes/macrophages as there 
are neutralizing antibodies against M (Kida et al., 2000). Upon addition of antibodies, 
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surface-expressed M-protein is internalized (like described above for S-protein), so this 
protein is also involved in this immune evasion process (Dewerchin et al., 2006). 
 
Nucleocapsid protein 
N-protein is a 42.7 kDa protein, highly phosphorylated on serine residues (Spaan et al., 
1988). After phosphorylation in the cytoplasm, the proteins become associated with 
intracellular membranes (Stohlman et al., 1983). N-proteins interact with viral RNA and 
stabilize the helical symmetric nucleocapsid structure that is packaged into virions (Fig. 2) 
(Zuniga et al., 2007). Antibodies against N-protein were able to block viral RNA transcription, 
suggesting another potential role for N-protein in infection (Compton et al., 1987; Baric et 
al., 1988). This is confirmed by the co-localization of N-protein with the replication complex 
in the sites of RNA synthesis at early times post-infection (Denison et al., 1999). Next to its 
presence at the replication site, N also accumulates in the Golgi region near the budding site 
and co-localizes with the viral spike (Stertz et al., 2007). N-M interactions might also be 
important for viral structure (Sturman et al., 1980).   
 
Accessory proteins 
All coronaviruses encode a number of accessory proteins in group-specific genes, that are 
thought to be dispensable for replication in cell culture, but apparently provide a selective 
advantage in vivo (de Haan et al., 2002; Ortego et al., 2003). For FIPV 79-1146, two regions 
of the genome have been identified that encode putative accessory proteins. They are 
known as ORFs 3abc and 7ab (Fig. 1). The gene products and function of ORF 3abc remain 
to be identified. The predicted size of the protein encoded by ORF 7a is 11 kDa. ORF 7b is 
known to encode a non-structural, secretory viral glycoprotein ‘gp7b’  of 26.5 kDa (Vennema 
et al., 1992). This secretory factor might be responsible for the observed induction of T-cell 
depletion during FIPV pathogenesis (Haagmans et al., 1996). The importance of the 
accessory proteins in FIPV pathogenesis was illustrated by the development of a live, 
attenuated vaccine by deletion of the group-specific genes from FIPV 79-1146 (Haijema et 
al., 2004).  
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1.1.4 Replication cycle 
 
1.1.4.1 Virus entry 
 
The process of virus entry, including binding to virus receptor(s), internalization into the cell 
and eventually uncoating or release of the genome in the cytosol will be discussed in detail 
in part 1.2 (Fig. 5, step 1-3). After release of the genome, replication and transcription can 
start in the cytoplasm of the infected cell. Replication is the process whereby genome-sized 
RNA, which also functions as mRNA, is produced. Transcription is defined as the process 
whereby subgenome-sized mRNAs are produced (Sawicki et al., 2007). 
  
1.1.4.2 Replication 
 
The 16 non-structural proteins encoded in ORF 1 are directly translated upon ‘arrival’ in the 
cytoplasm (Fig. 3 & Fig. 5, step 4). Together with viral N-protein and, possibly, cellular 
proteins, they assemble into the membrane-bound replication-transcription complex (RTC). 
In these complexes the production or copying of the genome- or subgenomic length RNA 
occurs. RTCs accumulate at perinuclear regions and are associated with double-membrane 
vesicles (Brockway et al., 2003; Snijder et al., 2006) (Fig. 5, step 5). The non-structural 
proteins include proteinase, polymerase and helicase (Snijder et al., 2003). The RTC copies 
the genome either continuously into genome-length template or discontinuously into various 
subgenome-length minus-strand templates. The minus-strand genomic template is used for 
genome synthesis (Fig. 4) (Sawicki et al., 2007).  
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Figure 3: Translation of the non-structural proteins encoded by open reading frame (ORF) 1. 
 represents positive-strand RNA.  represents protein.  pp stands for polyprotein. 
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1.1.4.3 Transcription 
 
Coronavirus transcription is characterized by the generation of a nested set of mRNAs, with 
each mRNA having the identical “leader” sequence (Fig. 1). During subgenome-length 
minus-strand mRNA synthesis, the nested set of mRNAs is generated through discontinuous 
extension (Sawicki & Sawicki, 1995). Each subgenome-length mRNA contains a 5’ leader 
sequence corresponding to the 5’ end of the genome. This 5’ leader is joined to a mRNA 
“body”, which represents sequences from the poly(A) stretch to a position that is upstream 
of each genomic ORF encoding a structural or accessory protein (cluster). The junction 
between leader and the mRNA body in each mRNA is called the transcription regulatory 
sequence (TRS) of about 10 nucleotides (Fig. 4) (Sawicki et al., 2007). The process of 
discontinuous transcription during minus-strand synthesis starts by the recruitement of the 
components of a functional RTC and the initiation of synthesis at the 3’ end of the genomic 
RNA until the first TRS is encountered. Then, some RTCs will just continue the synthesis, 
while a fraction will stop strand synthesis and relocate to the 5’ end of the genome to the 
leader. As there are 7 TRSs, there are 7 minus-strand mRNAs synthesized including the 
genomic mRNA template (Fig. 5, step 6). When the nested set of minus-strand subgenomic 
mRNAs is generated, positive-strand genomic and subgenomic mRNAs are produced as 
templates for translation (Fig. 4).  
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Figure 4: Genome replication and transcription.  represents minus-strand RNA. 
 represents positive-strand RNA.  
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1.1.4.4 Translation 
 
Viral (sub)genomic mRNAs resemble host mRNAs and are recognized by the host translation 
machinery (Fig. 5, step 7). The initiation of translation occurs through ribosomal scanning 
starting at the 5’ cap structure provided by the 5’ leader to an AUG codon (Kozak, 1989). 
Protein synthesis then continues until a termination codon is encountered and the ribosome 
complex detaches from the RNA. Coronavirus mRNAs are structural polycistronic but can be 
both functional monocistronic as polycistronic, the latter when a coding sequence contains 
more than one translational active ORF. 
Little is known about the regulation of translation. For functionally monocistronic RNAs, the 
level of protein expression depends on the amount of mRNA and therefore transcription. 
However, there are some indications that the leader sequence may influence translation 
levels (Luytjes et al., 1995). For the polycistronic mRNAs the mechanisms are more evident. 
The best known example is the ribosomal -1 frameshift in ORF 1 made by one third of the 
ribosomes on the slippery sequence AAAUUUC (Brierley et al., 1987; Bredenbeek et al., 
1990).  
N-proteins are expressed in the cytosol, while S, E and M are co-translationally embedded in 
the membranes of the rough ER.    
 
1.1.4.5 Budding 
 
Positive-strand genomic RNA interacts with N-protein in the cytosol to form the nucleocapsid 
(Fig. 5, step 7b). The viral structural proteins S, E and M migrate from the membranes of the 
ER to the ER-to-Golgi intermediate compartment (ERGIC). The presence of the E-protein is 
essential for efficient assembly (Lim & Liu, 2001). In the ERGIC, the nucleocapsid is 
surrounded by an envelope containing viral proteins through the interaction between M- and 
N-protein as the budding process proceeds (Fig. 5, step 8).  
It has not been established how the virus spreads to other cells. Egress via exocytosis could 
occur at lower levels of virus production and leaves the infected cell intact. Replication could 
also result in lysis and destruction of the host cells, releasing all produced virions (Baker, 
2008).    
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Figure 5: Replication cycle of FIPV. 1-2 Binding and internalization. 3 Release of the genome into 
the cytosol. 4 Translation of the 16 non-structural proteins. 5 Assembly of the RTC. 6 Genome 
synthesis and transcription to mRNAs. 7 Translation mRNAs to proteins. 7b Association of N 
proteins and genome to form nucleocapsid. 8 Accumulation of viral proteins in the ERGIC for 
budding into new virions. 9 Transport through the secretory pathway. 10 Release of progeny virus 
(Dewerchin, 2008).  
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1.1.5 Prevention and treatment 
 
1.1.5.1 Prevention 
Many attempts were made in the past to induce protective immunity against the 
development of FIP in cats through vaccination. Most of these attempts failed and even led 
to accelerated disease. The enhancement of disease was probably due to the induction of a 
humoral immune response rather than a protective, cellular immune response. The first and 
only commercially marketed vaccine is Primucell FIP®, a temperature-sensitive mutant of 
FIPV that is applied as a modified live vaccine. It induces a strong mucosal immune response 
(IgA) and a cell-mediated immune response measured by lymphocyte proliferation (Gerber 
et al., 1990). The vaccine does not offer full protection and needs to be administered 
frequently. The usefulness of this vaccine is being questioned as it only works when 
administered to seronegative cats. Further promising results - also with a modified live FIP 
vaccine - were obtained by Haijema et al. through vaccination with deletion mutants of a 
serotype II FIPV strain lacking the group specific genes 3a-c or 7ab (2004). The mutants 
replicate well in cell culture and show an attenuated phenotype in cats. Vaccinated cats are 
protected against a lethal homologous challenge. An extension of these data with challenges 
with serotype I strains are being expected. 
Another strategy to prevent or at least minimize FIPV infection is reducing the FCoV infection 
pressure in households. This can be achieved by separating seronegative from seropositive 
animals and applying high hygiene standards.   
 
1.1.5.2 Treatment 
As FIP is an immune-mediated disease, treatment is mostly aimed at controlling or 
modulating the immune response. Glucocorticoids are often used in an attempt to slow 
disease progression but do not provide a cure. The antiviral drug ribavirin, a nucleoside 
analogue, is active against FCoV in vitro but cannot be used to treat cats as it causes severe 
side effects when administered in vivo (Weiss et al., 1993). In cats treated with a 
combination of human interferon-α and Propionibacterium acnes, the mean survival time 
was prolonged for a couple of days (Weiss et al., 1990). The latest strategy in the search for 
an effective treatment is combining feline interferon-ω with glucocorticoids. While some 
results indicate prolonged survival, others did not (Ishida et al., 2004; Ritz et al., 2007). 
Clearly, there is no effective treatment available for FIPV. When a cat is diagnosed with FIP, 
it will most likely die.  
Introduction 
 27
The development of an effective vaccine or treatment for FIP remains a huge challenge in 
CoV research.                                
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1.2 VIRUS ENTRY 
 
1.2.1 Introduction 
 
Essential for a virus to cause infection is gaining entry into a cell. For a number of steps in 
the viral replication cycle, the virus relies on cellular factors and mechanisms to guide the 
way. Virus entry is a multistep process during which each step is pre-programmed and 
tightly regulated in space and time (Smith & Helenius, 2004). Virus entry starts with 
recognition of the target cell through cell surface receptors or attachment factors. These can 
vary from being abundant and ubiquitous to rare and cell specific. Receptors often determine 
the cell type that can be infected. They can be just binding receptors that capture the virus 
or they can be ‘true’ receptors that also lead the virus across the plasma membrane (Smith & 
Helenius, 2004). The internalization of the virus into the cell is the second step in the entry 
process. The viral membrane can fuse directly with the host cell plasma membrane or the 
virus particle can be endocytosed in a vesicle pinched off the plasma membrane. Upon direct 
fusion, the viral genome is delivered directly into the cytosol. Upon endocytosis, a further 
uncoating of the virion is necessary (Lanzrein et al., 1994). Uncoating can be triggered by a 
number of factors, eg interaction with an additional receptor, exposure to low pH or 
reimmersion into a reducing environment (Smith & Helenius, 2004). Uncoating results in 
release of the genome from the vesicle into the cytosol where transcription, and translation 
by the host cell ribosomes can start. For most RNA viruses, no transport to the nucleus is 
required.  
 
1.2.2 Receptors important for group 1 coronaviruses 
 
1.2.2.1 Aminopeptidase N 
  
Aminopeptidase N (APN) or CD13 is a type II metalloprotease that belongs to the M1 family 
of the MA clan of peptidases (Rawlings & Barret, 1999). The ‘MA’ clan of peptidases is the 
first (‘A’) clan of metallopeptidases (‘M’). Human APN is an integral membrane protein of 
approximately 967 amino acids (aa) and 110 kDa (Sjöström et al., 2000). Structural studies 
show that it consists of 7 domains (Fig. 6). Domain I is a short cytoplasmic N-terminal 
domain of only 8 to 10 aa. No signalling sequences have been found in this domain, 
therefore it has been suggested that APN signals over the membrane via an auxiliary 
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membrane protein (Sjöström et al., 2000). Domain II is a single transmembrane part. The 
large cellular ectodomain contains a stalk region (domain III) that ‘carries’ the four globular-
like domains (domain IV to VII). The Zn-dependent active catalytic site for the enzyme 
preferentially releases N-terminal neutral or basic residues of oligopeptides and is located 
between domain V and VI. In most species aminopeptidase N forms homodimers (Sjöström 
& Norén, 1982). The interaction between monomers is non-covalent and localized within 
domains V to VII. The charged C-terminal helix at domain VII might be involved in 
dimerisation. Dimerisation occurs before Golgi-associated processing, suggesting that this 
might be crucial for the transport of the intracellular high-mannose form of APN out of the 
ER (Danielsen, 1990a,b). In the Golgi, APN is N- and O-glycosylated (Fig. 6) (Sjöström et al., 
2000).        
 
 
 
 
 
 
 
 
 
 
Figure 6: Model of aminopeptidase N. The monomer consists of 7 domains and is highly 
glycosylated. APN forms non-covalently linked homodimers. 
 
Aminopeptidase N is both ubiquitous and multifunctional (Luan & Xu, 2007). It is present in 
a number of organs, tissues and cell types including endothelial and epithelial cells, and 
fibroblasts and leukocytes. It is, among other processes, related with tumorigenesis, 
trimming of antigen and the process of antigen presentation, and serves as a receptor for 
several pathogens. The function that APN plays, depends on the location and tissue of origin 
(Nocek et al., 2007). In monocytes, APN is linked with signal transduction pathways. 
Crosslinking of APN leads to an increase in intracellular Ca2+ ions and phosphorylation of 
mitogen-activated (MAP) kinases. Phosphatidyl-inositol 3 kinases (PI3K) are linked with this 
signalling cascade as well (Navarrete Santos et al., 2000). APN can also functionally 
associate with receptors for immunoglobulin G (FcγRs) and may act as a signal regulator of 
FcγR function (Mina-Osorio & Ortega, 2005). 
N
C
I
II
III
IV
V VI
VII
+
+
-- N-linked glycosylation site
O-linked glycosylation site
protease active site
possible dimerization area+--+
N
C
Chapter 1 
 
 30 
Human aminopeptidase N also mediates human cytomegalovirus infection in lung fibroblasts 
by binding, and possibly internalizing, virus to these susceptible cells (Söderberg et al., 
1993).  
 
Most group 1 coronaviruses can use aminopeptidase N of their natural host as receptors (see 
further in 1.2.3.1).  
 
1.2.2.2 DC-SIGN and L-SIGN 
  
The dendritic cell-specific ICAM-3 grabbing nonintegrin (DC-SIGN) or CD209 and its close 
relative DC-SIGNR (DC-SIGN related) or L-SIGN (liver/lymph node-specific) or CD209L are 
type II transmembrane proteins and members of the C-type lectin family. DC-SIGN and L-
SIGN consist of four domains: a cytoplasmic domain necessary for signalling with a di-leucine 
motif for internalization and a tri-acidic cluster for targeting to proteolytic vacuoles, a single-
spanning transmembrane region, a region with a series of seven and a half repeats of 23 aa 
and a carbohydrate-recognition domain (CRD) (Fig. 7) (Snyder et al., 2005). The 
extracellular domain of each receptor is a tetramer of approximately 145 kDa stabilized by an 
α-helical stalk or neck. DC-SIGN and L-SIGN recognize specifically high-mannose 
carbohydrates through the CRDs. The binding depends on Ca2+ and can be inhibited by 
mannan, mannose and EGTA. When the CRDs are clustered in the tetrameric extracellular 
domain, their arrangement provides a means of amplifying specificity for multiple glycans on 
host molecules targeted by DC-SIGN and L-SIGN (Mitchell et al., 2001).                                                   
                                                                                
Figure 7: Structure of the extracellular domains of DC-SIGN. A) Model of tetrameric DC-SIGN with 
the carbohydrate-recognition domain (CRD) and the α-helical stalk. B) Predicted model based on 
homology modelling and sequence-based prediction of secondary structure elements showing the 
repeats in the α-helical stalk (adapted from Snyder et al., 2005). 
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DC-SIGN is highly expressed in monocyte- and CD34+-derived dendritic cells (DCs) and in 
subsets of mature and immature DCs at various sites. L-SIGN is not expressed by these cells 
but by endothelial cells in lymph nodes, liver and lungs. Both DC-SIGN and L-SIGN act as cell 
adhesion and pathogen-recognition receptors (Khoo et al., 2008). As pathogen recognition 
receptors, both lectins recognize a wide range of micro-organisms. DC-SIGN captures viruses 
like human immunodeficiency virus 1 (HIV1), Ebola virus, hepatitis C virus, Dengue virus, 
cytomegalovirus and severe acute respiratory syndrome coronavirus (Alvarez et al., 2002; 
Geijtenbeek et al., 2000; Halary et al., 2002; Lozach et al., 2003; Pöhlmann et al., 2003; 
Tassaneetrithep et al., 2003; Marzi et al., 2004; Jeffers et al., 2004; Yang et al., 2004). 
Unlike L-SIGN that seems to function solely as an adhesion receptor, DC-SIGN is thought to 
mediate endocytosis next to adhesion, more specifically as a recycling receptor that releases 
its ligand at endosomal pH (Khoo et al., 2008). Both DC- and L-SIGN might also function as 
antigen-capturing receptors that bind antigens at the cell surface and internalize them into a 
low pH endosomal compartment for release and degradation for loading onto major 
histocompatibility complex molecules (Khoo et al., 2008).  
The interaction between DC-SIGN and some viruses is well studied. DC-SIGN captures HIV1 
from the periphery to transport it via unsusceptible DCs into the secondary lymphoid organs 
where it is transmitted to susceptible T-cells to enhance infection in trans (Geijtenbeek et al., 
2000). For hepatitis C virus, both DC-SIGN and L-SIGN function as attachment factors 
possibly to target virus to the site of replication. DC-SIGN might facilitate entry into DCs in 
cis. While binding to L-SIGN on endothelial cells in the liver, might concentrate the virus in 
this target organ and enhance infection in trans (Lozach et al., 2003; Pöhlmann et al., 2003).  
 
Some group 1 coronaviruses can interact with DC-SIGN or L-SIGN (see further in 1.2.3.1).  
 
1.2.3 Receptor use by different coronaviruses 
 
1.2.3.1 Group 1 coronaviruses 
 
Feline coronaviruses (FCoV) 
Feline aminopeptidase N (fAPN) can serve as a receptor for feline coronaviruses as well as 
canine, porcine and human coronaviruses. This was concluded after the observation that 
transfection with cDNA coding for fAPN isolated from a feline cell line, led to infection of non-
susceptible cells (Tresnan et al., 1996). However, the efficiency of inducing infection was 
different between FCoV serotype I and II strains. Later, Hohdatsu et al. explained this 
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difference by showing that fAPN was only a receptor for FCoV serotype II, but not serotype I 
(1998). This study was based on the capability of a monoclonal antibody (R-G-4) to block 
infection of various cell lines with type II FCoV strains, but not type I strains. Dye et al. 
confirmed the inability of type I feline coronavirus spike proteins to recognize 
aminopeptidase N as a receptor on cell lines (2007).  
Different regions of fAPN are involved in the interaction with different viruses. According to 
Hegyi & Kolb, aa 670 to 840 are necessary for the FCoV and transmissible gastroenteritis 
virus (TGEV) receptor function whereas aa 135 to 297 are essential for the human 
coronavirus 229E (HCoV-229E) receptor function (1998). Tusell and coworkers also 
performed a mutational analysis to refine the knowledge on aa regions of APN that are 
determining viral host range (2007). Three small, discontinuous regions in fAPN determine 
the host ranges of FCoV, TGEV, CCoV and HCoV-229E. They are located from aa 288-290, aa 
732-746 and aa 764-788. The first region from aa 288-290, is essential for HCoV-229E. TGEV 
requires the second region from aa 732-746, while CCoV and FCoV require both the second 
and the third region from aa 732-746 and from aa 764-788. The monoclonal antibody (mAb) 
R-G-4 produced by Dr Hohdatsu can block infection with all these different viruses (Hohdatsu 
et al., 1998). The antibody binds to an epitope within the region from aa 251-582 which 
correlates with domain V of APN (Tusell et al., 2007). This would imply that the three 
discontinuous regions determining the host range lie closely together on the folded protein. 
These studies were all performed using APN sequences obtained from a feline cell line. 
Rottier et al. studied the blocking effect of mAb R-G-4 on bone marrow-derived macrophage 
infection and saw a reduction from approximately 33 up to 3 % (2005). On the in vivo target 
cells, monocytes, the entry of FCoV has not been studied. Recently, Regan & Whittaker 
claimed that mAb R-G-4 also significantly reduced infection of monocytes (2008). Further, 
the expression level of fAPN is increased in macrophages of FIP cats. In vitro, replication of 
FIPV in macrophages leads to tumour necrosis factor α (TNF-α) production, which 
subsequently up regulates the expression of fAPN. Possibly this induces an enhanced 
susceptibility to infection. When there is ADE of FIPV infection, the expression of TNF-α and  
the upregulation of APN are even stronger (Takano et al., 2007). 
 
For the FCoVs, expression of human DC-SIGN in Crandell feline kidney cells induced an 
increase of infection that was blocked by mannan, a competitor of DC-SIGN binding. Further 
infection of feline monocytes, the in vivo target cell, was strongly reduced by mannan 
according to Regan & Whittaker (2008). 
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Canine coronavirus (CCoV) 
The entry of canine coronavirus is not extensively studied but it is known that CCoV binds to 
canine APN (Benbacer et al., 1997).  
 
Human coronaviruses (HCoV) 
Human coronavirus 229E (HCoV-229E) binds to human APN (hAPN) on human fibroblasts 
(Yeager et al., 1992). In human fibroblasts, APN is located in the raft fraction of the 
membrane (Nomura et al., 2004). After binding, receptor/virus complexes relocate to the site 
of internalization. Binding of HCoV-229E to hAPN may trigger conformational changes in the 
viral spike necessary to mediate internalization (Breslin et al., 2003). The region between 
amino acids 288-295 of hAPN is crucial for the HCoV-229E receptor function. Substitution of 
this region with a region originating from porcine APN (pAPN) and introducing an N-linked 
glycosylation site abolished recognition of HCoV. It is suggested that differences in 
glycosylation between coronavirus receptors from different species are critical for species 
specificity (Wentworth & Holmes, 2001). On the spike protein, the domain between aa 417-
547 is probably required for binding of HCoV-229E to the hAPN receptor (Bonavia et al., 
2003). 
HCoV-229E can bind and probably enter cells expressing L-SIGN via this receptor but there is 
no uniform cytoplasmic expression of viral proteins nor release of infectious viral particles 
from these cells (Jeffers et al., 2006). 
 
Human coronavirus NL63 (HCoV-NL63) is the only group 1 coronavirus that has not been 
linked with APN. It uses the severe acute respiratory syndrome (SARS) coronavirus receptor 
angiotensin-converting enzyme (ACE) 2 and possibly also DC-SIGN (Hofmann et al., 2005; 
2006). NL63 S-protein has a weaker interaction with the ACE2 receptor than SARS-CoV. The 
ACE2 binding site is located between residues 190 and 739 in the C-terminal part of the S1 
subunit of the spike protein (Hofmann et al., 2006; Mathewson et al., 2008). Lin et al. 
(2008) specified this information by mapping a minimal receptor-binding domain of 141 
residues between aa 476-616 in the spike protein. In this region 15 critical residues were 
identified: C497, Y498, V499, C500, K501, R518, R530, V531, G534, G537, D538, S540, 
E582, W585 and T591. These critical residues are clustered in three separate regions and 
may represent three receptor-binding sites. In ACE2, residue 354 is crucial for NL63 binding 
(Li et al., 2007). 
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HCoV-NL63 depends on ACE2 for infectious entry, but expression of DC-SIGN or L-SIGN 
slightly augments infection of susceptible cells. Expression of DC-SIGN in non-susceptible 
cells is however not sufficient to enable entry in these cells (Hofmann et al., 2006).  
 
Porcine coronaviruses 
Porcine aminopeptidase N is a major receptor for the enteropathogenic coronavirus TGEV. 
TGEV replicates selectively in differentiated enterocytes covering the villi of the small 
intestine (Delmas et al., 1992). Recombinant expression of APN confers infectivity to non-
susceptible cells. Transfected cells are not susceptible for FCoV, nor CCoV, but porcine 
respiratory coronavirus (PRCoV) does use pAPN for entry into the host cells (Delmas et al., 
1993). For TGEV, an additional receptor of approximately 200kDa has been described 
(Weingartl & Derbyshire, 1994). This receptor was not further identified, so its role in the 
entry process of other coronaviruses could not be examined.  
pAPN also functions as a receptor for porcine epidemic diarrhoea virus (PEDV) because 
transfection of non-susceptible cells with pAPN, led to infection and neutralizing antibodies 
against pAPN blocked infection (Oh et al., 2003; Li et al., 2007). 
 
For both bat coronavirus and rabbit coronavirus, receptor use has not been studied. 
 
1.2.3.2 Other important coronaviruses 
 
Mouse hepatitis virus (MHV) 
Mouse hepatitis virus (MHV) is one of the best studied viruses in coronavirus group 2. The 
receptor for MHV-A59, a substrain of MHV, belongs to the carcinoembryonic antigen family 
of glycoproteins in the immunoglobulin superfamily. More specifically, the virus binds to the 
carcinoembryonic antigen-related cell adhesion molecule 1a (CEACAM1a) receptor on murine 
cells via the MHV spike protein. It is a glycoprotein with four immunoglobulinlike domains, a 
transmembrane domain and a short cytoplasmic tail. Transfection into non-susceptible cells, 
confers infectivity (Dveksler et al., 1991). Isoform CEACAM1b can also function as an MHV 
receptor but with 10 to 100 times less affinity (Othsuka et al., 1996). The MHV receptor is 
not associated with lipid rafts and virus binding does not require cholesterol (Thorp & 
Gallagher, 2004). The N-terminal part of CEACAM1a is essential for binding and can induce a 
conformational change in the spike protein upon binding (Matsuyama & Taguchi, 2002; Zelus 
et al., 2003; Miura et al., 2004). The induced conformational change transforms the non-
fusogenic S-protein into a fusogenic form.  
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Infectious bronchitis virus (IBV) 
Avian infectious bronchitis virus (IBV) is the prototype for group 3 coronaviruses. IBV not 
only attaches to α2,3-linked sialic acids on erythrocytes, but the presence of these sialic 
acids on target cells determines susceptibility to infection by IBV (Schultze et al., 1992; 
Winter et al., 2006). Probably, sialic acids mediate primary attachment and a second, 
unknown receptor mediates tighter binding and internalization. Infection of ciliated and 
goblet cells in tracheal organ cultures also depends on the presence of sialic acids, 
confirming the in vivo relevance of sialic acid receptors (Winter et al., 2008; Rahman et al., 
2009). For a certain IBV strain, Beaudette, that has an extended host range in cell culture, 
heparan sulphate works together with sialic acids (Madu et al., 2007). This could be due to 
cell culture adaptations that are not relevant in vivo. Previously feline aminopeptidase N was 
also claimed to be capable of mediating IBV entry (Miguel et al., 2002). This was however 
countered by Chu et al., who showed that fAPN could not rescue infection by IBV strain 
Mass41 (2007). The alleged IBV receptor function of fAPN was explained by a low IBV 
susceptibility of feline cells that was however negligible compared to susceptibility of primary 
chick kidney cells.    
 
Severe acute respiratory syndrome virus (SARS-CoV) 
Angiotensing-converting enzyme 2 (ACE2) is a functional receptor for SARS virus (Li et al., 
2003). It is a type I transmembrane protein of 805 amino acids with carboxy-
metalloprotease activity. The proteolytic activity of ACE2 is however not important for SARS-
CoV receptor function. This receptor is present at the primary site for SARS-CoV replication, 
the lungs (Kuiken et al., 2003; Li et al., 2003). The ACE2 binding site is localized in a small 
region in the S1 domain of the spike protein, more specifically in a region of 193 aa between 
residues 318 and 510 (Babcock et al., 2004; Wong et al., 2004). The presence of ACE2 in 
lipid rafts would be important for efficient virus receptor interactions (Glende et al., 2008; Lu 
et al., 2008). SARS-CoV can also interact with L-SIGN and DC-SIGN. This interaction would 
lead to an enhancement of infection in susceptible cells by transmission of virus to 
susceptible cells (Marzi et al., 2004; Yang et al., 2004). Han et al. showed that DC/L-SIGN 
expression could rescue SARS-CoV infection in Hela cells (2007). The interaction between 
SARS-CoV and DC/L-SIGN occurs through glycans on the spike protein, more specifically 
asparagine residues at aa positions 109, 118, 119, 158, 227, 589 and 699 (Han et al., 2007). 
However, it is still unknown if DC/L-SIGN mediates infectious entry in vivo. 
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1.2.4 Virus internalization 
 
1.2.4.1 Direct fusion versus endocytosis 
 
The interaction with cellular receptors is indispensable for viruses to cross the plasma 
membrane. There are two major routes for enveloped viruses to cross the plasma membrane 
and deliver viral genomes in the cytoplasm: fusion with the plasma membrane (referred to 
as direct fusion) or receptor-mediated endocytosis followed by fusion with an intracellular 
vesicle membrane (referred to as endocytosis). The virus-receptor interaction can induce a 
conformational change in the viral fusion protein that exposes a fusion peptide. Fusion 
peptides originally reside in the ectodomain of the fusion protein. Upon binding to the right 
receptor, they are exposed to promote hydrophobic interactions between the viral envelope 
and the plasma membrane of the host cell (Voyles, 2002). The viral envelop is left behind in 
the plasma membrane and the viral nucleocapsid is released in the cytosol (Fig. 8). The 
virus-receptor interaction can however also induce invagination of the plasma membrane 
and the formation of an intracellular vesicle that contains the virus-receptor complex. This 
process of receptor-mediated endocytosis can occur through a number of pathways that are 
shown in Figure 9. Eventually, uptake via endocytosis also leads to a fusion event as 
described above, this time between the viral envelope and the membrane of the intracellular 
vesicle.  
 
 
 
 
 
 
 
 
 
 
 
Figure 8: Virus entry via direct fusion with the plasma membrane.  
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1.2.4.2 Endocytosis pathways 
 
Endocytosis pathways can be divided in two major categories: phagocytosis (the uptake of 
large particles) and pinocytosis (the uptake of fluid and solutes) (Conner & Schmid, 2003). 
Pinocytosis can be further subdivided into macropinocytosis, clathrin-mediated endocytosis, 
caveolae-mediated endocytosis or clathrin- and caveolae-independent endocytosis (Fig. 9). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 9: Overview of all possible endocytosis pathways with the main structural compounds 
involved and the intracellular destination (Dewerchin, 2008).  
 
Phagocytosis  
Phagocytosis is an active and highly regulated process for the uptake of ‘large’ (generally > 
0.5 µm) particles. It participates in several processes such as development, tissue 
remodelling, the immune response and inflammation (Aderem & Underhill, 1999). 
Phagocytosis in mammals is conducted primarily by specialized cells, such as macrophages, 
monocytes and neutrophils (Conner & Schmid, 2003).  
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Formation of phagosomes  
The process is initiated by binding of the ligand to specific cell-surface receptors. This 
triggers a signalling pathway involving activation of the Rho GTPases Cdc42 and Rac that 
induces actin assembly for the formation of lamellipodia. Lamellipodia are membrane 
extentions that zipper up around the ligand and engulf the particle into a phagosome. 
Another GTPase involved in the phagocytic process is dynamin. It is enriched in early 
phagosomes. The exact role of dynamin is unknown but blocking dynamin function arrests 
internalization at the stage of membrane extension around the particle (Gold et al., 1999). 
Phosphatidyl inositol 3-kinase (PI3K) mediates the closing of the lamellipodia and the capture 
in the phagosome. After internalization, actin is depolymerised from the phagosome and the 
vacuole membrane becomes accessible to early endosomes. Through a series of fusion and 
fission events, the vacuolar membrane and its contents mature, followed by fusion with late 
endosomes and ultimately lysosomes to form a phagolysosome (Aderem & Underhill, 1999).   
 
Inhibition of phagocytosis 
Latrunculin B that disrupts actin polymerization can be used to block phagocytosis as it will 
prevent the formation of lamellipodia (Spector et al., 1989). Wortmannin is a PI3K inhibitor 
that can be used as an inhibitor for phagocytosis (Araki et al., 1996). 
 
Macropinocytosis 
Macropinocytosis is a highly controlled and regulated process for the uptake of particles 
generally > 0.2 µm. Macropinocytosis fulfils diverse functions and can be induced in most 
cell types. For example, GTPase Rac and p21-activated kinase (PAK) are activated through 
platelet-derived growth factor-induced macropinocytosis and control directed cell migration 
(Ridley, 2001). Further, dendritic cells sample the extracellular milieu through 
macropinocytosis to fulfil their role in immune surveillance (Mellman & Steinman, 2001).  
 
Formation of macropinosomes  
Like for phagocytosis, Rho GTPases induce actin-rearrangements that form membrane 
protrusions. These protrusions are called membrane ruffles. More specifically, Rac regulates 
the assembly of an actin-nucleating complex at the plasma membrane where the ruffles 
originate from. Besides oriented actin polymerization, ruffling may also require contributions 
from actin-based mechanochemical enzymes, such as myosin. Cytoplasmic microtubules also 
appear to modulate the ruffling (Swanson & Watts, 1995). Unlike for phagocytosis, the 
protrusions do not zipper up along the particle but collapse onto and fuse with the plasma 
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membrane. In this way, large endocytic vesicles are formed, the macropinosomes, that 
sample large volumes of the extra-cellular milieu (Conner & Schmid, 2003). They are 
heterogeneous in size (generally from 0.2 up to 5 µm). During their life span of 
approximately 15 minutes, macropinosomes change from an early endosome-like organelle 
to a late endosome-like organelle, then merge completely into the lysosomal compartment 
(Racoosin & Swanson, 1993).  
 
Inhibition of macropinocytosis 
Latrunculin B, an inhibitor for phagocytosis also blocks macropinocytosis, as they both rely 
on actin polymerization (Spector et al., 1989). Further, as for phagocytosis, PI3K is involved 
in closure of the macropinosomes. In the presence of the inhibitor wortmannin, the formed 
ruffles recede into the cytoplasm (Araki et al., 1996).    
 
Clathrin-mediated endocytosis 
Clathrin-mediated endocytosis (CME) is probably the best studied internalization pathway. 
CME constitutively takes place in all mammalian cells. It is important for the uptake of 
essential nutrients such as cholesterol-laden low-density lipoprotein particles and iron-laden 
transferrin (Schmid, 1997; Brodsky et al., 2001). CME is also crucial for intercellular 
communication during tissue and organ development (Di Fiore & De Camilli, 2001; Seto et 
al., 2002). Further, it is also involved in serum homeostasis and neurotransmission (De 
Camilli & Takei, 1996; Beattie et al., 2000).  
 
Formation of the clathrin-coated vesicle 
CME is initiated by the concentration of high-affinity transmembrane receptors and their 
bound ligands. The ‘coated pits’ of approximately 120 nm are subsequently formed on the 
plasma membrane by the assembly of cytosolic coat proteins (Fig. 11, step 1 & 2). The coat 
proteins consist of clathrin and the assembly proteins. Clathrin is the main assembly unit. It 
is a tree-legged structure formed by three clathrin heavy chains, each with a tightly 
associated light chain (Brodsky et al., 2001). This structure is called a ‘triskelion’ (Fig. 10). 
There are two structurally and functionally different classes of assembly proteins: the 
monomeric assembly protein AP180 (in neuronal cells) or its isoform CALM (clathrin-
assembly lymphoid-myeloid leukaemia) and heterotetrameric adaptor protein (AP) 
complexes, AP1 to AP4. However, only AP2, composed of α-, β2-, µ2- and σ2-subunits, is 
involved in endocytic clathrin-coated vesicle formation (Fig. 10). Clathrin triskelions 
spontaneously self-assemble into lattices. AP2s direct clathrin assembly into curved lattices 
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to the site where cargo is recruited and where ligated receptors are concentrated through a 
direct interaction of AP2 with the receptors (Fig. 11, step 2) (Brodsky et al., 2001). The exact 
role for AP180/CALM is not known but in the absence of this protein fewer vesicles are 
formed and they are less uniform in size (Tebar et al., 1999). Eps15 binds directly to AP2 
and indirectly via epsin to clathrin. Thus, the coat proteins clathrin, AP2, AP180/CALM and 
Eps15 encode all the functions necessary to select cargo and form a vesicle. After the 
formation of the ‘coated pit’, the vesicle is pinched off the membrane and the receptor-ligand 
complexes are transported into the cell (Fig. 11, step 3).  
 
 
 
 
 
 
 
 
 
 
 
                                                                                                         
 
 
 
 
Figure 10: Structure of the main components of clathrin-coated pits: clathrin triskelions and 
adaptor complex 2 (AP2) (clathrin triskelion adapted from 
http://www.bio.indiana.edu/~ybelab/research.html). 
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Figure 11: Clathrin-mediated internalization. 1 Binding of ligands to receptors. 2 AP2 associates 
with the receptors through the µ2 subunit. The β subunit interacts with clathrin. 3 Internalized 
clathrin-coated vesicle. 4-5 Uncoating of the vesicle by dissociation of clathrin and AP2. 6 Sorting of 
the uncoated vesicle.  
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‘Pinching off’ the vesicle 
The ‘pinching off’ is attributed to the GTPase dynamin. Dynamin forms rings at the neck of 
invaginated clathrin-coated pits and a conformational change in the ring that correlates with 
GTP hydrolysis, is essential for vesicle fission (De Camilli et al., 1995). The dynamin-2 isomer 
is expressed ubiquitously. It interacts with itself to form oligomers, predominantly tetramers, 
to form rings (Hinshaw & Schmid, 1995). Next to the GTPase domain, dynamin also contains 
domains to interact with several binding partners that stimulate the GTPase activity or target 
dynamin to the plasma membrane (Hinshaw, 2000). The GTPase activity stimulating domain 
is the ‘GTPase effector domain’. Targeting to the plasma membrane occurs through 
interaction with the ‘pleckstrin homology (PH) domain’ of dynamin with phosphoinositides 
(Salim et al., 1996). Further, the ‘proline-rich domain’ at the C-terminus of dynamin interacts 
with SH3 domains of profilin and cortactin that interact with the actin cytoskeleton (Simpson 
et al., 1999). Another important binding partner for dynamin are amphiphysines. They not 
only bind dynamin but often also clathrin and AP2 to stabilize the clathrin-coated vesicle 
(Slepnev et al., 2000). Together with amphiphysine, dynamin binds endophilin and actin tails 
through pacsin/syndapin, to pinch-off the vesicle from the membrane.   
 
Intracellular fate of the internalized vesicle  
The uncoating of the internalized vesicle is initiated through auxilin that binds Hsc70-ATP 
(Lemmon, 2001). Hydrolization to Hsc70-ADP induces a conformational change in clathrin 
that is released from the vesicle and binds to Hsc70-ADP (Fig. 11, step 4). Dissociation of 
AP2 is induced by synaptojanin and after release from the vesicle AP2 is phosphorylated to 
prevent it from binding again to clathrin (Fig. 11, step 5) (Wilde & Brodsky, 1996; Cremona 
et al., 1999). The uncoated vesicle can subsequently fuse with other intracellular vesicle 
and/or continue its intracellular journey (Fig. 11, step 6). 
 
Inhibition of clathrin-mediated endocytosis (CME) 
Amantadine stabilizes the structure of clathrin-coated vesicles in purified pig brain (Phonphok 
& Rosenthal, 1991). Another, perhaps more specific inhibitor of CME, is chlorpromazine. It 
causes clathrin lattices to assemble on endosomal membranes and at the same time 
prevents coated pit assembly at the plasma membrane (Wang et al., 1993). It was also 
shown that the extraction of cholesterol with methyl-β-cyclodextrin perturbs formation of 
clathrin-coated endocytic vesicles (Rodal et al., 1999). Each protein involved in CME can also 
be targeted. Dynamin is often used as a target for blocking several endocytosis pathways, 
including CME. 
Introduction 
 43
Caveolae-mediated endocytosis  
Caveolae are approximately 60 nm, flask-shaped invaginations of the plasma membrane that 
occur on many cells and demarcate cholesterol and sphingolipid-rich microdomains of the 
plasma membrane. Most cell types contain some caveolae, while they are really abundantly 
present in other cells, like eg adipocytes. Some cells completely lack caveolae, such as 
lymphocytes and neuronal cells from the central nervous system. Caveolae-mediated 
endocytosis is important for intracellular cholesterol trafficking and intracellular cholesterol 
homeostasis. Further, it plays an organismal role in lipid homeostasis in adipocytes and it 
mediates transcellular transport in endothelial cells (Conner & Schmid, 2003).  
 
 
 
Figure 12: (a) Membrane topology of caveolin. (b) Different domains on caveolin (Williams & 
Lisanti, 2004). 
 
The nature of caveolae 
Unlike clathrin-coated vesicles, caveolae are not induced by binding of a ligand to its 
receptor but they are stationary and held in place by the cortical actin cytoskeleton 
underlying the plasma membrane (Fig. 13, step 1) (Pelkmans et al., 2001; Thomsen et al., 
2002). Only upon specific signals they will detach from the membrane as an endocytic 
vesicle. Caveolae have a protein coat, though not as dense as the clathrin coat, that consists 
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mainly of caveolin-1 (caveolin-3 in muscle cells) (Rothberg et al., 1992). Caveolins are 
integral membrane proteins with both N- and C-terminal ends directed into the cytosol and 
one transmembrane region that does not span the membrane (Fig. 12) (Dupree et al., 1993; 
Monier et al., 1995). They are located in the membrane in lipid raft-like domains. Lipid rafts 
are more rigid domains ‘floating’ in the plasma membrane, enriched in cholesterol and 
sphingolipids (glycosphingolipids and sphingomyelin). The presence of caveolins 
discriminates caveolae from the ‘ordinary’ rafts and is due to the high affinity of caveolin for 
sphingolipids and especially cholesterol (Murata et al., 1995). In caveolae, every 14-16 
caveolin monomers oligomerize to form the coat of the vesicle.  
 
Induction of internalization  
The internalization of Simian virus 40 (SV40), a DNA virus (Papovaviridae, polyomavirinae) of 
approximately 50 nm, is intensively studied and occurs via caveolae-mediated endocytosis. 
Based on the findings concerning the internalization of SV40, a model for caveolae-mediated 
endocytosis was proposed (Pelkmans & Helenius, 2002). After binding of a ligand to its 
receptor, this complex can diffuse laterally along the membrane until it is trapped in a 
caveola (Fig. 13, step 2) (Pelkmans et al., 2001). The caveolae are linked to the cortical actin 
that needs to depolymerise to enable internalization. This occurs via tyrosine phosphorylation 
in proteins associated with the caveolae (Pelkmans et al., 2002). In vivo Src phosphorylates 
caveolin but it is not known if this is necessary and/or sufficient to depolymerise the actin 
(Parton et al., 1994). The released actin monomers assemble into a small actin patch 
surrounding the vesicle. This is followed by peaks of actin polymerization that result in the 
formation of actin tails that function as propellers to direct the vesicle into the cytosol (Fig. 
13, step 3). Next to actin rearrangements, also dynamin is strictly necessary to enable 
vesicle closure and detachment from the plasma membrane (Pelkmans et al., 2002). Once 
the vesicle is released, the actin tail is no longer necessary (Fig. 13, step 4) (Pelkmans & 
Helenius, 2002). 
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Figure 13: Caveolae-mediated internalization. 1 Caveolae are not induced but stationary present in 
the plasma membrane. 2 Binding of ligand to receptor and diffusion of the complex along the 
membrane. 3 Dynamin recruitment and actin rearrangements to induce internalization. 4 Released 
vesicle. 5 Fusion with the caveosome. 6 A caveolin-free vesicle is split off the caveosome and sorted 
to the ER (adapted from Pelkmans & Helenius, 2003). 
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Intracellular fate of the internalized vesicle  
The vesicles released in the cytosol transfer their cargo to larger ‘caveosomes’ by membrane 
fusion (Fig. 13, step 5) (Pelkmans et al., 2001). Just like caveolae, membranes of 
caveosomes  contain caveolin-1, cholesterol and sphingolipids. Their pH is neutral and they 
are consistently present and distributed throughout the cytosol. After fusion of several 
caveolae into the caveosome, its structure becomes more dynamic and caveolin-free vesicles 
are split off and cargo is sorted to the ER via transport over the microtubules (Fig. 13, step 
6). 
 
Inhibition of caveolae-mediated internalization 
Caveolae-mediated internalization is often indirectly blocked by disrupting lipid rafts. This is 
done by sterol-binding or -extracting drugs like filipin and nystatin or methyl-β-cyclodextrin 
(Schnitzer et al., 1994). Although not specific, this approach is very effective. Again, all 
proteins involved in the cascade described above can be used as targets. For example, 
blocking tyrosine kinases by inhibitors like genistein blocks internalization through caveolae 
(Parton et al., 1994; Parton & Richards, 2003).  
 
Clathrin- and caveolae-independent endocytosis  
Little is known about the mechanisms underlying clathrin- and caveolae-independent 
pathways. However, probably they fulfil unique functions and the internalization is tightly 
regulated, as is the intracellular destination of the internalized ligands (Conner & Schmid, 
2003). In what follows, the independent pathways will be described based on some selected 
examples. The independent pathways are identified based on characteristics like (i) the 
dependency on dynamin, (ii) the association with lipid rafts and (iii) the dependency on Rho 
GTPases. Most likely, as these pathways are further characterized, more characteristics will 
be necessary to differentiate between independent pathways. 
 
Dynamin-dependent and cholesterol depletion sensitive pathway 
Both the β-subunit of the IL-2 receptor (IL-2R) and the common cytokine receptor γ (γc) are 
internalized through a clathrin- and caveolae-independent pathway that depends on dynamin 
and is associated with lipid rafts (Kirkham & Parton, 2005). Binding of IL-2 to the IL-2R 
increases the association between the receptor and rafts. The internalization is regulated by 
the Rho GTPases RhoA and Rac1 (Lamaze et al., 2001). The γc receptor is a subunit shared 
by several cytokine receptors, namely IL-2, -4, -7, -9, -15 and -21 receptors (Schluns & 
Lefrancois, 2003). The internalization of the γc cytokine receptor is further characterized by 
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recruitment and polymerization of actin and activity of the Rho GTPase RhoA (Sauvonnet et 
al., 2005). 
A dynamin-dependent and cholesterol depletion sensitive pathway is also (mis)used by 
rotavirus (Reoviridae) to gain entry into an epithelial cell line. It is not known if this pathway 
is regulated by Rho GTPases (Sanchez-San Martin et al., 2004).  
 
Dynamin-independent and cholesterol depletion sensitive pathway 
Endocytosis of the glycosylphosphatidylinositol (GPI) -anchored folate receptor can occur via 
clathrin-mediated internalization. But this is not sufficient for effective cytoplasmic folate 
delivery (Ritter et al., 1995). Efficient folate delivery results from internalization via a 
clathrin- and caveolae-independent pathway that does not rely on dynamin (Sabharanjak & 
Mayor, 2004). Further, the pathway is associated with lipid rafts via the GPI-anchor. After a 
couple of minutes, endocytosed proteins are detected in GPI-anchored protein enriched 
endocytic compartments (GEECs). Formation of these GEECs is regulated by the Rho GTPase 
Cdc42 (Sabharanjak et al., 2002). The final destination of the compounds inside the GEECs is 
cell type dependent and varies from recycling compartments to late endosomes. 
In cell lines that lack caveolae and in embryonic fibroblasts, SV40 is taken up by a clathrin- 
and caveolae-independent pathway that depends on cholesterol but not on dynamin (Damm 
et al., 2005).  
 
Dynamin-dependent and cholesterol depletion insensitive pathway 
A possible example of a dynamin-dependent clathrin- and caveolae-independent pathway 
that does not depend on cholesterol is influenza virus entry in Hela cells. It is definitely a 
cholesterol-independent, clathrin- and caveolae-independent pathway but the dependency 
on dynamin has not been studied yet and was only suggested in 2002 by Sieczkarski & 
Whittaker based on dependency on dynamin of influenzavirus in another cell type, Mv-1 lung 
cells (Roy et al., 2000). However, numerous viruses have been shown to use different 
pathways to enter different cell types, or even use different pathways in one cell. Therefore, 
dependency on dynamin should be further investigated before any conclusions can be made. 
 
Dynamin-independent and cholesterol depletion insensitive pathway 
The entry of murine polyomavirus strain RA in fibroblasts and kidney epithelial cells occurs 
via a clathrin- and caveolae-independent pathway that is independent from dynamin and 
cholesterol (Gilbert & Benjamin, 2000). A rearrangement of the actin microfilaments is 
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necessary for internalization. For intracellular transport to the nucleus, the virus relies on 
microtubules (Gilbert et al., 2003).  
Recently, it was shown that the antibody-induced internalization of surface-expressed 
antigens in FIPV-infected monocytes are internalized via a clathrin- and caveolae-
independent pathway that does not require dynamin or rafts. Further, this pathway is 
independent of actin and Rho GTPases, and phosphatases and tyrosine kinases. It did 
however depend on serine/threonine kinases (Dewerchin et al., 2008).   
 
1.2.5 Internalization of coronaviruses 
 
1.2.5.1 Group 1 coronaviruses 
 
Feline coronaviruses (FCoV) 
Together with the question whether FCoVs enter cells via direct fusion at the plasma 
membrane or fusion with the endosomal membranes after endocytosis, it is also questioned 
if uncoating of FCoV particles depends on low pH. Without resolving the first question and 
eliminating the possibility of direct fusion, Takano et al. claimed that acidification of the 
endosome is necessary for FIPV infection of monocytes (2008). However, Regan et al. claim 
that the pH drop in the endosome is necessary for infectious entry of eFCoV strain 79-1683, 
but not for FIPV strains 79-1146 and DF2 (2008). As such, the mystery around FCoV entry 
remains unresolved. 
Naturally, the FCoV S-protein will fulfil an important role in the internalization process. In 
monocytes/macrophages, the M-protein might also be involved in some crucial interactions, 
as neutralizing antibodies against M-protein suggest involvement in a post-absorption step 
(Kida et al., 2000).  
The role of proteases in FCoV entry is another point of discussion. Regan et al. reported a 
cathepsin-mediated cleavage of the viral spike protein (2008). For eFCoV 79-1683, both 
cathepsin B and L can perform this cleavage, while FIPV 79-1146 and DF2 depend on 
cathepsin B activity. However, de Haan et al. claim independence from cathepsins for FIPV 
79-1146, but report possible furin cleavage for some serotype I strains (2008).  
 
Canine coronavirus (CCoV) 
The internalization of canine coronavirus is not extensively studied. The exact internalization 
pathway is not known. It has been suggested that CCoV enters cells via endocytosis, as 
replication could be inhibited by chloroquine (Savarino et al., 2003). 
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Human coronaviruses (HCoV) 
HCoV-229E binds to APN in lipid rafts in human fibroblasts. At 37 °C the receptor/virus 
complexes redistribute to caveolae for virus entry through caveolae-mediated internalization 
(Nomura et al., 2004). This was shown by co-localization studies between the virus and 
caveolins, disruption of the rafts by cholesterol depleting drugs and caveolin knockdown by 
RNA interference. Kawase et al. showed that also in Hela cells, HCoV-229E enters via 
endocytosis through an endosomal pathway (2009). Infection was profoundly blocked by 
lysosomotropic agents as well as by protease inhibitors. Cathepsin L is involved in the 
fusogenic activation of HCoV-229E S-protein in endosomal infection. It is however very likely 
that this is not the only protease involved (Kawase et al., 2009).  
The mechanism of internalization has not been studied for HCoV-NL63. As this virus uses the 
same receptor(s) as SARS-CoV, it might be suggested that it also uses the same 
internalization pathway(s). This is possible but uncertain as viruses have been shown to 
interact in different ways with identical binding partners triggering various processes. It has 
already been shown that SARS-CoV and NL63 probably engage ACE2 differentially. NL63-
driven entry is also less dependent on a low pH environment and activity of endosomal 
proteases compared to infection with SARS-CoV (Hofmann et al., 2006). 
 
Porcine coronaviruses 
The mechanism of TGEV internalization has been studied in a cell line stably expressing 
porcine APN. Electron microscopic analysis showed TGEV in endocytic pits and apical vesicles 
so the virus clearly enters via endocytosis and not via direct fusion at the plasma membrane. 
Acidification of the endosome is required for infection. Thickening of the membrane below 
adsorbed TGEV particles, visible on electron microscopic pictures, indicates that TGEV enters 
cells via clathrin-mediated endocytosis (Hansen et al., 1998). Based on the finding that 
cholesterol is important for TGEV infection, it is suggested that TGEV entry may occur via 
lipid rafts (Ren et al., 2008). Further research is necessary to confirm this hypothesis 
because the effect of methyl-β-cyclodextrin is not necessarily due to raft-association of the 
internalization process, especially not if CME can possibly occur.  
The internalization mechanisms of PRCoV and PEDV have not been studied in detail. 
 
For both bat coronavirus and rabbit coronavirus, the internalization pathway has not been 
studied. 
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1.2.5.2 Other important coronaviruses 
 
Mouse hepatitis virus (MHV) 
Although virus binding does not depend on cholesterol and the MHV receptor is not present 
in lipid rafts, virus entry was reduced by cholesterol depletion (Choi et al., 2005). After virus 
binding independent from rafts, the virus particles shift to the raft-fraction of the membrane. 
This redistribution of spike proteins in the membrane and the interaction between lipid rafts 
and spikes may be necessary for internalization.  
In the past, both endosomal and non-endosomal routes have been described for MHV entry 
(Nash & Buchmeier, 1997). The route of entry used, was said to depend upon the virus 
strain and the cell type of the host cell. Kooi et al., suggested a minor role for the endocytic 
pathway and showed that MHV can induce direct fusion at pH 7.4 (1991). Binding of MHV 
(MHV-A59 and MHV-4) to its receptor can induce a conformational change in the spike 
protein into a fusogenic state, possibly ready to induce direct fusion at the plasma 
membrane (Matsuyama & Taguchi, 2002; Zelus et al., 2003; Miura et al., 2004). On the 
other hand, Krzystyniak and Dupuy reported that infection by MHV-3 is sensitive to 
lysosomotropic agents, suggesting virus entry via endocytosis (1984).  
Recently, a novel study was set up to resolve the discussion on the route of entry of MHV 
strain A59. It was shown that virus uptake occurs via endocytosis (Eifart et al., 2007). This is 
the natural consequence of the observed requirement for the low pH in endosomes to 
initiate fusion of the viral spike with the host cell membranes. The low pH-triggered 
conformational alterations in the S-ectodomain are irreversible because low pH-treatment of 
virus particles in the absence of target domains causes an irreversible loss of fusion activity. 
Protease activity is not required for MHV entry. As chlorpromazine is an efficient inhibitor of 
MHV entry, the virus is probably endocytosed via clathrin-mediated internalization (Eifart et 
al., 2007). This is consistent with the dependency on cholesterol, as methyl-β-cyclodextrin is 
a potent inhibitor of CME.  
Unlike for MHV-A59, endosomal protease activity is required for infection with MHV-2. Low 
pH activates cathepsins B and L, that are also involved in SARS-CoV infectivity, to mediate 
MHV-2 entry (Qiu et al., 2006). These results might confirm the statement of Nash & 
Buchmeier that entry pathways vary between different virus strains and their target cells 
(1997). Further analysis of MHV-2 entry showed the involvement of clathrin but remarkably 
not of Eps15, a component that until now was always involved in CME (Pu & Zhang, 2008). 
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Infectious bronchitis virus (IBV) 
Avian IBV uses an endocytic pathway for entry into cells. Cell fusion occurs in a low pH-
dependent manner in the endosomes without activity of endosomal proteases (Chu et al., 
2006). The low pH-induced conformational change is reversible, unlike the conformational 
change of MHV spikes. 
 
Severe acute respiratory syndrome virus (SARS-CoV) 
SARS-CoV infection of Vero E6 cells (and 293T and Huh-7 cells) requires acidification of 
endosomes, indicating that the virus enters cells via endocytosis (Simmons et al., 2004; 
Yang et al., 2004). The ACE2 receptor is located in lipid rafts that probably also function as a 
platform to mediate SARS-CoV entry (Lu et al., 2008). In (COS7) cells that are transfected 
with ACE2, the endocytosis entry pathway was further characterized using inhibitors and 
gene silencing and appeared to be clathrin-mediated. After CME, the virus relocates to EEA1-
positive early endosomes (Inoue et al., 2007). Wang et al. also studied the pathway of 
SARS-CoV internalization (2008). They used HEK293E cells transfected with ACE2 and Vero 
E6 cells for studies with inhibitors, expression of dominant-negative proteins, gene silencing 
and co-localization studies. They confirmed that endocytosis was associated with lipid rafts, 
brought the virus in early endosomes and depended on the pH drop in late endosomes. 
However, the pathway appeared independent from clathrin and caveolae. Next to low pH, 
activity of cathepsins is also required for successful SARS-CoV entry (Huang et al., 2006). 
Recently, a novel mechanism of priming for the SARS-CoV S-protein has been reported. 
Sequential trypsin cleavage at two different sites, namely cleavage at the S1/S2 boundary 
and position 797 in S2, would enable the S-protein to mediate membrane fusion, presumably 
at the cell surface (Belouzard et al., 2009).   
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Feline infectious peritonitis (FIP) is the most important infectious cause of death in cats. One 
to 5 % of the European cat population is a potential victim of this infection. At present, no 
means are available to heal cats. Furthermore, there is no effective vaccine available for 
prevention. Expanding the knowledge on FIP virus (FIPV) pathogenesis is indispensable in 
the search for a vaccine and treatment.  
 
The process of viral entry is an attractive target for the development of new therapeutic 
agents. For example in the battle against human immunodeficiency virus 1 infections, this 
approach already led to the development of promising agents (Cooley & Lewin, 2003). This 
study was set up to unravel the process of FIPV entry and identify possible targets for drug 
development. At the start of this research, little was known about FIPV entry. It was even 
questioned whether FIPV entry is mediated via direct fusion at the plasma membrane or via 
fusion with endosomal membranes after endocytosis.  
 
Viral entry consists of two major events. First, the virus binds to its receptor on the plasma 
membrane, leading to viral attachment. In a second step, bound virus particles pass the 
plasma membrane either via direct fusion or via endocytosis, which results in virus 
internalization. Internalization via endocytosis is followed by an extra uncoating step to 
release the viral RNA in the cytosol.  
 
The first study was aimed at providing insights in how attachment and internalization are 
regulated in time and to quantify virus binding and internalization over time in monocytes, 
the target cell for FIPV in vivo. Different virus strains and different cats were included. It was 
also checked if cell lines were valid models to study FIPV entry. This study was set up to 
reveal whether FIPV enters target cells via direct fusion or via endocytosis, or a combination 
of both (chapter 3), and to provide basic information that was needed for the experimental 
set-up for the following studies that focus on attachment and internalization separately. 
In chapter 4, the use of potential receptors for FIPV at different stages of the entry process 
was evaluated. This study was performed to provide new insights in the virus-receptor 
interactions upon viral contact with the host cell, the monocyte.   
In a third study, the mechanism of internalization was further analysed in monocytes. 
Therefore, a variety of techniques was included, ranging from inhibition experiments, 
lentiviral transduction to express dominant-negative proteins in monocytes and co-
localization studies (chapter 5). This study could identify cellular proteins that are necessary 
for FIPV entry in monocytes. 
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Finally, the release of the genome in the cytosol, necessary for genome replication, 
transcription and translation, was studied. A kinetical study of this process was performed to 
supply data on the efficiency of uncoating. Further, it was checked which triggers might 
induce release of the FIPV genome into the cytosol in monocytes (chapter 6).  
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ABSTRACT 
 
In this study, kinetics of attachment and internalization of feline infectious peritonitis virus 
(FIPV) serotype I strain Black and serotype II strain 79-1146, were determined in feline 
monocytes from two cats and in Crandell feline kidney (CrFK) cells. Attached FIPV I (Black) 
particles were observed on almost all monocytes. Within 1 hour, 17 particles were bound per 
cell and within 1 minute, 89 % of the bound particles were internalized. For FIPV II (79-
1146), attachment was observed on 66 % and 95 % of all monocytes from the two cats. 
After 1 hour, respectively 5 and 20 particles were bound per cell (all cells considered). Within 
1 minute, 60 % of the bound particles were internalized. Internalization in monocytes was 
efficient and proceeded via endocytosis. In CrFK cells, attachment and internalization were 
less efficient, especially for FIPV I (Black), so this cell line is not suitable for studying FIPV 
entry.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Kinetic analysis of attachment and internalization of FIPV 
 79
INTRODUCTION 
 
Feline infectious peritonitis virus (FIPV) is a coronavirus belonging to the order of the 
Nidovirales (Cavanagh, 1997; Cowley et al., 2000; Gorbalenya et al., 2006). Based on 
comparative sequence analysis, human coronavirus strain 229E (HCoV-229E), porcine 
transmissible gastroenteritis virus (TGEV), porcine epidemic diarrhoea virus (PEDV), canine 
coronavirus (CCoV) and feline coronaviruses (FCoV) are grouped in phylogenetic group 1 
(González et al., 2003; Spaan et al., 2005; Gorbalenya et al., 2006). Feline coronaviruses are 
divided into two serotypes: serotype I and the less prevalent serotype II (Pedersen et al., 
1984; Hohdatsu et al., 1992). Type II strains are closely related to CCoV and TGEV 
(Pedersen et al., 1983) and are thought to be recombinants of type I strains and CCoV 
(Vennema et al., 1995). Unlike type I strains, type II strains grow easily in cell culture, such 
as Crandell feline kidney (CrFK) cells, and are therefore used frequently in FIPV studies. 
To infect a target cell, a virus particle proceeds through a multistep entry process. Each step 
is pre-programmed and tightly regulated in time and space (Smith & Helenius, 2004). The 
first step in the viral entry process is the attachment of viral proteins to receptors on the 
surface of the target cell. Some receptors function solely as attachment receptors that recruit 
fitting ligands for the internalizing receptors. Others attach and internalize particles in a 
single step process. Attachment and internalization have not been studied in detail for most 
coronaviruses (Holmes & Compton, 1995). Aminopeptidase N (APN), also called CD13, is a 
150 kDa class II metalloprotease. This glycoprotein serves as a receptor for several group 1 
coronaviruses (Tresnan et al., 1996), including HCoV-229E (Yeager et al., 1992), porcine 
respiratory coronavirus (PRCoV) and TGEV (Delmas et al., 1992, 1993, 1994). For both 
serotype I and II FCoVs, stably expressed APN cDNA isolated from the Felis catus whole 
fetus (fcwf) cell line could induce susceptibility in FCoV-resistant cells. Although strains of 
both serotypes were able to infect these cells, the efficiency of infection was different 
(Tresnan et al., 1996). Hohdatsu et al. (1998) showed that only serotype II strains of FCoV 
use feline APN (fAPN) as a receptor for internalization into feline cell lines, like CrFK and fcwf 
cells. Infection of bone marrow-derived macrophages with FIPV II (79-1146) could be 
restricted from approximately 33 % to 3 % of the cells by a monoclonal antibody against 
fAPN (Rottier et al., 2005). Whether fAPN is the receptor for FIPV II on in vivo target cells, 
feline blood monocytes, is not known. The receptor for FIPV I has not been identified.  
Viruses may enter cells via two pathways. Viral envelopes may fuse with the plasma 
membrane or with endosomal membranes after entering cells via endocytosis. Several group 
1 coronaviruses enter cells via endocytosis. HCoV-229E enters human fibroblasts through 
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caveolae-mediated endocytosis (Nomura et al., 2004). TGEV causes infection in Madin-Darby 
canine kidney (MDCK) cells, transfected with porcine APN after receptor-mediated 
endocytosis (Hansen et al., 1998). CCoV also uses endocytosis to enter target cells (Savarino 
et al., 2003). Mouse hepatitis virus (MHV), a group 2 coronavirus, enters cells by both 
endosomal and non-endosomal pathways. The pathway of internalization was shown to 
depend upon the strain of virus and the nature of the cell being infected (Kooi et al., 1991; 
Nash & Buchmeier, 1997). Internalization of FIPV has not been studied in either primary cells 
or cell lines. Whether fusion at the plasma membrane or endocytosis occurs, is not known.  
In this study, kinetics of attachment and internalization were studied for FIPV in feline blood 
monocytes, the primary target cells, and compared with those in CrFK cells, used frequently 
as a model cell line for FCoV-cell interactions. In addition to the routinely used serotype II 
strain, 79-1146, a serotype I strain, Black, was included. Further, it was investigated whether 
FIPV enters monocytes and CrFK cells via fusion with the plasma membrane or via 
endocytosis. 
 
 
METHODS 
 
Cells and virus 
Monocytes were isolated from blood collected from two FCoV-, feline leukemia virus- and 
feline immunodeficiency virus-negative cats as described previously (Dewerchin et al., 2005). 
The obtained monocytes were resuspended in RPMI 1640 (Gibco-Invitrogen) medium, 
supplemented with 10 % foetal bovine serum (FBS), 0.3 mg glutamine ml-1, 100 U penicillin 
ml-1, 0.1 mg streptomycin ml-1, 0.1 mg kanamycin ml-1, 10 U heparin ml-1, 1 mM sodium 
pyruvate and 1 % non-essential amino acids 100x (Gibco-Invitrogen). Cells were seeded at a 
concentration of 2 x 106 cells ml-1 in 24-well dishes with cell culture coating (Nunc A/S) and 
cultivated at 37 °C with 5 % CO2. The adherent cells consisted of 86 ± 7 % monocytes 
[assessed with monocyte marker DH59B; Veterinary Medical Research and Development 
(VMRD)]. Experiments were performed at 36 hours post seeding. 
Type I FIPV strain Black (Black, 1980) and type II strain 79-1146 (McKeirnan et al., 1981) 
were kindly provided by Dr Egberink (Utrecht University, the Netherlands). FIPV strain Black 
was passaged on fcwf cells and FIPV strain 79-1146 on CrFK cells. 
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Virus purification and biotinylation  
FIPV I (Black) infected fcwf cells and culture fluids were subjected to three freeze thaw 
cycles. Batches of culture fluids from FIPV II (79-1146) infected CrFK cells were collected. 
For both serotypes, the obtained suspensions were clarified by centrifugation at 3000 x g for 
15 minutes. Purification and biotinylation were performed as described by Delputte et al. 
(2002) and Delputte & Nauwynck (2004). The supernatants were purified by 
ultracentrifugation with a Beckman Sw41 rotor (Beckman Coulter) on a 30 % sucrose 
cushion at 105 x g for 165 minutes. Pellets were resuspended in phosphate buffered saline 
(PBS) and centrifuged at 14000 x g for 30 minutes to remove cellular debris and virus 
aggregates. The purified virus was labelled with biotin by incubation of the virus suspension 
with a 10 g l-1 solution of Sulfo-NHS-LC-Biotin (Pierce, Perbio Science) in PBS in a 20 to 1 
ratio for 90 minutes at 4 °C. Tris buffer was added to a final concentration of 10 mM and 1 
% FBS was used as cryoprotectant for storage at -70 °C. Experiments were performed by 
incubating 200 µg of purified viral particle suspension with 104.4 monocytes or 106 CrFK cells. 
To confirm whether the biotinylated particles were indeed virions, a co-localization assay was 
carried out. Two stainings were performed: viral proteins were detected using polyclonal 
anti-FIPV-FITC (VMRD) and biotin was visualized with streptavidin-Texas Red (Molecular 
Probes). The concurrence of anti-FIPV polyclonal antibodies and conjugated streptavidin was 
confirmed (Fig. 1). Further, it was shown that the biotinylation procedure did not influence 
the kinetics of attachment and internalization (data not shown). 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1: Co-localization of biotinylated particles and virions. Confocal images of monocytes 
incubated with biotinylated FIPV particles at 4 °C. FIPV particles are visualized by α-FIPV-FITC, 
biotin was visualized by streptavidin-Texas Red. 
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Quantification of biotinylated particles in suspension  
For quantification, 2 µl of virus suspension, diluted 10-3, 10-4 and 10-5 in PBS, was applied to 
streptavidin-coated slides (Streptavidin Cover Slips, Xenopore) and left to dry for 45 minutes. 
Biotinylated particles were stained with FITC-labelled streptavidin (Molecular Probes), diluted 
1/500 in PBS, and incubated for 1 hour at 37 °C. The slides were washed with PBS and 
finally mounted on a microscope slide using glycerine-PBS in a 9 to 1 ratio with 2.5 % 1,4-
diazabicyclo(2,2,2)octane (Janssen Chimica). The number of particles in the suspension was 
calculated after manually counting fluorescent particles. 
It was shown that 200 µg of purified viral particle suspension contains 7.9 x 109 FIPV I 
(Black) particles and 5.0 x 1010 FIPV II (79-1146) particles. This amount of virus suspension 
was applied to 104.4 monocytes or 106 CrFK cells throughout the experiments.  
 
Kinetics of attachment 
Cells were chilled on ice (4 °C) for 15 minutes and inoculated with biotinylated FIPV I (Black) 
or II (79-1146) at 4 °C. At different time points, cells were washed with PBS and fixed with 1 
% formaldehyde. Attached particles were visualized using FITC-labelled streptavidin 
(Molecular Probes). Cell nuclei were stained with Hoechst 33342 (Molecular Probes). Finally, 
coverslips were mounted on microscope slides.  
 
Kinetics of internalization 
Cells were chilled on ice, inoculated with biotinylated FIPV I (Black) or II (79-1146) and then 
incubated until the maximum number of attached particles was reached. Cells were washed 
to remove unbound virus particles. Then, plates were transferred to 37 °C to enable virus 
uptake. Cells were fixed at different time points with 1 % formaldehyde. Particles attached to 
the outside of the cell were visualized using Texas Red-labelled streptavidin (Molecular 
Probes). After permeabilizing cells with 0.1 % Triton X-100, internalized particles were 
stained with FITC-labelled streptavidin. Finally, the cell nuclei were stained and coverslips 
were mounted on microscope slides.  
Using ethidium monoazide bromide (EMA), cell vitality was determined for cells subjected to 
the manipulations described above before fixation. For the monocytes, the vitality was 99.3 
% and for the CrFK cells, 97.8 %.  
 
Occurrence of internalization via fusion with the plasma membrane 
Stainings were performed on monocytes inoculated with FIPV I (Black) or FIPV II (79-1146) 
and CrFK cells inoculated with FIPV II (79-1146) to determine whether the biotinylated 
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material at the plasma membrane after virus uptake via endocytosis, consisted of intact 
virions or viral envelopes, left behind after fusion. Cells were chilled on ice, inoculated with 
FIPV I (Black) and FIPV II (79-1146) and incubated at 4 °C. When attachment was 
completed, cells were transferred to 37 °C as described for the determination of the kinetics 
of internalization. Cells were fixed when maximal uptake was reached and remaining 
material at the plasma membrane was stained with polyclonal, FITC-labelled, anti-FIPV 
antibodies (VMRD). After permeabilization of the cells with 0.1 % Triton X-100, co-
localization with mouse anti nucleocapsid antibodies was studied after staining with the 
monoclonal antibody E22-2 (kindly provided by Dr Hohdatsu, Kitasato University, Japan) and 
visualization with goat anti-mouse-Texas Red (Molecular Probes).  
 
Microscopy and statistics 
Analyses of virus attachment and internalization were performed by means of a DM IRB 
inverted microscope (Leica Microsystems). Images were obtained using a Leica TCS SP2 
laser scanning spectral confocal system linked to a DM IRB inverted microscope (Leica). 
Argon and He/Ne lasers were used for exciting FITC and Texas Red fluorochromes, 
respectively. Leica confocal software was used for image acquisition. 
Triplicate assays were performed and compared using the Wilcoxon Signed Ranks test from 
the SPSS software package (version 12.0, SPSS).   
 
 
RESULTS  
 
Kinetics of attachment 
Monocytes - Kinetics of attachment on monocytes from two cats were determined with 
both serotypes. The courses of the obtained kinetics are shown in Figure 2b. The number of 
particles attached at a certain time point is the average of the number of attached particles 
for 50 randomly chosen cells. Both cells with and without bound particles on their plasma 
membrane were included. For each cell, the entire plasma membrane was screened for the 
presence of particles. 
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Figure 2: Kinetics of attachment of FIPV I (Black) and FIPV II (79-1146) to monocytes of cat 1 and 
cat 2 and CrFK cells. Cells were inoculated with biotinylated FIPV and incubated at 4 °C. At 
designated timepoints virus was visualized using streptavidin-FITC. (a) Confocal images of single 
sections through cells. Green dots represent bound virus particles. (b) ---- courses determined in 3 
independently performed  experiments; ⎯ mean course based on the 3 independently performed  
experiments.  
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FIPV I (Black) – After monocytes were incubated with FIPV I (Black) particles at 4 °C, bound 
virus was observed on the membrane of almost all monocytes (98.8 % of the monocytes for 
cat 1 and 99.5 % for cat 2). During the first 15 minutes of incubation, the number of 
attached FIPV I (Black) particles to monocytes of cat 1, gradually increased to 14 ± 1 bound 
particles per cell. Longer incubation times did not increase the amount of virus that bound 
noticeably. For cat 2, similar kinetics of attachment were obtained. A slightly slower increase 
persisted for 1 hour to 18 ± 7 bound particles per cell. From 1 hour on, no further increase 
was observed and attachment maintained at the same level.  
FIPV II (79-1146) – Bound FIPV II (79-1146) particles were observed on the membrane of 
66.2 % of the monocytes isolated from cat 1. During the first hour of incubation, the number 
of attached particles slowly increased to 5 ± 3 particles per cell (all cells considered). Despite 
longer incubation times (up to 3 hours), no more particles bound to the cell surface. In 
contrast, almost all monocytes of cat 2 (95.0 %) attached FIPV II (79-1146) particles at their 
plasma membrane. Within the first 30 minutes of incubation on ice, the number of attached 
particles strongly increased to 19 ± 10 bound particles per cell. From 30 minutes on, 
attachment maintained at the same level. Clearly, cat 2 monocytes reached a higher level of 
attached FIPV II (79-1146) particles than cat 1 monocytes. 
CrFK cells - Kinetics of attachment of FIPV particles on the surface of CrFK cells are shown 
in Figure 2b for FIPV I (Black) and FIPV II (79-1146). The number of particles attached at 
different time points was determined as described for the monocytes.  
FIPV I (Black) - Attachment of FIPV I (Black) particles was restricted to 15.4 % of the CrFK 
cells. After two hours of incubation on ice only 1 ± 1 particle bound per cell (all cells 
considered). Despite longer incubation times no further increase of this number was 
observed.  
FIPV II (79-1146) - In contrast to the results for FIPV I (Black), almost all cells (99.8 %) had 
bound FIPV II (79-1146) particles on their plasma membrane. Also, more particles were 
attached, although the kinetics were slow. During 4 hours of incubation, the number of 
bound particles increased gradually to 49 ± 19 particles per cell. Longer incubation times 
increased the amount of bound virus slightly.  
In Table 1, a comparison was made between the number of particles added to the cells and 
the resulting level of attachment for the different virus strains and cell types. Virus particles 
were present in excess in all experiments, therefore it might be suggested that all possible 
FIPV binding sites were taken. This could be confirmed by evaluating attachment after 
incubation with viral particle suspensions of varying concentrations.   
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Kinetics of internalization 
Kinetics of internalization of FIPV were determined by incubating virus particles with the cells 
on ice until maximum attachment was reached, i.e. 1 hour for incubation of monocytes with 
both strains, and 2 hours and 5 hours for incubation of CrFK cells with respectively FIPV I 
(Black) and FIPV II (79-1146) (Fig. 2). Then, plates were transferred to 37 °C (= time point 
zero for the kinetics of internalization).  
The kinetics of internalization of FIPV are shown in Figure 3. The percentages shown were 
calculated by analyzing 10 cells for the presence of particles in the cytosol and on the 
surface of the cell. Only cells that had attached and/or internalized particles were taken into 
account. For each cell, the entire cell volume was screened for particles.  
Monocytes - The kinetics of internalization determined in monocytes are shown in Figure 
3b. 
FIPV I (Black) – The kinetics of internalization for FIPV I (Black) were similar for both cats. 
Almost all monocytes that bound FIPV I (Black) virions internalized virions (98.9 % of the 
monocytes that had bound particles for cat 1 and 98.5 % for cat 2). Remarkably, 
immobilization of the cells at 4 °C could not completely inhibit internalization as there were 
already particles internalized at time point zero. Within the first minute after the start of virus 
uptake, already 89 ± 6 % of the bound particles were internalized per cell. This level of 
internalization was roughly maintained during longer incubation times, though a slight 
decrease to 85 ± 13 % could be observed after one hour of incubation.  
FIPV II (79-1146) – As for FIPV I (Black), internalization of FIPV II (79-1146) was mediated 
by approximately all monocytes that had bound virus particles (92.5 % of the analyzed 
monocytes isolated from cat 1 and all analyzed monocytes from cat 2) and kinetics were 
similar for both cats. After one minute, an average of 60 ± 9 % of the bound virions were 
internalized per cell. However, internalization further increased gradually up to 1 hour of 
incubation at 37 °C. Then, an average of 90 ± 7 % of the bound particles were taken up per 
cell.   
CrFK cells - Kinetics of internalization of FIPV particles in CrFK cells are shown in Figure 3b.  
FIPV I (Black) – Unlike for monocytes, uptake was restricted in CrFK cells to 20.8 % of the 
monocytes that had bound virus or only 3.2 % of all cells. No internalization was observed 
after the first minute of incubation at 37 °C, but during the first 2 hours the kinetics 
gradually mounted to the maximal level of internalization where 52 % of the bound particles 
per cell were internalized. During longer incubation times, internalization maintained at the 
same level. The percentage of internalized particles per cell varied between 0 and 100 % as 
often only 1 particle was bound to the cell, so only 1 particle could be internalized. 
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Figure 3: Kinetics of internalization of FIPV I (Black) and FIPV II (79-1146) in monocytes of cat 1 
and cat 2 and CrFK cells. Cells were inoculated with biotinylated FIPV and incubated at 4 °C until 
saturation of attachment. Plates were then transferred to 37 °C. At designated timepoints virus at 
the plasma membrane was visualized using streptavidin-TR and - after permeabilization - 
internalized virus was visualized using streptavidin-FITC. (a) Confocal images of single sections 
through cells. Red dots represent virus particles at the cell surface, exclusively green dots 
internalized virus particles. (b) ---- courses determined in 3 independently performed  experiments; 
⎯ mean course based on the 3 independently performed  experiments.   
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FIPV II (79-1146) – All cells were capable of internalizing FIPV II (79-1146) virions. Within 
the first minute, no more than 3 ± 2 % of the bound particles were observed inside the cell. 
But, again, the percentage of internalization per cell increased gradually, and reached 67 ± 4 
% after 2 hours of incubation at 37 °C. Longer incubation times only slightly increased the 
percentage of internalization per cell.  
 
Table 1. Comparison of the number of FIPV particles added to the cells and the number of particles 
attached after incubation at 4°C until saturation 
 
Virus strain Particles added Cell type Bound particles 
FIPV I (Black) 7.9 x 109 CrFK 2.00 x 106 
  Monocytes cat 1 7.31 x 106 
  Monocytes cat 2 7.74 x 106 
FIPV II (79-1146) 5.0 x 1010 CrFK 1.44 x 108 
  Monocytes cat 1 2.58 x 106 
  Monocytes cat 2 9.46 x 106 
 
 
Occurrence of internalization via fusion with the plasma membrane 
The kinetics of internalization indicate that the majority of bound FIPV particles enters cells 
via endocytosis. But virus uptake via endocytosis did not reach 100 % in monocytes, nor in 
CrFK cells. A small fraction of biotinylated material remained at the outside of the cell. This 
could be bound virus particles, unable to enter the cell, or biotinylated envelopes that were 
left behind after fusion with the host cell membrane. A staining was performed to determine 
the nature of what was left at the plasma membrane after internalization was completed. 
Cells were therefore fixed after 1 hour and 2 hours of incubation at 37 °C for respectively 
monocytes and CrFK cells. The results are shown in Figure 4. It was obvious that all the 
biotinylated FIPV material at the plasma membrane co-localized with FIPV nucleocapsid 
proteins. Thus, the biotinylated material consisted of intact virions, unable to enter the cell. 
This implies that, under the present experimental conditions, both FIPV strains enter 
monocytes exclusively via endocytosis and so does FIPV II (79-1146) in CrFK cells. It can be 
stated that fusion at the plasma membrane is not involved in FIPV entry.  
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Figure 4: Co-localization of non-internalized biotinylated material and FIPV nucleocapsid protein. 
Confocal images of sections through monocytes and CrFK cells incubated at 4 °C, transferred to and 
left at 37 °C until uptake was completed. Biotinylated material was stained with α-FIPV-FITC, 
nucleocapsid protein with mAb E22-2 and goat α-mouse-TR. 
 
 
DISCUSSION 
 
Feline infectious peritonitis (FIP) is a fatal viral infection. No effective treatment is 
commercially available as several important questions concerning the pathogenesis of FIP 
remain unanswered. Especially virus-cell interactions need to be studied in greater detail in 
order to obtain insights on possible targets for drug development. Interfering with the 
internalization process of viruses is a new strategy for development of antiviral compounds 
as has been described for e.g. human immunodeficiency virus, hepatitis C virus and dengue 
virus (Altmeyer, 2004; Este, 2003; Le Calvez et al., 2004). In this study, the initial steps in 
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FIPV infection were analyzed for the first time in the FIPV target cell by determining kinetics 
of attachment and internalization, using biotinylated virus.  
Feline blood monocytes are the target cells in vivo for feline infectious peritonitis virus, 
therefore these cells were used in the experiments to approximate the natural situation as 
much as possible. Two virus strains were included: the FIPV serotype I strain Black and the 
routinely used serotype II strain 79-1146.  
The kinetics of attachment for FIPV I (Black) were quite similar for both cats. However, the 
kinetics of attachment of FIPV II (79-1146) determined for the two cats were significantly 
different (Wilcoxon Signed Ranks (WSR): p=0.025). This difference could be the 
consequence of variable expression levels of one of the cellular components involved in 
attachment, e.g. a specific serotype II FIPV receptor, between the two cats. Another 
difference in kinetics of attachment was observed between FIPV I (Black) and FIPV II (79-
1146) for the monocytes of cat 1 (WSR: p=0.012) and cat 2 (WSR: p=0.036). This could 
indicate that type I and II strains use different receptors on monocytes and that the serotype 
II receptor may be differentially expressed in between cats, while apparently the serotype I 
receptor is not. Differences in receptor use between type I and II have already been 
demonstrated in cell culture (Hohdatsu et al., 1998). As only two cats were considered, 
these data cannot lead to general conclusions. Further research will focus on the receptors 
of FIPV in monocytes, which will allow interpretation of the present findings.  
 
Internalization in monocytes was very efficient for both serotypes. The efficiency of TGEV 
internalization in the MDCK cell line is evenly efficient as that of FIPV in monocytes. TGEV is 
another group 1 coronavirus. TGEV virions can be observed in endocytic pits and apical 
vesicles, by electron microscopy, after 3 to 10 minutes of incubation at 38 °C with MDCK 
cells, stably expressing the receptor, porcine aminopeptidase N (Hansen et al., 1998). For 
HCoV-229E, most particles are internalized in human fibroblasts within the first hour of 
incubation at 37 °C, but a fraction is still bound to the cell membrane upon 3 hours of 
incubation (Nomura et al., 2004). Similar results as those for FIPV are obtained for the 
attachment and internalization of porcine reproductive and respiratory syndrome virus 
(PRRSV), another member of the Nidovirales, in macrophages (Nauwynck et al., 1999). 
Attachment of biotinylated PRRSV reaches saturation after 1 hour. After 1 minute, confocal 
images showed uptake of virus particles and after 1 to 2 hours the uptake was completed. 
The kinetics determined for FIPV led to the same conclusion (Nauwynck et al., 1999).  
PRRSV particles start to accumulate in endosomes approximately 1 or 2 hours after the start 
of the virus uptake. For FIPV, more intense and larger fluorescent spots were already 
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observed in confocal images at 15 minutes after the start of virus uptake. TGEV virions start 
to accumulate in endosomes, already 10 minutes after initiation of endocytosis (Hansen et 
al., 1998).  
Another mutual observation between PRRSV and FIPV is the decreasing number of particles 
inside the cell at later time points in the kinetics: for FIPV within 1 hour (data not shown), 
for PRRSV after 3 to 5 hours (Nauwynck et al., 1999). The decreasing number of particles 
explains the apparent drop in internalization described for FIPV I (Black) where the 
percentages of uptake per cell were higher after 1 minute than after 1 hour. The decrease in 
particle number is probably the result of particle disassembly. This has also been described 
for TGEV where genome penetration is situated around 1 hour after the onset of 
internalization (Hansen et al., 1998). 
 
Replication of FIPV is limited to a small fraction (less than 1 % for FIPV 79-1146) of 
monocytes (Dewerchin & Cornelissen, 2005) and peritoneal macrophages (Morahan et al., 
1985; Stoddart & Scott, 1989). However, virus binding and uptake took place in almost all 
monocytes. Thus, the mechanism behind the resistance of most monocytes/macrophages 
must lie in an inhibition of genome release and/or genome translation. Further research will 
clarify which step in virus replication is blocked in cells resistant to FIPV infection. Replication 
of PRRSV in alveolar macrophages is also restricted in a step after binding and 
internalization. Although bound particles and internalization were observed in almost all 
alveolar macrophages, viral PRRSV antigens could be detected in only 12.3 % of the cells 
(Duan et al., 1997; Nauwynck et al., 1999).   
 
Attachment and internalization of FIPV I (Black) virions to the plasma membrane of CrFK 
cells were very inefficient. It is possible that no specific mechanism is involved. Particles may 
accidentally co-internalize with other compounds. The ability of FIPV I (Black) to induce 
infection of CrFK cells was studied by inoculating cells with the same concentration of virus 
as used for determining the kinetics, and a subsequent incubation for 12 hours at 37 °C. 
Staining with polyclonal anti-FIPV antibodies revealed that only 0.003 % of the cells were 
infected (data not shown). Infectivity of FIPV I (Black) in CrFK cells is the subject of 
contradictory literature. According to Black (1980), FIPV strain Black is able to infect and 
cause cytopathogenic effects (CPE) in CrFK cells 3 to 5 days post inoculation. Possibly 
plaques are being formed at later time points post inoculation due to cell-to-cell spread of 
the virus by the few primary infected cells that were observed 12 hours post inoculation. On 
the other hand, Hohdatsu et al. (1998) reported that CrFK cells were not susceptible to 
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infection with FIPV I (Black) as no CPE, nor virus specific antigens could be detected 3 days 
post inoculation. It is possible that the susceptibility of CrFK cells of different laboratories 
may differ due to genetic changes during long term subpassaging of the cell lines.  
CrFK cells are often used as a model cell line for FIPV serotype II infection studies. However, 
internalization of FIPV II (79-1146) was slower and less efficient than in monocytes. Thus, 
FIPV seems to interact differently with CrFK cells than with monocytes. This confirms earlier 
observations where inoculation of CrFK cells with FIPV II (79-1146) resulted in a high 
percentage of infected cells, but low production of newly synthesized virions. In contrast, 
inoculation of monocytes led to a low percentage of infected cells, but to large amounts of 
newly produced virions (Dewerchin et al., 2005).  
 
Viruses may enter cells via two pathways. The envelope of the virion may directly fuse with 
the plasma membrane or the envelope may fuse with the endosomal membrane after 
entering the cell via endocytosis. The pathway used depends upon the virus strain and the 
nature of the cell being infected (Kooi et al., 1991; Nash & Buchmeier, 1997). Certain viruses 
even use both pathways in a particular cell type (Schaeffer et al., 2004). The results of this 
study indicate that bound FIPV particles enter target cells exclusively via endocytosis. Several 
other group 1 coronaviruses have also been shown to enter cells via endocytosis, e.g. HCoV-
229E, TGEV and CCoV. Further research will focus on determining the characteristics of the 
endocytic pathway that is used by the FIPV serotype I and II virions in monocytes.  
 
In this study, kinetics of attachment and internalization of FIPV in its primary target cell, the 
blood monocyte, were studied in detail for the first time. Attachment and especially 
internalization proceeded very efficiently for the strains of both serotypes. Bound particles 
entered target cells via endocytosis and not via fusion. Although infection is restricted to a 
small fraction of monocytes, virus uptake took place in the majority of cells, indicating that 
blocking of infection occurs at the level of genome release or translation/transcription. In 
contrast, attachment and internalization in CrFK cells were shown to proceed inefficiently, 
especially for FIPV I (Black) virions. It is concluded that this cell line is not suitable for 
studying FIPV entry into target cells.  
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ABSTRACT 
 
Two potential receptors have been described for feline coronaviruses (FCoV). Feline APN 
(fAPN) can serve as a receptor for serotype II, but not serotype I, FCoVs in cell lines. 
Secondly, FCoVs can use dendritic cell-specific intercellular adhesion molecule grabbing non-
integrin (DC-SIGN) for entry into host cells. In this study, the interplay between APN and DC-
SIGN as receptors for FIPV was analysed in Crandell feline kidney (CrFK) cells and in 
monocytes. First, the effect of blocking the potential receptor(s) on attachment, 
internalization and infection was evaluated and secondly, the level of co-localization of FIPV 
and the receptors was determined. It was found that blocking fAPN completely inhibited 
binding to and infection of CrFKs and that FIPV co-localized with fAPN. In contrast, on 
monocytes, binding and infection were only reduced by 53 % and 44 % respectively and 
only 60 % of bound FIPV co-localized with fAPN. Transduction of human DC-SIGN was found 
to render CHO cells susceptible to binding and internalization of FIPV but not to infection. 
Blocking feline DC-SIGN (fDC-SIGN) did not influence binding and infection of monocytes 
and there was no co-localization. However, blocking fDC-SIGN caused a further inhibition of 
infection from 56 % up to 18 % infection in APN-blocked monocytes. APN is capable of 
binding and internalizing FIPV and APN-mediated entry leads to infection in monocytes. 
However, this is not the exclusive receptor for FIPV on monocytes, unlike in CrFK cells. fDC-
SIGN is not directly required for attachment or internalization in monocytes, but important 
for infection via an alternative pathway independent of APN. Finally, this study indicates that 
caution should be taken when using certain cell lines for receptor and entry studies. 
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INTRODUCTION 
 
Feline coronaviruses belong to coronavirus subgroup 1 and occur in two pathotypes: the 
often unapparent enteric feline coronavirus (eFCoV) and the deadly feline infectious 
peritonitis virus (FIPV). Each pathotype comprises two serotypes. Serotype I causes most 
natural infections, whereas serotype II is mostly used for research purposes because it 
grows better in culture (Pedersen et al., 1984).  
The process of viral entry is an attractive target for the development of new therapeutic 
agents. To this end, a lot of research has been focussing on entry processes for a range of 
viruses (Cooley & Lewin, 2003; Timpe & McKeating, 2009). This has led to the development 
of a number of promising agents, for example in the treatment of HIV-1 (Cooley & Lewin, 
2003). Over the last couple of years, the knowledge on the entry of feline coronaviruses in 
host cells has expanded. After binding to the receptor(s), the virus is internalized in 
monocytes through endocytosis, more specifically via a clathrin- and caveolae-independent 
pathway using dynamin (Van Hamme et al., 2007, 2008). According to Regan et al. (2008), 
subsequent escape from endosomes is mediated by cathepsin B for FIPV strains 79-1146 
and DF2, while for the enteric strain 79-1683 low pH in endocytic compartments and 
cathepsin L need to assist cathepsin B. In contrast, de Haan et al. (2008) observed that 
infection with FIPV 79-1146 appears to be insensitive to cathepsin inhibitors.   
Two potential receptors have been described for the feline coronaviruses. The first one is  
aminopeptidase N (APN), also designated CD13, a ubiquitous and multifunctional 
glycoprotein of approximately 110 kDa and 967 amino acids (Luan & Xu, 2007). It is a type 
II metalloprotease that contains seven domains (Sjöström et al., 2000). Domains V to VII 
can interact to form non-covalently linked homodimers (Sjöström et al., 2000). Feline APN 
(fAPN) serves as a receptor for feline, canine, porcine and human coronaviruses in 
coronavirus subgroup 1 (Tresnan et al., 1996). However, only serotype II and not serotype I 
FCoV strains are able to recognize fAPN (Hohdatsu et al., 1998; Dye et al., 2007). Binding of 
serotype II strains to fAPN from cell lines can be blocked completely by the monoclonal 
antibody R-G-4 that binds to a region on fAPN between aa 251 to 582, i.e. in domains V or 
VI (Hohdatsu et al., 1998; Tusell et al., 2007). The attachment of FIPV to fAPN was mainly 
studied on cell lines and by means of a fAPN cDNA clone originating from the fcwf-4 cell line. 
Secondly, it has been described that feline coronaviruses use dendritic cell (DC)-specific 
intercellular adhesion molecule (ICAM) grabbing non-integrin (DC-SIGN, CD209) for entry 
into Crandell feline kidney (CrFK) cells, mouse 3T3 cells transfected with DC-SIGN and 
monocytes (Regan & Whittaker, 2008). DC-SIGN is a C-type lectin, which implies that it 
Chapter 4 
 102 
recognizes its ligands, high-mannose oligosaccharides, through Ca2+-dependent 
carbohydrate-recognition domains (Drickamer, 1999). Many viruses, such as HIV, Ebola and 
hepatitis C, use DC-SIGN or the homologue L-SIGN, expressed in liver and lymph nodes, to 
augment infection (Geijtenbeek et al., 2000; Alvarez et al., 2002; Lozach et al., 2003; 
Pöhlmann et al., 2003). Some coronaviruses also interact with these lectins. For SARS-CoV, 
DC-SIGN and L-SIGN can enhance infection of cells that co-express the major SARS 
receptor, ACE2 (Marzi et al., 2004; Jeffers et al., 2004; Yang et al., 2004). DC-SIGN, but not 
L-SIGN, can similarly augment infection with human coronavirus (HCoV) NL63, that also 
relies on ACE2 for infectious entry (Hofmann et al., 2006). Further, L-SIGN expressed in non-
susceptible cells can bind HCoV-229E (Jeffers et al., 2006). For the feline coronaviruses, 
expression of human DC-SIGN in CrFK cells induced an increase of infection that was blocked 
by mannan, a competitor of DC-SIGN binding. Further, infection of feline monocytes, the in 
vivo target cell, was strongly reduced by mannan (Regan & Whittaker, 2008). 
In this study, the role of the candidate receptors was determined in the distinct steps of the 
multi-step entry process in primary target cells, blood monocytes. The effects of blocking 
fAPN and fDC-SIGN in monocytes were studied for the processes of attachment, 
internalization and infection by FIPV 79-1146. In addition, co-localization studies were 
performed between FIPV and these potential receptors. The aim of this study was to 
understand how FIPV interacts with its receptors on the primary FIPV target cells in vivo, the 
blood monocytes.  
 
 
METHODS 
 
Cells and virus 
Feline blood monocytes were isolated from blood collected from a feline coronavirus-, feline 
leukaemia virus- and feline immunodeficiency virus-negative cat and cultured as described 
before (Dewerchin et al., 2005). CrFK cells were purchased from the ATCC. CHO control cells 
and CHO transfectants stably expressing wild-type human DC-SIGN (de Witte et al., 2006) 
were a gift of Dr Geijtenbeek (Department of Molecular Cell Biology and Immunology, VU 
University Medical Centre Amsterdam, Amsterdam, The Netherlands). FIPV serotype II strain 
WSU 79-1146 (FIPV II) was a kind gift of Dr Egberink (Department of Infectious Diseases 
and Immunology, Utrecht, The Netherlands) and passaged on CrFK cells (McKeirnan et al., 
1981).  
 
Role of APN and DC-SIGN in FIPV II entry 
 103
Antibodies  
The monoclonal antibody R-G-4 (mAb R-G-4) directed against feline aminopeptidase N 
(fAPN) (Hohdatsu et al., 1998) was a kind gift of Dr Hohdatsu (Department of Veterinary 
Infectious Diseases, Towada, Japan). The monoclonal antibody 25-2B against fAPN, also 
designated CD13, was purchased from Veterinary Medical Research and Development 
(VMRD, Pullman, USA). A polyclonal mouse antibody raised against full-length human DC-
SIGN, also designated CD209, was purchased from Abnova (Taipei, Taiwan). mAb DH59B 
(VMRD) was used to stain CD172a in the plasma membrane of monocytes. Immunoglobulin 
G1 13D12 against pseudorabies virus gD was produced in the laboratory (Nauwynck & 
Pensaert, 1995) and was used as an irrelevant isotype-matched control antibody. Polyclonal 
anti-FIPV antibodies against FIPV serotype II strain WSU 79-1146 were a kind gift of Dr 
Rottier (Department of Infectious Diseases and Immunology, Utrecht, The Netherlands). 
 
Inhibition assays 
The experimental design to study attachment and internalization separately and the time 
points used to evaluate the potency to inhibit these processes, were determined based on 
data obtained earlier on the kinetics of attachment and internalization of FIPV (Van Hamme 
et al., 2007). 
 
Attachment inhibition assay. Cells were washed at 68 h post-seeding and pre-incubated 
at 4 °C for 60 minutes with mAb R-G-4 (25 mg/ml) and/or mannan (50 mg/ml), or an 
irrelevant isotype-matched mAb. After pre-treatment, FIPV was added to the cells at a 
multiplicity of infection (moi) of 1 (resulting concentrations: 8 mg/ml antibody and/or 16 
mg/ml mannan). Cells and virus were incubated further at 4 °C for 1.5 h (monocytes) or 3 h 
(CrFK and CHO cells). Then, cells were washed with ice-cold RPMI 1640 and fixed with 
formaldehyde (1 %). Bound particles were stained with anti-FIPV-biotin, followed by 
streptavidin-FITC (Molecular Probes-Invitrogen, Merelbeke, Belgium). After mounting of the 
coverslips, attachment was quantified per cell by counting the number of bound particles for 
at least 20 cells.  
 
Entry inhibition assay. Cells were washed at 68 h post-seeding and pre-incubated at 37 
°C for 60 minutes with mAb R-G-4 and/or mannan, or an irrelevant isotype-matched mAb. 
After pre-treatment, FIPV was added to the cells at an moi of 1. Cells and virus were 
incubated at 37 °C for 10 minutes (monocytes) or 1 h (CrFK and CHO cells). Then, cells were 
washed with ice-cold RPMI 1640 and fixed with formaldehyde (1 %). Bound particles were 
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stained with anti-FIPV-biotin, followed by streptavidin-Texas Red (Molecular Probes-
Invitrogen, Merelbeke, Belgium). After permeabilization with Triton X-100 (0.1 %), 
internalized particles were stained with anti-FIPV-biotin, followed by streptavidin-FITC. After 
mounting of the coverslips, internalization was quantified per cell as the ratio of internalized 
virus particles to the total number of cell associated particles. At least ten cells were 
analyzed and all particles over the entire volume of the cell were monitored. 
  
Infection inhibition assay. At 56 h post-seeding, cells were washed with RPMI 1640 and 
pre-incubated for 1 h at 37 °C with mAb R-G-4 and/or mannan, or an irrelevant isotype-
matched mAb. After pre-treatment, FIPV was added to the cells at an moi of 1. Then, after 1 
h the inoculum was replaced by medium supplemented with the antibodies or mannan, at 
the same concentrations as for pre-treatment. The cells were incubated for another 11 h at 
37 °C. Finally, cells were washed, fixed and permeabilized. Permeabilization was followed by 
1 h of incubation at 37 °C with anti-FIPV-FITC and 10 minutes with Hoechst 33342 
(Molecular Probes). Coverslips were mounted onto microscope slides and analyzed by 
confocal microscopy. Cells with cytoplasmic expression of viral proteins were scored as 
infected cells. All cells on the coverslips were evaluated. 
 
Co-localization assays  
Monocytes, CrFK cells and CHO cells were washed at 68 h post-seeding and chilled at 4 °C 
for 20 minutes. Then, cells were inoculated with FIPV at an moi of 1. Cells and virus were 
incubated further at 4 °C for 1.5 h. Then, cells were washed with ice-cold RPMI 1640 and 
fixed with formaldehyde (1 %). Bound particles were stained with anti-FIPV-biotin, followed 
by streptavidin-FITC (Molecular Probes-Invitrogen, Merelbeke, Belgium). Slides were 
incubated with mAb 25-2B to stain fAPN, or with pAb anti-DC-SIGN antibodies to stain DC-
SIGN. The mAb DH59B was used to visualize CD172a (VMRD). As a conjugate, Texas red-
labelled goat anti-mouse antibodies were used (Molecular Probes). Coverslips were mounted 
onto microscope slides and analyzed by confocal microscopy.  
 
Microscopy and statistics 
Infection assays were analyzed by a DM IRB inverted microscope (Leica Microsystems 
GmbH, Wetzlar, Germany). Attachment, internalization and co-localization assays were 
analyzed with a Leica TCS SP2 laser scanning spectral confocal system linked to a DM IRB 
inverted microscope (Leica). Argon and He/Ne lasers were used for exciting FITC and Texas 
red fluorochromes, respectively. Leica confocal software was used for image acquisition.   
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Triplicate assays were performed and compared with the Mann-Whitney U test using the 
SPSS software package (version 12.0, SPSS Inc. Chicago, Illinois, USA). P values < 0.05 
were considered significantly different. 
 
 
RESULTS 
 
Expression of the potential receptors fAPN and DC-SIGN on monocytes  
fAPN was present on all monocytes and it was expressed in the plasma membrane as well as 
in the cytosol. This was assessed by stainings with mAb 25-2B before and after 
permeabilization (Fig. 1). It was, however, remarkable that the R-G-4 epitope was only 
abundantly present extracellularly on approximately 10 % of the monocytes. After 
permeabilization, the R-G-4 epitope could be detected in all cells (Fig. 1). In contrast, on 
CrFK cells, the R-G-4 epitope was extracellularly present on all cells (data not shown). This 
suggests that the expression pattern and/or the conformation of APN is cell type dependent. 
Furthermore, it was shown that the extracellular expression of the R-G-4 epitope on 
monocytes increased over time, from no cells with extracellular R-G-4 epitope expression on 
day 0, up to 16 % of cells with extracellular expression at day 5 post seeding (data not 
shown). For DC-SIGN, practically all monocytes expressed a substantial amount of DC-SIGN 
in their plasma membrane. DC-SIGN was also present intracellular (Fig. 1).  
 
Evaluation of the role of fAPN in FIPV entry  
The role of fAPN as an entry mediator for FIPV was evaluated in CrFK cells and in monocytes 
by means of inhibition studies with mAb R-G-4 and co-localization studies between FIPV and 
fAPN stained with mAb 25-2B.  
 
fAPN is the major receptor for infectious entry on CrFK cells. On CrFK cells, (pre-
)treatment with mAb R-G-4 completely (and significantly) blocked binding of FIPV (Fig. 2). 
Further, viral particles were not observed in CrFK cells treated with this mAb due to the fact 
that there was no virus binding (Fig. 3). This is clear from the picture in Figure 3 where no 
bound particles (in red) are visible. As infection was also blocked completely (and 
significantly) by this antibody (Fig. 4), it is safe to say that internalization after binding to 
fAPN leads to infection. All the particles bound to the cell surface co-localized with the 
epitope bound by mAb 25-2B and therefore co-localized with fAPN (Fig. 5). It is clear that 
fAPN is a necessary receptor for FIPV infection in the CrFK cell line. 
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Figure 1: Expression of fAPN and fDC-SIGN on blood monocytes. fAPN on monocytes was stained 
with two mAbs on the plasma membrane and/or in the cell. DC-SIGN in the plasma membrane of 
monocytes was stained with a pAb.  
 
fAPN is a receptor for infectious entry on monocytes. After incubation of cells with 
mAb R-G-4, attachment of FIPV was significantly reduced to 46.6 % of attachment on 
control cells (Fig. 2). Despite the fact that there was a big reduction by the mAb, this 
inhibition was not complete like observed for the CrFK cells. The internalization of bound 
FIPV in the presence of R-G-4 in monocytes was unaffected (Fig. 3). This means that the 
percentage of the virions that still bound to monocytes in the presence of mAb R-G-4 that 
was internalized, was similar to the percentage of particles that was internalized in the 
absence of inhibition. Particles that got internalized could also productively infect the 
monocyte as infection can be significantly reduced to 56.2 % of the control through 
administration of mAb R-G-4. Co-localization studies showed that 59.9 ± 16.2 % of the FIPV 
particles that bound to monocytes, co-localize with fAPN (Fig. 5). This amount of co-
localization was significantly higher than what was expected based on coincidence (27.8 ± 
5.2 %), as shown by the co-localization staining between FIPV and CD172a, an irrelevant 
surface protein. This confirms the involvement of fAPN in virus binding to monocytes. 
However, a relatively high percentage of binding and infection with FIPV is still unaccounted  
 
25-2B
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+ permeabilisation- permeabilisation
αDC-SIGN
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Figure 2: Attachment of FIPV on CrFK cells, CHO-DC-SIGN cells and monocytes in the presence of 
mAb R-G-4 and/or mannan. Confocal images of single sections through cells are shown. Green dots 
represent bound virus particles. Next to each image the number of particles bound per cell under 
*
*
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the described conditions is indicated. The graphs illustrate FIPV binding per cell in the presence of 
an irrelevant mAb (irr mAb), mAb R-G-4 and/or mannan relative to binding in control cells. Data 
represent means ± standard deviations of triplicate assays. ‘p’ stands for particles. * marks values 
that are significantly different from the control. 
 
for, indicating that fAPN is a receptor for FIPV but not the sole receptor. Moreover, these 
results show that the entry events in CrFK cells do not reflect what occurs in monocytes.     
 
Evaluation of the role of DC-SIGN in FIPV entry  
The role of DC-SIGN as an entry mediator for FIPV was evaluated on wild type CHO cells, 
CHO cells stably transduced with human DC-SIGN and in monocytes by means of inhibition 
studies with mannan and co-localization studies between FIPV antigens and feline DC-SIGN 
stained with pAb anti-DC-SIGN.  
 
Human DC-SIGN (hDC-SIGN) can bind and internalize FIPV. Wild type CHO cells do 
not bind or internalize FIPV (data not shown). However, after stable transduction with hDC-
SIGN, virus binds efficiently to all cells (Fig. 2) and is also able to enter these cells (Fig. 3). 
As virus attachment on the cells can be completely (and significantly) blocked by mannan, 
hDC-SIGN is the virus binding receptor on these cells. This is confirmed by the full co-
localization between FIPV and hDC-SIGN on these cells (Fig. 5). The small number of 
particles that bound to cells in the presence of mannan were not internalized in the cells, 
indicating that DC-SIGN is responsible for both binding and internalization in CHO-DC-SIGN 
cells. The cells are however not susceptible to infection, which means that hDC-SIGN can not 
mediate infectious entry in these cells. 
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Figure 3: Internalization of FIPV in CrFK cells, CHO-DC-SIGN cells and monocytes in the presence of 
mAb R-G-4 and/or mannan. Confocal images of single sections through cells are shown. All red dots 
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represent bound virus particles that are not internalized, while exclusively green dots represent 
internalized virus particles. Next to each image the percentage of internalized particles (p) per cell 
under the described conditions is indicated. The graphs illustrate the internalization per cell in the 
presence of an irrelevant Ab (irr mAb), mAb R-G-4 and/or mannan relative to internalization in 
control cells. Data represent means ± standard deviations of triplicate assays. * marks values that 
are significantly different from the control. 
 
Role of feline DC-SIGN (fDC-SIGN) in binding and internalization of FIPV in target 
cells. As hDC-SIGN can bind and internalize FIPV particles, the role of fDC-SIGN, naturally 
present on the in vivo target cells for FIPV, was evaluated in monocytes. Figure 2 showed 
that blocking fDC-SIGN with mannan had no effect on virus binding. This was further 
confirmed by the fact that combining mannan and R-G-4 did not significantly increase the 
inhibition of attachment caused by R-G-4. Accordingly, internalization could not be influenced 
by the presence of mannan alone or a combination of mAb R-G-4 and mannan (Fig. 3). For 
infection, like for attachment and internalization, no inhibiting effect was observed when only 
mannan was added. This suggests that fDC-SIGN is not involved in the entry process of FIPV 
in primary cells and that the binding capacities of hDC-SIGN observed in cell lines do not 
reflect the situation in the natural target cells. The results of the co-localization study 
between FIPV and fDC-SIGN on monocytes supported this conclusion as the observed co-
localization of 28.9 ± 4.5 % did not significantly exceed the level of ‘background’ co-
localization (27.8 ± 5.2 %; Fig. 5). However, when both mAb R-G-4 and mannan were added 
to the cells, infection was reduced significantly more efficiently than when only 
aminopeptidase N was blocked: a reduction to 17.8 % of infection in control cells compared 
to 56.2 % when only APN is blocked. Based on these results, it appears that fDC-SIGN does 
seem to have a role in the infection process, even though the underlying mechanism remains 
elusive thus far.  
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Figure 4: Graph illustrating the percentage of infected cells in the presence of an irrelevant mAb (irr 
mAb), mAb R-G-4 and/or mannan relative to the percentage of infected control cells. Data 
represent means ± standard deviations of triplicate assays. * marks results that are significantly 
different from the control. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
%
 o
f i
nf
ec
te
d
ce
lls
re
la
tiv
e
to
 c
on
tro
l
0
20
40
60
80
100
120
140
co
nt
ro
l
irr
 m
A
b
R
G
4
co
nt
ro
l
irr
 m
A
b
R
G
4
m
an
na
n
R
G
4+
m
an
na
n
CrFK MONOCYTES
%
 o
f i
nf
ec
te
d
ce
lls
re
la
tiv
e
to
 c
on
tro
l
co
nt
ro
l
irr
 m
A
b
R
G
4
co
nt
ro
l
irr
 m
A
b
R
G
4
m
an
na
n
R
G
4+
m
an
na
n
*
*
*
Chapter 4 
 112 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5: Co-localization of FIPV with membrane proteins. Co-localization stainings are performed 
after attachment of FIPV to the cells at 4 °C. FIPV was stained with biotinylated anti-FIPV 
antibodies and streptavidin-FITC. fAPN was stained with mAb 25-2B, and hDC-SIGN and fDC-SIGN 
with pAbs. All these Abs were visualized with goat anti-mouse-Texas Red antibodies. The figure 
shows confocal images of single sections through cells. 
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DISCUSSION 
 
The main goal of this study was to evaluate the role and interplay of two described receptors 
for FIPV, aminopeptidase N (APN) and DC-SIGN, in its natural host cell, the monocyte. This 
was pursued through a combination of inhibition assays at different stages of the entry 
process, infection inhibition assays and co-localization studies.  
 
Feline aminopeptidase N (fAPN) was shown before to be a receptor for type II FIPV on cell 
lines (Tresnan et al., 1996; Hohdatsu et al., 1998; Dye et al., 2007). Our results confirmed 
and extended these findings showing that fAPN is a necessary receptor for FIPV II on CrFK 
cells and the major attachment receptor on these cells. Although it was not possible to 
confirm that fAPN is also involved in the subsequent internalization of the virus in CrFK cells, 
as virus did not bind in the presence of mAb R-G-4 (directed against fAPN), it is most likely 
as FIPV was found to co-localize with fAPN inside these cells (data not shown). For human 
coronavirus 229E, that uses human APN as a receptor, it was also indirectly shown that APN 
is involved in internalization. The virus was shown to co-localize with caveolin inside human 
fibroblast cells, and caveolin was shown to co-localize with APN inside the cells (Nomura et 
al., 2004).  
On feline monocytes, fAPN also acts as a virus binding receptor. However, it is not the only 
receptor as virus binding could not be completely blocked by anti-fAPN antibodies (mAb R-G-
4). The internalization experiments indicated that the fraction of the virus bound to the other 
unknown receptor, that is internalized, is similar to the fraction of bound virus, that is 
internalized when fAPN is available. Further, binding to fAPN can lead to infection as 
infection was reduced by mAb R-G-4. Because blocking fAPN did not completely prevent 
infection, it is most likely that internalization through the other receptor also leads to 
infection.  
Hence, entry in CrFK cells provides useful information about the FIPV-fAPN interaction but 
does not reflect the complete picture of what happens during virus entry in monocytes. This 
is in line with previous findings that indicate that CrFK cells are of limited use as a model cell 
line to study interactions of FIPV with target cells (Dewerchin et al., 2005; Van Hamme et 
al., 2007). 
 
The virus binding and internalizing capacities of human DC-SIGN (hDC-SIGN) became 
evident based on the fact that transduction of CHO cells with hDC-SIGN rendered them 
capable of binding and internalizing FIPV. However, internalization through hDC-SIGN did 
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not lead to infection in these cells. This might be due to the absence of a factor necessary 
for escape of the virions from endosomes as internalization through hDC-SIGN targets the 
endosomal/lysosomal pathway (Engering et al., 2002). Unfortunately, these experiments 
could not be performed with cells transduced with fDC-SIGN, as cloning and characterization 
of the feline homologue has yet to be achieved. This also has hampered research on another 
feline virus, feline immunodeficiency virus (FIV), where interactions between FIV surface 
glycoproteins and hDC-SIGN were shown and the authors remained cautious with 
conclusions towards fDC-SIGN (de Parseval et al., 2004). Nevertheless, the experiments with 
the CHO-hDC-SIGN cells provide a positive control for the set-up of the inhibition and co-
localization assays.  
Even though it would be very interesting to evaluate the FIPV binding and internalizing 
capacities of fDC-SIGN by expressing this protein in non-susceptible cells, there are already 
strong indications that fDC-SIGN is not necessary for virus binding and internalization in its 
natural host cell, the monocyte. Blocking fDC-SIGN with mannan on monocytes did not affect 
FIPV binding and internalization. Also infection of monocytes was not affected by blocking 
DC-SIGN with mannan. Additionally, when fAPN is blocked, FIPV binding does not transfer to 
fDC-SIGN because even then virus binding is not reduced by mannan. It seems clear that 
fDC-SIGN is not the unknown receptor for FIPV that is responsible for the fraction of binding 
and infection that remains after blocking fAPN. However, treating fAPN-blocked cells with 
mannan, did cause a supplemental reduction of infection. The involvement of DC-SIGN is 
most likely situated in a step after internalization because when both fAPN and fDC-SIGN are 
blocked, there is still efficient internalization of bound particles.  
Having listed the results from this study, a comparison can be made with the results 
obtained by Regan & Whittaker (2008). They induced susceptibility to infection in 
unsusceptible cells (mouse 3T3 cells) after transfection with hDC-SIGN. In our study, virus 
internalization could be induced in transfected CHO cells, but infection could not be. A 
possible explanation is that CHO cells lack a factor necessary to release the FIPV genome 
from intracellular vesicles, while this factor is present in the mouse cells used by Regan & 
Whittaker. Further, Regan & Whittaker found that transfection of hDC-SIGN in CrFK cells 
enhanced infection of these cells. This could be explained by increased virus binding and 
internalization. Infection of monocytes could also be blocked with mannan, according to 
Regan & Whittaker. In our hands, no inhibition of infection was observed after treating 
monocytes with mannan. There is no obvious explanation for the different outcome of this 
experiment. Maybe multiple passaging in the laboratory, induced culture adaptations in the 
virus that influence virus-receptor interactions.  
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The data obtained in this study provide the following insights in FIPV type II entry in 
monocytes. Virus can bind to fAPN and will probably be internalized into the cell via this 
receptor. A particle internalized via this pathway can lead to infection of the cell. A second, 
unknown receptor can also bind and internalize FIPV. This pathway probably also leads to 
infection. fDC-SIGN is not the unknown receptor, but can fulfil a role in infection via this 
unknown receptor in a post-internalization step. Hypothetically, fDC-SIGN might be involved 
in genome release of virus that enters cells via the unknown receptor. 
The experiments showed that blocking fDC-SIGN did not affect infection. This might suggest 
that the fAPN-mediated pathway can compensate for fDC-SIGN malfunction or unavailability.  
 
The receptor for serotype I FIPV in monocytes is still unknown. Probably, FIPV type I does 
not use APN (Hohdatsu et al., 1998; Dye et al., 2007). Possibly, the pathway for type II 
using the unknown receptor with/without DC-SIGN might also be the pathway used by type I 
FIPV. This will be studied in the future by comparing binding of FIPV type I to monocytes, 
with binding of FIPV type II in the presence of antibodies against APN on these monocytes. 
Further, the effect of blocking DC-SIGN with mannan, on infection with FIPV type I in 
monocytes will be studied. 
 
An interesting observation was that the epitope recognized by mAb R-G-4 was extracellularly 
present on all CrFK cells, but only on a small fraction of monocytes. Some possible 
explanations might be that the epitope could no longer be recognized by mAb R-G-4 on the 
majority of monocytes because the epitope is masked by glycosylation of sites near the R-G-
4 epitope or by the presence of (other) proteins interacting with APN.  
Because the R-G-4 binding epitope might be different between monocytes and CrFK cells, 
the R-G-4 mAb could be less capable of blocking potential virus binding to monocytes. 
However the virus binding sequences might be intact. This could explain the difference in 
blocking potential of the mAb between CrFK cells and monocytes. In that case, virus binding 
to fAPN would be underestimated on monocytes. However, the co-localization assay seems 
to confirm that not all bound virus is attached to fAPN.  
It would be very interesting to identify the differences between APN expressed on cell lines 
and on primary monocytes and to determine if the FIPV-APN interaction occurs at the same 
epitopes of APN in these different cell types. 
 
Taken together, in this study, the role of aminopeptidase N and DC-SIGN as receptors for 
FIPV were analysed for the first time in the in vivo target cell, the monocyte, at different 
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stages of entry and infection. fAPN is capable of binding and internalizing FIPV in these cells 
and fAPN-mediated entry leads to infection. However, this is not the exclusive receptor for 
FIPV on monocytes, like it appears to be in CrFK cells. DC-SIGN can also play a role during 
FIPV entry in monocytes. However, DC-SIGN is not directly required for attachment or 
internalization, but is probably involved in infection via an alternative pathway independent 
of fAPN. Besides elucidating some aspects about FIPV entry in monocytes, these new 
insights reveal how much is unknown about FIPV entry. This study is again a reminder that 
results of studies obtained in cell culture should be analysed with care, knowing that viruses 
can use different receptors and a variety of cellular proteins to gain entry into different cells.   
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ABSTRACT 
 
Feline infectious peritonitis virus (FIPV), a coronavirus that causes a lethal chronic disease in 
cats, enters feline monocytes via endocytosis. In this study, the pathway of internalization is 
characterized by evaluating the effect of chemical inhibitors and/or expression of dominant-
negative (DN) proteins on the percentage of internalized virions per cell and infection. 
Further, co-localization studies were performed to determine the involvement of certain 
cellular internalization proteins. FIPV is not internalized through a clathrin-mediated pathway, 
as chlorpromazine, amantadine and DN eps15 did not influence virus uptake and FIPV did 
not co-localize with clathrin. The caveolae-mediated pathway could be excluded based on 
the inability of genistein and DN caveolin-1 to inhibit virus uptake and lack of co-localization 
between FIPV and caveolin-1. Dynamin inhibitory peptide and DN dynamin effectively 
inhibited virus internalization. The inhibitor strongly reduced uptake to 20.3 ± 1.1 % of 
uptake in untreated cells. In the presence of DN dynamin, uptake was 58.7 ± 3.9 % relative 
to uptake in untransduced cells. Internalization of FIPV was slightly reduced to 85.0 ± 1.4 % 
and 87.4 ± 6.1 % of internalization in control cells by the sterol-binding drugs nystatin and 
methyl-β-cyclodextrin, respectively. Rho GTPases were inhibited by Clostridium difficile toxin 
B, but no effect was observed. These results were confirmed with infection studies showing 
that infection was not influenced by chlorpromazine, amantadine and genistein but was 
significantly reduced by dynamin inhibition and nystatin. In conclusion, these results indicate 
that FIPV enters monocytes through a clathrin- and caveolae-independent pathway that 
strongly depends on dynamin and is slightly sensitive to cholesterol depletion.  
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INTRODUCTION 
 
Viral entry occurs through a number of successive steps allowing the virus to bring its 
genome inside the cell. The virus either fuses with the host cell membrane or utilizes the 
endocytosis machinery of the cell. Endocytosis can be divided in two categories: 
phagocytosis of large cargo and pinocytosis of smaller cargo (Conner & Schmid, 2003). 
Phagocytosis is an active and highly regulated process involving specific cell surface 
receptors and signalling cascades mediated by Rho GTPases (Hall & Nobes, 2000; Conner & 
Schmid, 2003). Pinocytosis can occur through several pathways. The cargo and its receptor 
determine which pinocytic pathway will be used (Conner & Schmid, 2003). A first possible 
route for pinocytosis is ‘macropinocytosis’ (Swanson & Watts, 1995). Other pathways are 
named after the main structural compound involved: ‘clathrin-mediated endocytosis’ 
(Brodsky et al., 2001) and ‘caveolae-mediated endocytosis’ (Pelkmans & Helenius, 2002). 
Finally, there is a group called ‘clathrin- and caveolae-independent pathways’. They are 
differentiated based on their dependency on cholesterol and/or association with lipid rafts, 
dynamin and Rho GTPases (Nichols & Lippincott-Schwartz, 2001; Conner & Schmid, 2003). 
Viruses are specialized in misusing these endocytic pathways to gain entry into the cell 
(Sieczkarski & Whittaker, 2002a; Pelkmans & Helenius, 2003). 
Recently, we have demonstrated that feline infectious peritonitis virus (FIPV), a devastating 
coronavirus in cats, enters its host cell, the monocyte, via endocytosis (Van Hamme et al., 
2007). The pathway used is unknown. Transmissible gastro-enteritis virus (TGEV), canine 
coronavirus and human coronavirus 229E (HCoV-229E) are coronaviruses that - like FIPV - 
belong to phylogenetic group 1. They have all been shown to enter cells via endocytosis 
(Hansen et al., 1998; Savarino et al., 2003; Nomura et al., 2004). The pathways used for 
internalization have not been studied, except for HCoV-229E that enters human fibroblast 
cells through the caveolae-mediated pathway (Nomura et al., 2004). Severe acute 
respiratory syndrome (SARS), an emerging disease in humans, is caused by a coronavirus 
belonging to phylogenetic group 2 (Kim et al., 2006). Due to its threat, many studies have 
been done to better understand how the virus interacts with its host and host cells. It was 
shown that SARS virus enters HepG2 cells expressing ACE2 via pH-dependent endocytosis 
through clathrin-coated vesicles (Yang et al., 2004; Inoue et al., 2007). More recently, SARS 
virus was shown to enter Vero E6 cells through receptor-mediated, clathrin- and caveolae-
independent endocytosis, likely involving lipid rafts (Wang et al., 2008). The entry of murine 
coronavirus, also belonging to group 2, is extensively studied. Although entry via non-
endosomal routes has been suggested, recent publications assign a major role for 
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cholesterol-dependent endocytosis, possibly through clathrin-coated pits, in murine cells 
(Thorp & Gallagher, 2004; Choi et al., 2005; Eifart et al., 2007). 
In this study, the mechanism of internalization of FIPV in monocytes was determined 
through chemical inhibition of internalization, transduction of monocytes with constructs to 
induce expression of dominant-negative (DN) proteins that hinder some pathways and co-
localization studies. Our results indicate that FIPV is internalized through a clathrin- and 
caveolae-independent pathway that strongly depends on dynamin and is slightly cholesterol 
depletion sensitive.   
 
 
METHODS 
 
Cells and virus 
Monocytes were isolated from blood, collected from feline coronavirus-, feline leukaemia 
virus- and feline immunodeficiency virus-negative cats as described previously (Dewerchin et 
al., 2005) and seeded on glass coverslips in medium [RPMI 1640 enriched with 10 % fetal 
bovine serum, 0.3 mg glutamine ml-1, 1mM sodium pyruvate and 1 % non-essential amino-
acids 100x (GIBCO-Invitrogen)]. Cells consisted of 86 ± 7 % monocytes. FIPV serotype II 
strain 79-1146 was kindly provided by Dr Egberink (Faculty of Veterinary Medicine, Utrecht 
University, The Netherlands) and passaged in a feline cell line (CrFK) (McKeirnan, et al., 
1981). Batches of culture fluids were purified by ultracentrifugation and purified virus was 
biotinylated as described previously (Van Hamme et al., 2007). Purified viral particle 
suspension (200 µg) was applied to 104.4 monocytes throughout the experiments. This 
amount of suspension contains 5.0 x 1010 virus particles of which 1.9 x 105 particles are 
infectious (Van Hamme et al., 2007). This suspension was used exclusively in entry assays, 
not in the infection and co-localization studies. 
  
Entry inhibition assay 
Monocytes were washed extensively at 68 h post-seeding and pre-incubated at 37 °C for 30 
minutes with one of the following compounds dissolved in RPMI 1640 (Gibco-Invitrogen) (all 
products were purchased from Sigma-Aldrich; unless stated otherwise): 0.1 µM wortmannin, 
20 µM latrunculin B (ICN Biochemicals), 2 µM chlorpromazine, 500 µM amantadine, 50 µg 
nystatin ml-1, 10 mM methyl-β-cyclodextrin, 50 µg genistein ml-1, 40 and 80 µM dynamin 
inhibitory peptide (dip) (batch 5 - Tocris Cookson) or 0.74 nM Clostridium difficile toxin B. 
Working concentrations were optimized qualitatively in internalization assays with control 
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ligands while insuring that viability of the cells was always over 99%. After pre-treatment, 
monocytes were inoculated with biotinylated FIPV in the presence of the compound used for 
pre-treatment. Cells and virus were incubated at 37 °C for 1 h. Then, cells were briefly 
washed with ice-cold RPMI 1640 and fixed with formaldehyde (1 %). Bound particles were 
stained with streptavidin-Texas red (Molecular Probes) and after permeabilization with Triton 
X-100 (0.1 %) internalized particles were stained with streptavidin-fluorescein isothiocyanate 
(FITC) (Molecular Probes). After mounting of the coverslips, internalization was quantified 
per cell as the ratio of internalized virus particles to the total number of cell-associated 
particles. At least ten cells were analysed and all particles over the entire volume of the cell 
were monitored. The procedure described above, from seeding of the cells up to the 
analysis, was performed three times. 
To assess the effectiveness of all agents, internalization of biotinylated transferrin (Sigma-
Aldrich), FITC-labelled albumin and fluorescent 1µm FluoSpheres (Molecular Probes) was 
studied in the presence of appropriate inhibitors. After fixation and permeabilization, 
biotinylated transferrin was visualized with streptavidin-FITC and in the cells incubated with 
fluorescent beads, cortical actin was stained using falloidin-Texas red (Molecular Probes). 
Coverslips were mounted on microscope slides and analysed by confocal microscopy. Cells 
were scored as internalizing cells if all control ligands were internalized. For each experiment 
50-100 cells were analysed and experiments were performed three times. 
 
Plasmid constructions and production of lentiviral supernatants  
Transfer vectors were prepared by deletion of green fluorescent protein (GFP) from the 
TRIP∆U3-CMV-GFP-WPRE vector (=TRIP∆U3-CMV-WPRE). The enhanced GFP (EGFP) tagged 
DN eps15 construct, named DIII and the EGFP tagged control construct D3∆2, a kind gift 
from Dr Benmerah (Benmerah et al., 1998), were excised from pEGFP-C2 and cloned into 
TRIP∆U3-CMV-WPRE. EGFP tagged wild type (WT) and DN caveolin-1, a kind gift from Dr 
Helenius (Kurzchalia et al., 1992; Pelkmans et al., 2001), and WT and DN dynamin 2(aa), a 
kind gift from Dr McNiven (Cao et al., 1998; 2000) are also cloned into TRIP∆U3-CMV-WPRE. 
Biological activity of the constructs in the original plasmids and after transfer into pTRIP∆U3-
CMV-WPRE was tested in CrFK cells.  
pMD.G and p8.91 were used as envelope and packaging plasmids, respectively, as described 
previously (Stove et al., 2005).  At 70 % confluency, 293FT cells (Invitrogen) were co-
transfected with 1.66 µg packaging plasmids, 3.33 µg envelope plasmids and 3.33 µg 
transfer plasmids using a calcium phosphate transfection kit (Invitrogen). Lentiviral 
supernatants were harvested after 40 h (Stove et al., 2005). 
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Inhibition of virus internalization pathways through lentiviral gene 
transfer  
At 3 h post-seeding, cells were washed and medium was replaced by lentiviral supernatants. 
At 24 h post-seeding, cells were washed and fresh medium was added. Internalization 
assays were performed at 68 h post-seeding. After washing the cells, biotinylated FIPV was 
added and incubated with the cells for 1 h at 37 °C. Then, cells were briefly washed with ice-
cold RPMI 1640 and fixed with formaldehyde (1 %). Bound particles were stained with 
streptavidin-Alexa Fluor 350 (Molecular Probes) and after permeabilization with Triton X-100 
(0.1 %) internalized particles were stained with streptavidin-Texas red. Coverslips were 
mounted and the level of internalization was quantified as described above. 
For the controls, transduced cells were incubated with biotinylated transferrin or biotinylated 
cholera toxin B (Sigma-Aldrich). After fixation and permeabilization, ligands were visualized 
with streptavidin-Texas red. Coverslips were mounted onto microscope slides and analysed 
by confocal microscopy. Cells were scored as internalizing cells if all control ligands were 
internalized. 
 
Co-localization with clathrin 
At 68 h post-seeding, cells were washed with RPMI 1640 (37 °C) and incubated with non-
biotinylated FIPV at an m.o.i. of 5 for 0, 5, 15 and 45 minutes at 37 °C. Then, cells were 
washed with RPMI 1640 and fixed. Cells were washed again, first with RPMI 1640 followed 
by Tris-buffered saline (TBS; 20 mM Tris/HCl, 150 mM NaCl, pH 7.5) with 4.5 % sucrose and 
2 % inactivated goat serum (TBS-GS) and permeabilized with methanol for 30 s at -20°C 
(Racoosin & Swanson, 1994). Clathrin was stained with anti-clathrin heavy-chain IgM 
antibodies (ICN Biochemicals), diluted 1 : 50 in PBS supplemented with 0.3 % gelatine (PBS-
G) (Van de Walle et al., 2001; Misinzo et al., 2005). Afterwards, cells were washed in TBS-
GS and incubated for 1 h at 37 °C with biotin-labelled goat anti-mouse IgM antibodies (Santa 
Cruz Biotechnology) diluted 1 : 100 in PBS-G. Then, cells were washed and incubated with 
streptavidin-Texas red (Molecular Probes) diluted 1 : 50 in PBS-G. After washing, FIPV was 
stained with anti-FIPV-FITC [Veterinary Medical Research Development (VMRD)]. Coverslips 
were mounted on microscope slides and analysed by confocal microscopy. 
    
Co-localization with caveolin-1 
At 68 h post-seeding, cells were washed with RPMI 1640 (37 °C) and incubated with non-
biotinylated FIPV at an m.o.i. of 5 for 0, 5, 15 and 45 minutes at 37 °C. Then, cells were 
washed with RPMI 1640 and fixed. Cells were permeabilized with Triton X-100 (0.1 %) and 
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washed with PBS. Caveolin-1 was stained with polyclonal rabbit anti-caveolin-1 antibodies 
(Abcam), diluted 1 : 200 in PBS, by incubation for 1 h at 37 °C. Afterwards, cells were 
washed and incubated for 1 h at 37 °C with Texas red-labelled goat anti-rabbit antibodies 
(Molecular Probes) diluted 1 : 100 in PBS. After washing, FIPV was stained with anti-FIPV-
FITC. Coverslips were mounted onto microscope slides and analysed by confocal microscopy. 
 
Infection inhibition assay  
At 56 h post-seeding, cells were washed with RPMI 1640 and pre-incubated for 30 minutes 
at 37 °C with inhibitory compounds (wortmannin, latrunculin B, chlorpromazine, amantadine, 
nystatin, genistein, dip and toxin B) dissolved in RPMI 1640. Then, cells were inoculated with 
non-biotinylated FIPV (m.o.i. of 1 except for dip and the corresponding control: m.o.i. of 0.1 
of FIPV grown in serum-free medium) in the presence of the inhibitors in RPMI and 
incubated at 37 °C. After 1 h the inoculum was washed off and cells were treated with a 
trypsin/EDTA (0.25 %/0.02 % in RPMI) solution for 5 minutes at 37 °C to remove bound, 
non-internalized virus particles from the plasma membrane. Figure 1 shows the effective 
removal of non-internalized virus particles by this method. Thereafter, cells were extensively 
washed with RPMI 1640 and medium was added. After 11 h of incubation at 37 °C, cells 
were washed, fixed and permeabilized. Permeabilization was followed by 1 h of incubation at 
37 °C with anti-FIPV-FITC and 10 minutes with Hoechst 33342 (Molecular Probes). 
Coverslips were mounted onto microscope slides and analysed by confocal microscopy. Cells 
with cytoplasmic expression of viral proteins were scored as infected cells. All cells on the 
coverslips were evaluated. 
 
 
 
 
 
 
Figure 1: Confocal images of single sections through monocytes. Green signals represent attached 
FIPV virions without and with trypsin/EDTA treatment. 
 
Microscopy and statistics 
Internalization and infection assays were analysed by a DM IRB inverted microscope (Leica 
Microsystems). Images of internalization assays were obtained with a Leica TCS SP2 laser 
scanning spectral confocal system linked to a DM IRB inverted microscope (Leica). Argon 
     +Trypsin/EDTA - Trypsin/EDTA 
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and He/Ne lasers were used for exciting FITC and Texas red fluorochromes, respectively. 
Leica confocal software was used for image acquisition.   
Triplicate assays were performed and compared using the Mann-Whitney U test from the 
SPSS software package (version 12.0, SPSS). P ≤ 0.05 were considered significantly 
different. 
 
 
RESULTS 
 
FIPV entry does not occur via phagocytosis nor macropinocytosis  
Wortmannin and latrunculin B interfere with phagocytosis and macropinocytosis through 
their action on phosphatidyl-inositol-3 kinases and actin respectively (Spector et al., 1983; 
Araki et al., 1996). The influence of these compounds on the internalization of FIPV in 
monocytes was studied. Wortmannin and latrunculin B reduced the uptake of control ligands 
(fluorescent beads) significantly to 36.6 ± 4.0 % and 17.2 ± 3.8 %, respectively, relative to 
the untreated controls. The internalization of FIPV was unaffected: 104.7 ± 9.9 % for 
wortmannin and 100.1 ± 9.0 % for latrunculin B relative to the untreated controls (Fig. 2). 
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Figure 2: The effect of various inhibitors on the internalization of control ligands and biotinylated 
FIPV in monocytes. Cells were pre-treated with the inhibitors for 30 minutes at 37°C. Respective 
control ligands (‘c-lig’) or FIPV were added to the cells and subsequently incubated with the cells in 
the presence of the inhibitor for 1h at 37°C. After fixation and staining, internalization was 
quantified. Percentages shown are relative to internalization of control ligands or FIPV without 
inhibitor (control). Data represent means ± standard deviations of triplicate assays. * marks values 
that are significantly different from the control. 
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FIPV entry is mediated by a clathrin-independent pathway 
The internalization of several ligands into the cell occurs through clathrin-coated pits. To 
determine whether FIPV enters monocytes through this pathway, cells were treated with 
chlorpromazine and amantadine, both are potent inhibitors of clathrin-mediated 
internalization (Phonphok & Rosenthal, 1991; Wang et al., 1993). Transferrin uptake occurs 
constitutively via clathrin-mediated endocytosis, and was therefore used as a control 
(Harding et al., 1983). After treatment of monocytes with chlorpromazine and amantadine, 
transferrin uptake was reduced significantly to 28.9 ± 0.4 % and 13.0 ± 15.4 % respectively, 
of the control. The internalization of FIPV, however, remained at the same level (94.0 ± 5.0 
% and 99.3 ± 9.2 % of the control for chlorpromazine and amantadine, respectively), 
despite the presence of inhibitors (Fig. 2).  
Secondly, monocytes were transduced with a control construct (D3∆2) or with DN eps15 
(DIII). Eps15 protein is crucial for clathrin-mediated endocytosis (Benmerah et al., 1998). To 
assess the effectiveness of the constructs, internalization of transferrin was studied in 
transduced cells: in cells with D3∆2, the uptake was 103.3 ± 21.7 % relative to the uptake in 
untransduced control cells; in DIII transduced cells, the uptake was 47.9 ± 8.5 % relative to 
the control. Thus, the uptake of transferrin was reduced significantly relative to the uptake in 
D3∆2 transduced cells. The internalization of FIPV showed no reduction: in cells with D3∆2, 
the uptake was 98.3 ± 0.7 % relative to the uptake in untransduced control cells; in DIII 
transduced cells, the uptake was 90.3 ± 10.6 % relative to the control. Thus, transduction 
with dominant negative eps15 did not influence the cell’s ability to internalize FIPV (Fig. 3, 
1A-B).  
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Figure 3: Internalization of control ligands and biotinylated FIPV in transduced monocytes. After 
transduction, cells were incubated with control ligands or FIPV for 1h at 37°C. Finally, cells were 
fixed, permeabilized and stained. The results depicted in panel 1 were obtained in untransduced 
cells and in cells transduced with constructs D3∆2 and DIII, for non-functional and functional 
eps15. The results depicted in panel 2 were obtained in untransduced cells and in cells transduced 
with wild type (WT) and dominant-negative (DN) constructs for caveolin-1 (‘cav’). The results 
depicted in panel 3 were obtained in untransduced cells and in cells transduced with WT and DN 
constructs for dynamin 2(aa) (‘dyn’). Panels A show the graphs in which the quantified 
internalization for both control ligands (transferrin ‘c-Tfn’ and Cholera toxin B ‘c-Chol tox B’) and 
FIPV is represented by percentages relative to internalization in untransduced cells. Panels B 
represent confocal images of monocytes. Single optical sections through the cell are depicted. The 
green signal indicates expression of the transferred gene and the red signal represents control 
ligands or FIPV inside the cell. * marks values that are significantly different from the control. 
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Finally, no co-localization between clathrin molecules and FIPV proteins was detected 
between 0 and 45 minutes after the start of virus uptake (Fig. 4). Taken together, the 
experiments clearly show that clathrin is not involved in the internalization of FIPV in 
monocytes. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4: Visualization of FIPV and clathrin during internalization. Confocal images of single 
sections through cells are shown. Green signals represent FIPV stained with anti-FIPV-FITC and red 
signals represent clathrin stained by anti-clathrin heavy-chain IgM antibodies, biotin-labelled goat 
anti-mouse IgM antibodies and streptavidin-Texas red. 
 
FIPV entry is mediated by a caveolae-independent pathway 
Another well characterized pathway is caveolae-mediated endocytosis. Like lipid rafts, 
caveolae are rich in cholesterol and sphingolipids (Brown & London, 1998; Simons & 
Toomre, 2000). Therefore, sterol-binding drugs, like nystatin and methyl-β-cyclodextrin, 
disrupt the caveolar function (Rothberg et al., 1992). Genistein blocks caveolae-mediated 
internalization through inhibition of protein tyrosine kinases. The effect of these drugs on 
FIPV internalization was investigated. Albumin is internalized through caveolae and was used 
as a control ligand (Schnitzer et al., 1994). Nystatin and methyl-β-cyclodextrin reduced the 
uptake of albumin to 54.9 ± 14.5 % and 22.2 ± 4.4 %, respectively, of the control. The 
uptake of FIPV was reduced slightly to 85.0 ± 1.4 % and 87.4 ± 6.1 %, respectively, of the 
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control (Fig. 2). Genistein reduced internalization of albumin significantly to 32.6 ± 5.3 % of 
the control. However, internalization of FIPV was unaffected (107.1 ± 10.7 % of the control) 
(Fig. 2). Thus, despite the slight effect of sterol-binding drugs, caveolae are probably not 
involved in FIPV entry as it is not affected by genistein.  
Another experiment was performed to confirm that caveolae do not play a role in the 
internalization of FIPV. The most important protein compounds of the caveolae are 
caveolins. The presence of DN caveolin-1 directly inhibits the endocytic process through 
caveolae (Pelkmans et al., 2001; Pelkmans & Helenius, 2002). Monocytes were transduced 
with either WT or DN caveolin-1. To confirm the effectiveness, the uptake of Cholera toxin B 
was studied in transduced cells (Montesano, et al., 1982; Parton et al., 1994): in cells with 
WT caveolin-1, the uptake was 105.1 ± 3.2 % relative to the uptake in untransduced control 
cells and in cells with DN caveolin-1, the uptake was 34.8 ± 7.8 % relative to the uptake in 
untransduced control cells. For FIPV, no reduction was observed: in cells with WT caveolin-1, 
FIPV uptake was 102.1 ± 3.4 % and in cells with DN caveolin-1, FIPV uptake remained at 
100.1 ± 7.1 % relative to the untransduced control (Fig. 3, 2A-B). These results indicate that 
caveolin-1 is not involved in FIPV entry.  
Further, most FIPV protein clusters (93.1 ± 4.1 %) did not co-localize with caveolin-1 
between 0 and 45 minutes after the start of virus uptake (Fig. 5). Only occasionally, particles 
were found in the proximity of caveolin-1. A co-localization study between caveolin-1 and an 
irrelevant protein (transferrin) showed that the observed level of co-localization does not 
exceed the expected level for coincidental co-localization (data not shown). 
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Figure 5: Visualization of FIPV and caveolin-1 during internalization. Confocal images of single 
sections through cells are shown. Green signals represent FIPV stained with anti-FIPV-FITC and red 
signals represent caveolin-1 stained by rabbit polyclonal anti-caveolin-1 antibodies and goat anti-
rabbit-Texas red. The arrows indicate the few sites of co-localization. In the first picture (5min) 
FIPV and caveolin-1 completely co-localize, in the last picture (45min) they only partly co-localize.  
 
Thus, both clathrin- and caveolae-mediated pathways are not involved in FIPV entry in 
monocytes. The sterol-binding inhibitors, nystatin and methyl-β-cyclodextrin, slightly 
influenced the uptake of FIPV in monocytes.  
 
FIPV entry depends on dynamin 
Dynamin is a GTPase that is involved in many internalization pathways: phagocytosis, 
clathrin-mediated internalization, caveolae-mediated internalization and some clathrin- and 
caveolae-independent pathways (Gold et al., 1999; Hinshaw, 2000; Mayor & Pagano, 2007). 
Dynamin is thought to pinch off formed vesicles from the plasma membrane (Hinshaw, 
2000). Cells were treated with dynamin inhibitory peptide (dip) and analysed for 
internalization of the control ligand transferrin and FIPV (Grabs et al., 1997). Dip (40 µM) 
reduced transferrin uptake significantly to 27.4 ± 8.4 % relative to the uptake in untreated 
cells. For FIPV, a strong, significant reduction was observed to 40.1 ± 9.6 % and 20.3 ± 1.1 
% of the uptake in control cells for 40 and 80 µM, respectively, of dynamin inhibitor (Fig.2). 
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To confirm these results, the uptake of FIPV was studied in cells transduced with WT and DN 
dynamin 2(aa) (Cao et al., 1998; 2000). The effectiveness of transduction was studied by 
monitoring the uptake of transferrin in transduced cells: in cells with WT dynamin 2(aa), the 
uptake was 86.5 ± 13.4 % relative to the uptake in untransduced control cells and in cells 
with DN dynamin 2(aa), the uptake was 39.0 ± 12.2 % relative to the uptake in 
untransduced control cells. Internalization of FIPV was reduced significantly in cells 
expressing DN dynamin 2(aa), compared with cells expressing WT dynamin 2(aa): in cells 
with WT dynamin 2(aa), FIPV uptake was 105.6 ± 6.3 % and in cells with DN dynamin 2(aa), 
FIPV uptake was 58.7 ± 3.9 % relative to the uptake in untransduced control cells (Fig. 3, 
3A-B). Clearly, dynamin plays an important role in the internalization of FIPV in monocytes. 
 
Rho GTPases are not involved in FIPV entry 
Several independent internalization pathways have been characterized by their dependency 
on Rho GTPases (Mayor & Pagano, 2007). Rho GTPases are a subfamily of the Ras 
superfamily of small GTPases. They play an important role in regulating the actin 
cytoskeleton and in a broad range of aspects of endocytic traffic (Hall, 1998; Ellis & Mellor, 
2000). Rho GTPases are involved in phagocytosis and macropinocytosis and also in clathrin- 
and caveolae-mediated internalization pathways (Ellis & Mellor, 2000; Grimmer et al., 2002). 
To determine whether they are involved in the internalization of FIPV in monocytes, cells 
were treated with Clostridium difficile toxin B, a general Rho GTPase inhibitor (Just et al., 
1995). The activity of the inhibitor was confirmed by its effect on the internalization of 
fluorescent beads: a significant reduction to 10.0 ± 2.2 % of the uptake in untreated cells 
(Fig. 2). The internalization of FIPV was not significantly affected: internalization remained at 
the level of 89.2 ± 11.1 % of the control. These results were confirmed by less general Rho 
GTPase inhibitors like Rac1 inhibitor (Calbiochem), secramine A [inhibits Cdc42 activation 
(Pelish et al., 2006)] and Y-27632 (selective inhibitor of the Rho associated protein kinase 
ROCK; Sigma-Aldrich) (data not shown). 
 
The effect of entry inhibitors on FIPV infection 
After establishing the effect of inhibitors on the uptake of virus, the effect on infection was 
studied. Therefore, cells were inoculated and incubated with FIPV in absence and in 
presence of entry inhibitors. Bound, non-internalized virions were removed from the cell 
surface by trypsin wash. Viral replication was stopped after 1 cycle of replication, i.e. at 12 h 
post inoculation. Figure 6 shows that the inhibitors that did not significantly influence FIPV 
entry, had no effect on infection rates. The actual influence of the inhibitors on percentages 
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of infected cells were from 2.1 to 1.9 % for wortmannin, 1.9 to 1.7 % for latrunculin B, 2.1 
to 2.1 % for chlorpromazine, 1.9 to 2.3 % for amantadine, 1.9 to 1.9 % for genistein and 
1.9 to 2.4 % for toxin B. However, inhibition of FIPV internalization by dynamin inhibitory 
peptide is reflected in significantly reduced infection (45.7 ± 10.3 % and 23.0 ± 9.5 % of 
infection of control cells for 40 and 80 µM, respectively, of dynamin inhibitor or reductions 
from 0.48 to 0.22 % and 0.32 to 0.065 % infected cells). Nystatin treatment during entry led 
to a reduction to 61.7 ± 5.2 % of infection of control cells or absolutely from 1.9 to 1.2 % 
infected cells.  
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Figure 6: The effect of various entry inhibitors on infection of monocytes with FIPV. Cells were pre-
treated with the inhibitors for 30 minutes at 37°C. FIPV was added to the cells in the absence 
(‘control’) or presence of inhibitor and subsequently incubated with the cells for 1h at 37°C. After 
trypsin wash, cells were further incubated for 11h. Then, cells were fixed and stained and infection 
was quantified. Percentages shown are percentages of infected cells in the presence of a certain 
inhibitor, relative to the percentage of infected ‘control’ cells. Data represent means ± standard 
deviations of triplicate assays. * marks values that are significantly different from the control. 
 
  
 
DISCUSSION 
 
Previously, we showed that FIPV enters its target cell via endocytosis and not via direct 
fusion with the plasma membrane (Van Hamme et al., 2007). In the present study, the 
mechanism of endocytosis involved in FIPV entry was determined. Multiple strategies were 
combined: internalization pathways were blocked by use of chemical inhibitors and 
expression of DN mutants, and co-localization assays were performed.  
* *
*
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FIPV is not phagocytosed nor macropinocytosed as the inhibitors wortmannin and latrunculin 
B did not affect the entry and Rho GTPases were not involved in the internalization. 
Independency from clathrin was proven based on the facts that inhibition with 
chlorpromazine and amantadine was ineffective and that expression of DN eps15 had no 
effect on FIPV internalization. FIPV and clathrin did not co-localize either. Further, it was 
shown that caveolae are not involved in FIPV internalization as genistein and expression of 
DN caveolin-1 had no effect on FIPV internalization, and FIPV and caveolin-1 did not co-
localize inside the cell. In conclusion, FIPV enters monocytes through a clathrin- and 
caveolae-independent pathway. This pathway is further characterized by its dependency on 
dynamin and independency from Rho GTPases.  
Further, the sterol-binding drugs nystatin and methyl-β-cyclodextrin slightly affected FIPV 
internalization. Cholesterol depletion affects internalization pathways associated with lipid 
rafts. The association with rafts can be crucial for initiating and proceeding signalling 
cascades necessary for internalization. However, requirement for cholesterol is not 
necessarily related to lipid rafts. For example, cholesterol depletion disturbs clathrin-
mediated internalization, which is not associated with lipid rafts (Subtil et al., 1999; Nichols 
& Lippincott-Schwartz, 2001). As the observed decrease in internalization of FIPV is much 
smaller than the decrease in internalization of the control ligand and as the observed 
reduction due to methyl-β-cyclodextrin is smaller than those described in literature (ranging 
from 30 to >90 % for different pathways) (Rodal et al., 1999; Subtil et al., 1999; Grimmer et 
al., 2002; Sanchez-San Martin et al., 2004; Barrias et al., 2007), it seems likely that the 
pathway is not dependent on cholesterol. Possibly, a fraction of the virus binding receptor is 
present in lipid rafts. Disturbance of rafts could then cause a decrease in receptor 
availability. Reduced virus binding subsequently leads to a drop in the number of internalized 
virions. Further research is needed to confirm the effect of sterol-binding drugs and to 
enlighten the underlying cause. 
To our knowledge, no identical physiological internalization pathway has been described. 
However, the characteristics of the internalization of the β-chain of interleukin 2 receptors 
(IL-2R-β) are very similar to those of FIPV internalization (Lamaze et al., 2001). Like FIPV, 
IL-2R-β  is internalized via a clathrin- and caveolae-independent pathway and is dependent 
on dynamin and sensitive to cholesterol depletion. The sensitivity to cholesterol depletion is 
caused by raft-association of the receptor. A clear difference with the uptake of FIPV, is the 
dependency on Rho GTPases. The internalization of the common cytokine receptor γ (γc) is 
categorized in the same group as the IL-2R-β-pathway (Kirkham & Parton, 2005; Sauvonnet 
et al., 2005). The γc receptor is a subunit shared by several cytokine receptors, namely the 
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IL-2, -4, -7, 9, -15, and -21 receptors (Schluns & Lefrancois, 2003). When expressed by 
itself, the γc receptor is rapidly and efficiently endocytosed (Morelon & Dautry-Varsat, 1998). 
Clathrin- and caveolae-independent pathways have also been linked to the entry of many 
viruses (Marsh & Helenius, 1989; Sieczkarski & Whittaker, 2002a; Sanchez-San Martin et al., 
2004). Like FIPV, SARS virus is internalized through a clathrin- and caveolae-independent 
pathway that is sensitive to treatment with methyl-β-cyclodextrin (Wang et al., 2008). The 
involvement of dynamin and Rho GTPases has however not been studied. Rotavirus cell 
entry resembles FIPV entry as it is also internalized via a clathrin- and caveolae-independent 
pathway that depends on dynamin, but the pathway is highly cholesterol depletion sensitive. 
The role of Rho GTPases in this endocytic process has not been studied either. In addition, 
there are similarities between the entry pathways used by influenza virus and FIPV. 
Influenza virus enters HeLa cells via a clathrin- and caveolae-independent pathway that is 
not associated with lipid rafts. It is not known whether this pathway depends on dynamin 
(Sieczkarski & Whittaker, 2002b). Influenza virus entry in Mv-1 lung cells has been shown to 
depend on dynamin but further characterization has not been performed (Roy et al., 2000). 
As the route of entry depends on the host cell type, it is impossible to predict whether 
influenza virus entry in HeLa cells will also depend on dynamin. Thus, for both FIPV and 
influenza virus, the internalization pathways need further characterization to compare them.  
HCoV-229E belongs to the same phylogenetic group as FIPV and is the only member of the 
group of which the internalization process has been characterized. It was shown that HCoV-
229E binds to its receptor, human aminopeptidase N (APN), in rafts and enters human 
fibroblasts through caveolae (Nomura et al., 2004). Human APN has been reported to be a 
component of rafts in various cell types (Danielsen, 1995; Santos et al., 2000; Riemann et 
al., 2001; Nomura et al., 2004). For TGEV, that is endocytosed after binding to porcine APN, 
it has been suggested that clathrin might be involved in the internalization (Hansen et al., 
1998). For type II FIPV, feline APN is the receptor for entry in cell lines. Whether this is also 
a receptor in primary target cells is not known. Even if APN would be the internalizing 
receptor, no conclusions can be made based on the entry mechanisms of HCoV and TGEV as 
these coronaviruses already use two different mechanisms of internalization through APN.  
 
Despite the low number of infected cells, which is an inevitable obstacle for FIPV research in 
target cells, infection assays in the presence of entry inhibitors qualitatively confirmed the 
results from the internalization assays and show that virions infect their host cell via the 
described pathway. Inhibition of dynamin function and nystatin treatment reduced infection. 
The reduction in infection caused by nystatin is larger than expected based on the reduction 
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of internalization. Possibly, cholesterol binding by nystatin affects post-entry events, e.g. 
intracellular transport, despite the trypsin wash.  
 
In this study, the mechanism of internalization for FIPV 79-1146 in monocytes was 
determined. The pathway is clathrin- and caveolae-independent, strongly depends on 
dynamin and is slightly cholesterol depletion sensitive. The identified pathway proceeds 
similarly, though not exactly like IL-2R-β endocytosis and SARS- and rotavirus entry. Gaining 
insights in the initial virus-cell interactions is valuable in the search for an effective treatment 
or prevention of FIP. Obviously, the pathway should be further characterized and its 
components should be identified in order to obtain well-defined targets for antiviral therapy.     
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ABSTRACT 
 
Upon entry via endocytosis, feline infectious peritonitis virus (FIPV) particles are ‘trapped’ in 
intracellular vesicles. To initiate viral replication, transcription and translation, the virus needs 
to release its genome into the cytosol. This uncoating process occurs through fusion of the 
viral envelope with membranes of the intracellular vesicles. In general, such a process can 
be initiated by low pH, cleavage by proteases, conformational changes by receptor 
interaction or a combination of these factors. In this study, the process of serotype II FIPV 
uncoating was visualized in time by specifically staining nucleocapsids that have been 
released from intracellular vesicles into the cytosol. To perform this staining, the plasma 
membrane was selectively permeabilized without affecting intracellular membranes. At each 
time point, the percentage of cells with genome release was determined. Further, the 
requirement for endosomal low pH for FIPV infection was checked. The results indicate that 
the percentage of cells with genome release increased over time to a maximum (8.4 % of 
the cells) at 35 minutes after the start of internalization, and then decreased again. This 
release did not depend on a low pH as infection could not be blocked by lysosomotropic 
agents. In conclusion, despite the uptake of FIPV in practically all monocytes, release from 
vesicles appears to be restricted to a subpopulation. These findings suggest that the 
presence of uncoating mediators may be a determining factor in cell susceptibility for FIPV 
type II.  
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INTRODUCTION 
 
Entry of enveloped viruses via endocytosis results in intact virions ‘trapped’ in intracellular 
vesicles. Most internalized vesicles travel through the endosomal/lysosomal pathway and the 
virus needs to escape before lysosomal degradation is completed. To escape from 
intracellular vesicles, the viral envelope has to fuse with the membrane of the intracellular 
vesicle. This process is mediated by viral fusion proteins. The viral envelope is left behind in 
the membrane of the intracellular vesicle while the nucleocapsid is released in the cytosol so 
that genome replication, transcription and translation can be initiated.  
Based on structural similarities, there are two classes of viral fusion proteins (Lescar et al., 
2001). Class I viral proteins contain 4,3 hydrophobic (heptad) repeat (HR) regions and an N-
terminal or N-proximal fusion peptide. Class II viral fusion proteins lack HR regions and have 
an internal fusion peptide. The fusion peptide is the actual mediator of fusion. The initiation 
of membrane fusion occurs upon induction of conformational changes in the viral fusion 
protein. These changes bring HR regions in class I fusion proteins in a conformation that 
inserts the fusion peptide into the cell membrane during the fusion event. As a result, the 
cellular and viral membrane are brought closely together for the actual fusion event (Eckert 
& Kim, 2001). 
The viral spike protein is the main protein involved in coronavirus entry. This protein was 
extensively studied for the group 2 coronavirus, mouse hepatitis virus (MHV). The fusion 
core complex was structurally and functionally characterized and the data indicated that this 
coronavirus spike protein is a class I virus fusion protein (Bosch et al., 2003). Sequence 
alignments of HR regions in spike proteins among coronaviruses, including feline coronavirus 
spikes, show significant similarity, suggesting that they all are class I fusion proteins (Xu et 
al., 2004). To bring spike proteins into a fusogenic state, conformational changes in the S-
protein are required. These conformational changes can be induced in several ways (Smith & 
Helenius, 2004). Certain viruses require protonation and depend on the pH drop in late 
endosomes for the initiation of fusion activity. Dependency on low pH in endosomes can be 
shown by inhibiting virus entry by lysosomotropic weak bases like chloroquine or ammonium 
chloride. Other viruses undergo a conformational change through the interaction with a 
certain receptor. A third group requires cleavage by proteases to reveal the fusogenic 
domains. Possibly there are more, still unknown, triggers for fusion.      
There are some data available on uncoating of group 1 coronaviruses. It has been suggested 
that canine coronavirus entry depends on low pH in endosomal organelles (Savarino et al., 
2003). For human coronavirus 229E, both pH drop and proteases, more specifically 
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cathepsin L, are necessary to mediate genome release into the cytosol (Kawase et al., 2009). 
For the group 2a coronavirus MHV, binding of viral spikes of the strains MHV-A59 and MHV-4 
to their receptor induces a conformational change into a fusogenic state (Matsuyama & 
Taguchi, 2002; Zelus et al., 2003; Miura et al., 2004). On the other hand, infection by MHV-3 
is sensitive to lysosomotropic agents and therefore depends on the endosomal pH drop 
(Krzystyniak and Dupuy, 1984). Protease activity is not required. However, for strain MHV-2, 
low pH is not required but cathepsins B and L are (Qiu et al., 2006). For severe acute 
respiratory syndrome virus, a human coronavirus belonging to group 2b, both low pH and 
cathepsins mediate viral entry via endocytosis (Huang et al., 2006; Wang et al., 2008). 
Recently it has been reported that sequential cleavage by trypsin at the S1/S2 boundary and 
inside S2 might prime the spike protein for direct fusion (Belouzard et al., 2009). Avian 
infectious bronchitis virus, a group 3 coronavirus, undergoes a conformational change after 
exposure to low pH, probably inducing membrane fusion after endocytosis (Chu et al., 
2006).  
Studies on uncoating of feline coronaviruses have resulted in many contradictory statements. 
Takano et al. claimed that the entry of feline infectious peritonitis virus (FIPV) strain 79-1146 
depends on acidification of the endosome (2008), while Regan et al. claimed that this is not 
true for FIPV strains 79-1146 and DF2, but only for enteric feline coronavirus (eFCoV) strains 
like 79-1683 (2008). Further, Regan et al. stated that FCoV spikes are cleaved by cathepsins, 
more specifically by cathepsin B for the FIPV strains and both cathepsins B and L for the 
eFCoV strains (2008). However, de Haan et al. claimed that cathepsins are refractory for 
FIPV infection (2008). To provide more insights on these contradictory statements, we 
performed the present study. Therefore, a kinetical study was performed to situate 
uncoating in the entry and infection process. In addition, the effect of pH drop inhibitors on 
FIPV infection was investigated.      
 
 
METHODS 
 
Cells and virus 
Feline blood monocytes were isolated from blood collected from feline coronavirus-, feline 
leukaemia virus- and feline immunodeficiency virus-negative cats and cultured as described 
before (Dewerchin et al., 2005). FIPV serotype II strain WSU 79-1146 was kindly provided 
by Dr Egberink (Department of Infectious Diseases and Immunology, Utrecht, The 
Netherlands) and passaged on CrFK cells (McKeirnan et al., 1981).  
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Antibodies  
The monoclonal antibody (mAb) against FIPV nucleocapsid (N) protein was produced in the 
laboratory as described previously by Lefebvre et al. (2008) after immunization of Balb/c 
mice with FIPV serotype II strain WSU 79-1146 infected cells. Polyclonal anti-FIPV antibodies 
labelled with FITC were purchased from Veterinary Medical Research and Development 
(VMRD). 
 
Lysosomotropic agents 
The lysosomotropic weak base ammonium chloride and bafilomycin A1, a specific inhibitor of 
vacuolar type H+-ATPase (Sigma-Aldrich) were used to prevent acidification of endosomal 
vesicles. Ammonium chloride was used at a concentration of 5 mM and bafilomycin A1 at a 
concentration of 10nM.  
 
Kinetics of uncoating 
At 68 h post seeding, cells were chilled on ice and incubated with virus at 4 °C. After 2 h, 
when the maximal number of virions was bound to the cells as determined previously (Van 
Hamme et al., 2007), cells were shifted to 37 °C. At different time points (after 15, 25, 35, 
45, 55 and 65 minutes), cells were fixed with formaldehyde (1 %). After washing with 
phosphate buffered saline (PBS), cells were put at 4 °C and washed with ice-cold buffer that 
consisted of 110 mM KOAc, 20 mM Hepes at pH 7.2 and 2mM MgCl in ultra pure H2O (KHM 
buffer). Then, the plasma membrane was permeabilized with 30 µg digitonin ml-1 KHM buffer 
for 4 minutes without affecting intracellular membranes. After washing with PBS, released 
nucleocapsid proteins were stained with anti-nucleocapsid mAbs for 1 h at 37 °C. Cells were 
washed and permeabilized with 0.1 % Triton X-100. Finally, virus particles were stained with 
FITC-labelled anti-FIPV antibodies (Molecular probes).  
 
Infection inhibition assay 
At 56 h post-seeding, cells were washed with RPMI 1640 and pre-incubated for 1 h at 37 °C 
with pH drop inhibitors. After pre-treatment, cells were inoculated with FIPV in the presence 
of the inhibitors used for pre-treatment. Cells were infected at an moi of 5. Then, after 1 h 
the inoculum was replaced by medium supplemented with the inhibitors used for pre-
treatment. The cells were incubated for another 11 h at 37 °C. Finally, cells were washed, 
fixed and permeabilized. Permeabilization was followed by 1 h of incubation at 37 °C with 
anti-FIPV polyclonal antibodies labelled with FITC and 10 minutes with Hoechst 33342 
(Molecular Probes). Coverslips were mounted onto microscope slides and analyzed by 
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confocal microscopy. Cells with cytoplasmic expression of viral proteins were scored as 
infected cells. All cells on the coverslips were evaluated. 
 
Microscopy and statistics 
All assays were analyzed by a DM IRB inverted microscope (Leica Microsystems GmbH). 
Triplicate assays were performed and compared using the Mann-Whitney U test from the 
SPSS software package (version 12.0, SPSS). P values ≤ 0.05 were considered significantly 
different. 
 
 
RESULTS 
 
Kinetics of uncoating   
Kinetics of uncoating were determined by evaluating the presence of ‘free’ nucleocapsids in 
the cytosol at different time points after internalization. To visualize these nucleocapsids that 
are released from intracellular vesicles into the cytosol, nucleocapsid protein (N) was stained 
after selectively permeabilizing the plasma membrane (with digitonin), leaving the 
intracellular vesicular membranes intact. At each time point, the percentage of cells with 
released genomes, was determined. The first cells with released genomes in the cytosol, 
appeared immediately after internalization as shown in the kinetics presented in Figure 1. 
The maximum percentage of cells with uncoating of endocytosed particles was observed at 
35 minutes after the start of virus uptake. Then, in 8.4 ± 3.0 % of the cells, nucleocapsids 
were observed in the cytosol. From 35 minutes onwards, that percentage of cells with 
uncoating decreased. This might be due to the release of nucleocapsid protein from the RNA 
genome for translation, transcription and replication. Possibly, single N-proteins are not 
visible under the microscope or they become incorporated in replication/transcription 
complexes and are therefore no longer accessible for antibodies.   
 
Effect of lysosomotropic agents on FIPV infection of monocytes  
Figure 2 shows the influence of treatment of monocytes with ammonium chloride and 
bafilomycin A1 on FIPV infection. None of these pH drop inhibitors had a significant effect on 
FIPV infection. It seems that release from FIP virions out of endosomal/lysosomal vesicles 
does not depend on a drop in pH. 
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Figure 1: (A) Visualization of genome release in monocytes. Virus particles are stained with anti-
FIPV-FITC and released N-protein by a mAb followed by Texas Red labelled goat anti-mouse 
antibodies. The arrows indicate sites of genome release. (B) Kinetics of internalization (open 
squares) and kinetics of uncoating of the FIP virions after endocytosis (filled squares). The 
percentage of monocytes with internalized virions and the percentage of cells with uncoated 
particles released in the cytosol, are represented in function of time after the start of virus uptake. 
Data represent means ± standard deviations of triplicate assays. 
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Figure 2: The influence of lysosomotropic agents on FIPV infection. For monocytes treated with 
ammonium chloride or bafilomycin A1, the relative percentage of infection was determined relative 
to the percentage of infection that was observed in control cells. Data for ammonium chloride 
represent means for duplicate assays, while data for bafilomycin A1 represent means ± standard 
deviations of triplicate assays. 
 
 
DISCUSSION 
 
In this study, the process of uncoating of endocytosed FIP virions was monitored by 
determining the kinetics of uncoating. To selectively visualize uncoated viral genomes in the 
cytosol, the plasma membrane was permeabilized with digitonin that leaves intracellular 
membranes intact. Digitonin permeabilizes membranes by complexing with membrane 
cholesterol, producing holes in the membrane (Schulz, 1990). The selectivity of this process 
is due to the relatively high cholesterol content of the plasma membrane (Adam et al., 
1992). The digitonin-based membrane permeabilization method has been previously applied 
in macrophages by Diaz et al. (1989) and LeDoan et al. (1999).  
Uncoating apparently starts immediately after internalization and at 35 minutes, the 
maximum number of cells in which nucleocapsid is detected in the cytosol, is reached. This 
number decreases after 35 minutes. These kinetics can be interpreted in two ways. Possibly 
the population of cells that is capable of mediating uncoating is restricted to approximately 
8.4 %, or alternatively, released genomes only remain visible for a short period of time. In 
that case the number of cells actually mediating release, is the total of the number of cells 
with uncoating visualized at each time point. In the future, this will be studied by visualizing 
genome release in Crandell feline kidney cells, to determine how long uncoated 
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nucleocapsids can be detected in the cytosol. In these cells, release is expected to occur in 
all cells as they are all susceptible to infection. Because we know that experiments with cells 
from cell lines can give indications about processes in target cells but need to be confirmed 
in the target cell itself, release in monocytes should be studied in an alternative assay to 
check the results obtained in CrFK cells.  
Using our assay, it seems that only a subpopulation of monocytes released the FIPV genome 
in the cytosol. This suggests that the capacity of a cell to mediate FIPV uncoating, might be 
a factor that determines if a cell is susceptible to infection with FIPV. This would explain 
(partially) why infection in monocytes is restricted to approximately 1 % of the cells, while 
virus uptake occurs in the majority of cells (Dewerchin et al., 2005; Van Hamme et al., 
2007). It is evident that there might be other limiting factors that characterize the 
subpopulation of monocytes susceptible for FIPV infection.  
 
In literature, there are conflicting data regarding the dependency of FIPV genome release on 
the pH drop in endosomal vesicles (Regan et al., 2008; Takano et al., 2008). Our results 
suggest that low pH is not required to initiate uncoating of FIPV 79-1146 in monocytes. This 
could have been expected as genome release seems to be a selective process while 
acidification of endosomes is likely to occur in all cells. Regan et al. also suggested that entry 
of serotype II FIPV occurs independently from a low pH (2008). Their results were obtained 
solely in feline cell lines but they did use a variety of type II FIPV strains. The concentrations 
of inhibitor used in this study lie in the range of concentrations used in the study performed 
by Regan. In contrast, Takano et al. claim that genome release of FIPV in monocytes does 
depend on low pH (2008). Their study was performed in monocytes. The effect of the 
inhibitors was evaluated by comparing virus titres after three days of cultivation instead of 
counting infected cells after one cycle of replication as done by Regan and us. Incubation of 
monocytes with lysosomotropic agents for several days at relatively high concentrations (500 
nM of bafilomycin A1) might have side effects that could influence the result of the assay.    
 
Another possible trigger for uncoating is cleavage by proteases. There are four main 
categories of proteases, named serine proteases, cysteine proteases, aspartyl proteases and 
metalloproteases (Barrett, 1994). Preliminary experiments suggest that a serine and/or 
cysteine protease might be necessary for FIPV infection of monocytes (data not shown). In 
the future, the involvement of each class of proteases in FIPV infection will be studied by 
using specific inhibitors: 4-(2-aminoethyl)benzenesulfonyl fluoride hydrochloride (AEBSF), 
trans-epoxysuccinyl-L-leucylamido-(4-guanidino)butane (E-64), pepstatin A and 
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phosphoramidon. Then, the specific involvement of these proteases in the process of 
genome release, will be studied. Because we want to identify proteases necessary for 
uncoating, it needs to be checked if the observed protease activity is not due to the virus-
encoded proteins necessary for processing of the polyproteins pp1a/pp1ab in the early steps 
of virus replication (Hegyi & Ziebuhr, 2002). When the exact class(es) of proteases involved 
in the process of genome release is determined, inhibitors can be applied to specify which 
protease(group) is involved. Identification of a specific protease may increase the chance of 
finding an inhibitor that is able to reduce infection. Involvement of protease activity can be 
explained by a necessity for cleavage of the spike to reveal a fusion peptide (Bosch et al., 
2008). After identification of a certain protease, it should be confirmed and checked if and 
how the viral spike is cleaved by this protease. Further, it would be interesting to verify 
whether the expression pattern of the protease in the population of monocytes may correlate 
with the apparent restriction on genome release to a limited number of cells. If not, this 
implies that another factor is crucial for efficient uncoating, for example the presence of 
another receptor that induces a conformational switch into a fusogenic protein. It is clear 
that the available data and knowledge need to be extended, before a model for feline 
coronavirus uncoating can be proposed.  
 
This study reveals that uncoating of endocytosed FIP virions may not occur in all cells. 
Possibly, the cellular capacity to mediate uncoating could be an important determinant for 
cell susceptibility. A low pH seems not necessary to enable uncoating. The involvement of 
proteases will be studied in the future. 
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Feline infectious peritonitis virus (FIPV) causes a progressive vasculitis in cats that cannot be 
treated. The current knowledge on the pathogenesis of FIPV is an unsound basis for the 
development of effective antivirals. In this thesis, the entry process of FIPV was studied to 
add to the current knowledge and to evaluate the presence of possible viral and/or host 
targets for antiviral therapy. 
  
Characteristics of FIPV serotype I and II entry in monocytes and Crandell feline kidney cells 
Feline infectious peritonitis virus causes a monocyte-derived viremia (Weiss & Scott, 1981). 
Therefore, virus entry was studied in feline primary monocytes. Because it is laborious to 
obtain primary feline monocytes, Crandell feline kidney (CrFK) cells were also included in the 
study to evaluate if they could be used as a model cell line to study FIPV entry. 
Unfortunately, FIPV interacted differently with CrFK cells than with monocytes at the level of 
virus entry. Both attachment and internalization of FIPV were slower and less efficient in 
CrFK cells than in monocytes (Chapter 3). This confirms what was reported before by Nash & 
Buchmeier (1997), namely that one should be careful when generalizing data obtained in 
different cell types because entry can depend on the host cell type. Our studies made it clear 
that for FIPV, all data that were previously obtained with cell lines, for example the use of 
receptors for FIPV, should be verified in primary monocytes. Therefore, primary feline 
monocytes were included in all following experimental work.   
 
FIPV strains are divided in two serotypes: serotype I (FIPV I) and the less prevalent serotype 
II (FIPV II) (Pedersen et al., 1984; Hohdatsu et al., 1994). In Chapter 3, kinetics of virus 
binding were determined for one strain of each serotype. It was clear that virus binding to 
monocytes differed between the serotype I and II strain. This could suggest that serotype I 
and II strains use different receptors in monocytes, as has been shown by others in cell 
lines. In those cell lines, type II strains use feline aminopeptidase N (fAPN) as a receptor, 
while type I strains do not (Hohdatsu et al., 1998; Dye et al., 2007). Further, the kinetics of 
the serotype II strain showed that virus binding was different between monocytes of two 
cats. This could be due to differences in expression levels of receptor protein(s) involved in 
FIPV entry. More virus strains and more cats will need to be included to come to general 
conclusions.  
 
In general, viruses can enter a cell via two pathways: direct fusion with the plasma 
membrane or receptor-mediated endocytosis. The pathway that is used, can vary depending 
on the virus strain or the cell type (Nash & Buchmeier, 1997). Some viruses even use both 
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pathways in one single cell type (Schaeffer et al., 2004). Based on observations for murine 
coronavirus, FIPV was supposed to enter cells via direct fusion at the plasma membrane 
(Krzystyniak & Dupuy, 1984). Nevertheless, the kinetic experiments performed in Chapter 3, 
showed that both serotypes are internalized via endocytosis and not via direct fusion at the 
plasma membrane. Direct fusion could be excluded because biotinylated envelopes were 
present in the cytosol and not left behind in the plasma membrane. Other group 1 
coronaviruses, like human coronavirus 229E (HCoV-229E), transmissible gastroenteritis virus 
(TGEV) and canine coronavirus (CCoV), also enter cells via endocytosis (Hansen et al., 1998; 
Savarino et al., 2003; Nomura et al., 2004). The kinetics of internalization in Chapter 3 show 
that internalization of FIPV in monocytes via endocytosis was very efficient for both 
serotypes. Comparing these results with data on virus entry of TGEV in Madin-Darby canine 
kidney (MDCK) cells and HCoV-229E in human fibroblasts (Hansen et al., 1998; Nomura et 
al., 2004), shows that they all occur with comparable efficiency. 
It was observed that at 15 minutes after the start of FIPV internalization, envelopes started 
to accumulate in endosomes. Possibly, these are sites where fusion with endosomal 
membranes occurs to release the nucleocapsid into the cytosol. Data for TGEV indicate that 
accumulation in endosomes starts at 10 minutes after virus uptake and genome release is 
situated around 1 hour after the onset of uptake (Hansen et al., 1998).   
In Chapter 3, the efficiency of FIPV internalization is not only noticeable in the quantity and 
velocity of particle uptake, it is also reflected by the fact that a large majority of the cells 
takes up virus particles. However, this is in contrast to the low percentage of infection that 
was previously seen in monocytes (Dewerchin et al., 2005). Combining these observations, 
we hypothesize that there is a cellular mechanism to resist viral replication in monocytes 
after virus internalization. This mechanism would restrict infection at the level of genome 
release, transcription or translation. 
 
Virus-receptor interactions during the entry of FIPV II in monocytes  
As mentioned above, cell lines and more specifically CrFK cells interact differently with FIPV 
during entry compared to monocytes. The two potential receptors described for type II FIPV, 
fAPN and dendritic cell (DC)-specific intercellular adhesion molecule (ICAM) grabbing non-
integrin (DC-SIGN), were studied mainly in cell lines (Tresnan et al., 1996; Hohdatsu et al., 
1998; Dye et al., 2007; Regan & Whittaker, 2008). Therefore, the role and interplay between 
these two proteins during the entry process of FIPV, were evaluated in monocytes and 
compared with results obtained in cell lines, under the same experimental conditions 
(Chapter 4). 
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In our assays, virus binding to CrFK cells was completely blocked by APN-specific antibodies 
and there was complete co-localization between FIPV II and APN. These data confirmed 
once more that fAPN is the exclusive virus binding receptor in CrFK cells. Virus bound to 
fAPN is most likely internalized by APN itself (as FIPV and fAPN also co-localized inside the 
cell). Entry through fAPN leads to infection of CrFK cells as in our study, infection could also 
be completely blocked with APN-specific antibodies.  
However, in monocytes, the entry process seems to occur differently. APN-blocking 
antibodies only reduced virus binding by half. Therefore, it can be suggested that FIPV 
binding partly depends on fAPN and partly on another unknown receptor. The internalization 
assays in Chapter 4 showed that the fraction of virions that is internalized by the unknown 
receptor, was similar to the fraction of virions that was internalized when all receptors were 
available. Thus it is clear that both receptors contribute to the efficiency of internalization 
observed in Chapter 3. Furthermore, infection could not be blocked completely by shutting 
down one pathway, so entry via each of both receptors can lead to infection of monocytes. 
The involvement of a second receptor, besides APN, has also been described for the porcine 
coronavirus TGEV. TGEV uses porcine APN for entry into cells (Delmas et al., 1992; 1993), 
but Weingartl & Derbyshire described an additional receptor of approximately 200 kDa, that 
was not further identified (1994). Possibly the feline variant of that protein is involved in 
FIPV entry.     
 
Regan & Whittaker reported DC-SIGN as a mediator of feline coronavirus entry into host cells 
(2008). Therefore, the role of DC-SIGN and potential interplay with APN was studied in the 
entry process of FIPV. Because feline DC-SIGN (fDC-SIGN) is not completely characterized 
yet, a human DC-SIGN (hDC-SIGN) construct was used to see if FIPV interacted with hDC-
SIGN-expressing cells. Expression of hDC-SIGN in Chinese hamster ovary (CHO) cells 
enabled the cells to bind and internalize virus, but infection could not be established. It is 
known that DC-SIGN can target the endosomal/lysosomal pathway (Engering et al., 2002), 
so probably virus particles are degraded because they lack a factor necessary for genome 
release. These experiments demonstrated the capacities of hDC-SIGN to bind and internalize 
FIPV.  
Knowing this, the presence of FIPV-fDC-SIGN interactions was also studied in monocytes, 
and this was done by assessing the effect of blocking fDC-SIGN on virus binding, 
internalization and infection. In monocytes, no role could be attributed to fDC-SIGN in 
binding and internalization of FIPV as non of these processes were influenced by incubation 
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with mannan, a competitor for binding to DC-SIGN. Also when fAPN was blocked, blocking 
binding to fDC-SIGN did not cause a supplemental inhibition of FIPV binding. Therefore, we 
can conclude that fDC-SIGN in monocytes is not important for virus binding and 
internalization and hence, fDC-SIGN cannot be the unknown receptor X that binds and 
internalizes FIPV. Moreover, these results suggest that FIPV has a relatively low affinity 
towards fDC-SIGN compared to fAPN and the unknown receptor, and maybe even towards 
hDC-SIGN. Besides in binding and internalization, we also checked the role of fDC-SIGN in 
infection by evaluating if mannan could reduce infection. No effect on infection was observed 
when fDC-SIGN was blocked with mannan. However, when fAPN was blocked, fDC-SIGN did 
seem to have a role in the infection process. Because fDC-SIGN does not contribute to 
binding and internalization, the role in infection will most likely be in a step following 
internalization. Further studies are needed to further elucidate the role of fDC-SIGN in 
infection. 
Having listed the results from this study, a comparison can be made with the results 
obtained by Regan & Whittaker (2008). They induced susceptibility to infection in 
unsusceptible cells (mouse 3T3 cells) after transfection with hDC-SIGN. In our study, virus 
internalization could be induced in transfected CHO cells, but infection did not take place. A 
possible explanation is that CHO cells lack a factor necessary to release the FIPV genome 
from intracellular vesicles, while this factor is present in the mouse cells used by Regan & 
Whittaker. Further, Regan & Whittaker found that transfection of hDC-SIGN in CrFK cells 
enhanced infection of these cells. This could be explained by an increase of virus binding and 
internalization. Infection of monocytes could also be blocked with mannan, according to 
Regan & Whittaker. In our hands, no inhibition of infection was observed after treating 
monocytes with mannan. There is no obvious explanation for the different outcomes 
between these studies, but maybe the FIP viruses have a different passaging history. And 
since it is known that multiple passaging can induce adaptations in viruses, these 
adaptations might have had an effect on virus-receptor interactions.  
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Figure 1: Schematic representation of hypothetical receptor use by FIPV type II upon entry in 
monocytes. The virus can enter the monocytes via two pathways. ‘Rec X’ stands for a yet 
unidentified receptor that can be used by FIPV to gain entry into the cell. 
APN Rec X
infection
PATHWAY 1 PATHWAY 2
DC-SIGN APN
infection infection
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All the data we obtained on interactions between FIPV II and fAPN, the unknown receptor 
‘rec X’, and fDC-SIGN led to the hypothetical model on receptor use in monocytes, depicted 
in Figure 1. Infection can be mediated by fAPN after virus binding to and internalization via 
this protein. This is pathway 1 in Figure 1. The unknown rec X can bind and internalize FIPV, 
but by itself, it can probably not (efficiently) induce infection. Possibly, rec X mediates 
infection through association with fDC-SIGN or fAPN after internalization to mediate genome 
release. This is pathway 2 in Figure 1. The association with fDC-SIGN or fAPN can result 
from vesicle fusion between the internalized FIPV-containing vesicle and a recycling fDC-
SIGN-containing or fAPN-containing vesicle. Based on the experimental data, it cannot be 
excluded that fDC-SIGN or fAPN associate with rec X in the plasma membrane after binding 
of FIPV to rec X and that fDC-SIGN or fAPN co-internalize with rec X.  
Going even one step further, the possibility cannot be excluded that rec X might also 
associate with fAPN in the plasma membrane in pathway 1. This way, rec X could determine 
the mechanism of internalization in both pathways. 
 
A potentially interesting observation on the side, was that visualization of a certain epitope 
on fAPN, recognized by mAb R-G-4, resulted in different staining patterns between cells from 
feline cell lines and monocytes. In all cells from the CrFK cell line, this fAPN epitope could be 
visualized in the plasma membrane. In monocytes, this epitope was only present in the 
plasma membrane of a minority of monocytes, while the full fAPN protein was expressed in 
the plasma membrane of all monocytes (as shown by staining another epitope of the 
protein). Possibly, different glycosylation patterns occur in subpopulations of monocytes, that 
mask the epitope. Alternatively, the epitope might be masked due to di- or multimerization, 
or interactions with other proteins. It would be very interesting to characterize monocytic 
fAPN and define the exact differences with fAPN from feline cell lines. Especially since most 
receptor studies have been performed with constructs expressing the APN gene isolated 
from such a feline cell line. This would allow to compare interaction sites and binding 
affinities between FIPV and fAPN from monocytes on the one hand and from feline cell lines 
on the other hand. For example, it would be interesting to see if affinity for monocytic APN is 
higher than that for APN from feline cell lines. This can be assumed based on the kinetics 
obtained in Chapter 3, which indicate that binding of FIPV II to CrFK cells is less efficient 
than binding to monocytes. Evidently, the presence of the ‘extra’ receptor X might also 
contribute to the higher efficiency, by providing a secondary route to deliver virus particles to 
intracellular vesicles.  
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To date, the receptor for serotype I FIPV in monocytes is not known. It has been proposed 
that fAPN is not important for serotype I FIPV (Hohdatsu et al., 1998; Dye et al., 2007). 
Therefore we would like to suggest that the unknown receptor X, with or without DC-SIGN, 
might be important for type I FIPV infection. Type I FIPV would then use receptor X for 
entry, while type II FIPV could use both receptor X as well as fAPN. This hypothesis is in 
accordance with the observation that type I FIPV cannot bind to CrFK cells which presumably 
do not express receptor X, as type II FIPV only binds to fAPN on CrFK cells.  
Upon the recombination event between serotype I FIPV and CCoV from which serotype II 
arose (Herrewegh et al., 1998), type II FIPV might have acquired affinity for APN from CCoV 
(that uses canine APN as a receptor), next to the ‘existing’ affinity for the type I receptor X. 
In the kinetics of virus binding (Chapter 3), there were significant differences between type I 
and type II FIPV, which could be explained if fAPN is not a receptor for type I FIPV while it is 
for type II FIPV (Chapter 4 - model Fig. 1). A future experiment will evaluate if type II FIPV 
binding, gives similar results as seen for type I FIPV binding when APN is blocked on 
monocytes from the same cat. If affinity for APN is a supplemental feature for type II, 
compared to type I that can only bind receptor X, then blocking APN in the kinetics of type II 
would result in the kinetics obtained for type I. This could be possible for the second cat 
included in the study, where binding of serotype II FIPV reaches slightly higher levels in a 
shorter period of time than binding of serotype I FIPV. However for the first cat, there was 
less type II FIPV binding than type I FIPV binding, which does not fit the hypothesis. The 
low level of type II FIPV binding might be due to a lack of or ‘different’ expression of APN on 
the monocytes of that cat, what would imply that pathway 1 (in Figure 1) is not used 
intensely in monocytes of that cat. The small amount of type II virus that did bound, would 
have bound to receptor X and follow pathway 2 (in Figure 1). The reason that this level of 
FIPV II binding is lower than the binding observed in the kinetics for type I, could be that 
type I FIPV has a higher affinity for receptor X than type II FIPV. If this is true, one could 
hypothesize that the price for type II to gain affinity for fAPN upon the recombination event, 
was a loss in affinity for receptor X. In the future, it will be studied if pathway 1, where only 
APN is used, is indeed less available in monocytes of this cat. This could be studied by 
evaluating if blocking infection of type II FIPV with APN-specific antibodies has less effect on 
infection of monocytes in this cat compared to the second cat.  
In addition, it will also be studied in the near future if type I FIPV infection depends on DC-
SIGN. 
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Taken together, this study obviously provided data on the entry of FIPV II which could be 
very useful for studying entry of FIPV I.   
 
The mechanism of internalization of FIPV II in monocytes 
In Chapter 3, FIPV II was shown to use the endocytosis machinery of the cell to gain entry 
into monocytes. In Chapter 5, this pathway was further characterized by identifying which 
cellular proteins are necessary for FIPV internalization. Several strategies were applied: 
blocking entry with inhibitors, transduction with dominant-negative mutants of internalization 
proteins and co-localization studies looking at FIPV and internalization proteins. The 
combination of different strategies guaranteed a reliable result. Including co-localization 
assays prevented us to draw wrong conclusions due to shifting to another pathway when a 
certain pathway is blocked.  
 
The experiments showed that the entry of FIPV is independent of phagocytosis and 
macropinocytosis, clathrin-mediated endocytosis and caveolae-mediated endocytosis. 
Blocking dynamin function by an inhibitor and expression of a dynamin dominant-negative 
mutant strongly reduced virus uptake. Inhibition of Rho GTPases did not. In conclusion, the 
pathway used by FIPV II to enter monocytes is clathrin- and caveolae-independent and 
depends on dynamin.   
 
Sterol binding drugs (nystatin and methyl-β-cyclodextrin) slightly reduced FIPV entry in our 
assay. Reduction by sterol binding drugs could imply the involvement of lipid rafts in the 
entry process. However, the reduction obtained in virus entry by these drugs was rather 
small and probably too small to conclude that the entry process is associated with lipid rafts 
and depends on them to initiate and sustain the necessary signalling cascades.  
Perhaps, one of the receptor(s) or components that needs to be recruited for the 
internalization process is located in lipid rafts. Disturbing rafts might hereby reduce the 
availability of that receptor/protein and slightly influence the efficiency of internalization, 
possibly by reducing virus binding.  
Another possibility is that the pathway requires cholesterol, like for example clathrin-
mediated internalization requires cholesterol independent from lipid rafts (Subtil et al., 1999; 
Nichols & Lippincott-Schwartz, 2001). 
 
In accordance with the model from Chapter 4, there might be two internalization pathways. 
If this is true, it would be most likely that both pathways are independent from clathrin and 
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caveolae. The rather low inhibiting effect of cholesterol binding drugs, could be explained if 
one of the two pathways is linked to rafts. The moderate effect could be due to a pathway 
shift or by a bigger contribution by the raft-independent pathway in the internalization 
process. In pathway 1, fAPN might be present in lipid rafts because its human homologue is 
localized in rafts (Nomura et al., 2004). For pathway 2, fDC-SIGN or a fraction of fDC-SIGN, 
might also be localized in rafts. In human monocytes, hDC-SIGN is not localized in rafts 
immediately after they are brought in culture, but during culture in the presence of IL-4 and 
GM-CSF a relocation to rafts is observed (Cambi et al., 2004). Of course, nothing is known 
about possible raft-association of the unknown receptor X. Even if the receptors are located 
in rafts, it remains uncertain if the association with rafts is necessary for the internalization 
process. For example, TGEV enters cells through porcine APN (presumably localized in rafts) 
via clathrin-mediated internalization and this process does not depend on rafts. Possibly, the 
small effect of the sterol binding drugs, we observed for FIPV, is just due to the localization 
of the receptors in rafts. Further, it is also not certain that both internalization pathways 
depend on dynamin as internalization could not be completely blocked by dynamin inhibitors. 
However, reductions by dynamin inhibitors are much larger than those with sterol binding 
drugs. Therefore, it seems most likely that both pathways depend on dynamin. Another 
internalization pathway that is mediated by hAPN, the internalization pathway of HCoV-229E, 
depends on dynamin (Nomura et al., 2004). However this does not imply that all pathways 
via APN recruit dynamin. In general, there is no direct interaction between dynamin and the 
internalizing receptor.  
 
All monocytes internalize FIPV II virus particles, while only a very limited number gets 
infected. Therefore it might be questioned if the internalization pathways studied, lead to 
infection. After treatment of monocytes with entry inhibitors, infection of monocytes was 
reduced to similar levels as virus entry. This suggests that the internalization pathways 
studied, indeed lead to infection. However, for the sterol binding drugs, the reduction of 
infection was larger than expected based on the reduction of entry. Therefore, other post-
internalization processes are probably also hampered by the inhibitor, like for example 
intracellular transport. Another possibility is that the small effect of the sterol binding drugs 
was due to involvement of rafts in one of the two entry pathways or for one of the two 
receptors. The larger reducing effect on infection would imply that the only pathway that is 
involved in infection is the one linked to rafts. However, this would contradict earlier results 
from Chapter 4 that indicate that both pathways are important for infection.  
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As far as we know, the entry pathway of FIPV II, namely the clathrin- and caveolae-
independent pathway that depends on dynamin and is slightly cholesterol depletion 
sensitive, has no physiological equivalent. However, there are pathways that resemble the 
entry pathway of FIPV. The β-strain of interleukin 2 receptors (IL-2R) is internalized via a 
clathrin- and caveolae-independent pathway. The pathway depends on dynamin and is 
sensitive to cholesterol depletion due to raft-association of the receptor. The pathway 
depends on Rho GTPases (Lamaze et al., 2001). The internalization of the common cytokine 
receptor γ (γc) follows the same route as the IL-2R (Kirkham & Parton, 2005; Sauvonnet et 
al., 2005).  
Clathrin- and caveolae-independent pathways are also used by several viruses, including a 
coronavirus (Marsh & Helenius, 1989; Sieczkarski & Whittaker, 2002; Sanchez-San Martin et 
al., 2004). The internalization pathway of SARS-CoV in HEK293E cells transfected with ACE2, 
and Vero E6 cells, is also independent from clathrin and caveolae and associated with lipid 
rafts (Wang et al., 2008). Further characterization, however, has not been performed to 
date. Rotavirus entry resembles FIPV entry the most, except for the higher susceptibility for 
cholesterol depletion. The role of Rho GTPases in this process has not been studied 
(Sanchez-San Martin et al., 2004).  
Not many entry pathways of group 1 coronaviruses are characterized profoundly. The 
characterized pathways are diverse and different from the pathway described for FIPV. 
HCoV-229E enters human fibroblasts via caveolae-mediated internalization (Nomura et al., 
2004), while TGEV enters cells that stably express APN presumably via clathrin-mediated 
internalization (Hansen et al., 1998). It is clear that their common characteristics, including 
the use of APN as a receptor, do not lead to a shared internalization mechanism.    
 
Genome release after internalization via endocytosis of FIPV II 
After internalization via endocytosis, the virus is ‘trapped’ in intracellular vesicles and the 
genome has to be released into the cytosol for viral replication to occur. In Chapter 6, this 
uncoating process was visualized. Uncoating could be observed in some cells as soon as 
internalization started. The maximal percentage of cells with released genomes in the 
cytosol, was observed 35 minutes after the start of internalization. These data correlate very 
good with the observed accumulation of FIPV envelopes in endosomes at 15 minutes after 
the start of internalization in Chapter 3. Moreover we observed that the release of the FIPV 
genome from these vesicles appears to be restricted to a subpopulation of cells (Chapter 6). 
This suggests a restriction on the uncoating process which may explain (in part) the 
discrepancy between the number of cells with internalized particles and the number of 
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infected cells that was observed in Chapter 3. Still, further research is necessary to verify if 
there is an additional restriction besides the one on uncoating.  
 
Possible triggers for genome release are low pH, cleavage by proteases and receptor-
induced conformational changes. For FIPV type II infection of monocytes, the requirement 
for low pH has been the subject of contradictory literature (Regan et al., 2008; Takano et al., 
2008). Our results from infection inhibition experiments in monocytes with lysosomotropic 
agents, suggest that low pH is not important to mediate genome release. This is in 
agreement with the results that Regan et al. (2008) obtained in several cell lines for several 
FIPV strains. In contrast, Takano et al. (2008) suggest that low pH is important for FIPV 
infection in monocytes. They used a different set-up by using relatively high concentrations 
of inhibitors (500 nM of bafilomycin A1 while we used 10 nM) for a longer incubation time (3 
days compared to 6-12 hours). This might explain the different results.  
 
The second possible trigger for genome release is protease activity. Proteases are divided in 
four main categories: cysteine proteases, serine proteases, aspartyl proteases and 
metalloproteases. The precise role of proteases in FIPV infection will be studied in the future 
by treating monocytes with several protease inhibitors. Preliminary experiments suggest that 
cysteine and/or serine proteases may be involved in FIPV II infection. In the future, it will be 
determined if (a) cysteine or serine protease(s) is/are important for genome release in 
particular, and if so, which (subclass of) protease(s). This is of great interest as both furin, a 
serine protease, and cathepsin B, a cysteine protease, have been suggested to play a role in 
feline coronavirus entry for at least some strains (Regan et al., 2008; de Haan et al., 2008). 
The involvement and role of the other proteases (aspartyl proteases and metalloproteases) 
will also be studied. Possibly, more than one protease is involved in the uncoating, as has 
been described for HCoV-229E (Kawase et al., 2009).  
 
Another potential trigger is a receptor-induced conformational change. The involvement of 
conformational changes to initiate fusion for uncoating, was not evaluated in our study and 
therefore cannot be excluded. The hypothesis in Chapter 4 namely that in pathway 2 fDC-
SIGN binding might be necessary to induce uncoating remains possible. However, fDC-SIGN 
does probably not initiate uncoating itself by inducing a conformational change, but rather 
targets compartments where other release factors like proteases are present.   
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Hypothetical model for the entry of FIPV II in feline monocytes 
The work in this thesis has led to a hypothetical model of the entry of FIPV II in feline blood 
monocytes, the in vivo target cells. In Figure 2, the different steps during entry are 
schematically represented. The first pathway of internalization (pathway 1) results from 
binding to APN in the plasma membrane. Possibly APN resides in lipid rafts, but probably this 
association is not required for internalization. After binding, dynamin is most likely recruited 
and a vesicle containing the virus-receptor complex is internalized via a clathrin- and 
caveolae-independent pathway. To release the viral genome from the vesicle into the 
cytosol, cysteine and/or serine protease activity might initiate the exposure of a fusion 
peptide that mediates membrane fusion between the viral envelope and the membrane of 
the intracellular vesicle. Another, yet unknown receptor can also bind and internalize FIPV 
(pathway 2). It is not known if this receptor is present in lipid rafts. The internalization also 
occurs via a clathrin- and caveolae-independent pathway, that probably also depends on 
dynamin. After internalization, the internalized vesicle can fuse with a DC-SIGN- or an APN-
containing vesicle to mediate genome release (unless the association between the unknown 
receptor and DC-SIGN or APN already took place at the plasma membrane). How genome 
release is mediated, is not known. The trigger might be a DC-SIGN-induced conformational 
change or most likely, DC-SIGN might target the virus-receptor complex to an intracellular 
compartment with the appropriate physiological conditions, like the presence of cysteine 
and/or serine proteases, to induce fusion.  
 
The relevance of this hypothetical model and the obtained data might be questioned based 
on the relatively small number of animals included in the study. It would be interesting to 
compare similar data for other cats. However, the data presented are clearly more 
representative for the in vivo situation than previous data obtained in cell lines.  
Knowing that there are big differences in susceptibilities of cats, it can be questioned if the 
proposed model can be generalized. This could be verified in the future but it seems more 
likely that differences in susceptibility are caused by differences in the immune response 
upon infection than by different receptor use or expression.   
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Figure 2: Hypothetical model for the entry of FIPV type II in feline blood monocytes based on the 
data obtained in this thesis.  
Rec XDC-SIGN
dynamin lipid rafts (cysteine and/or serine) protease
APN
PATHWAY 1 PATHWAY 2
??
?
?
release
?
release
?
release
?
? ? ?
General discussion 
 173
The main conclusions that can be drawn from this thesis are: 
- Crandell feline kidney cells can not be used as a model cell line to study FIPV entry. 
- Serotype I and II FIPV strains might use different receptors on monocytes as they do 
in CrFK cells. 
- FIPV serotype I and II internalization in monocytes is extremely efficient and occurs 
exclusively via endocytosis. 
- fAPN is a virus binding and internalizing receptor for serotype II FIPV on monocytes, 
while DC-SIGN is not. 
- fAPN is not the only receptor for serotype II FIPV on monocytes. 
- FIPV serotype II internalization in monocytes is clathrin- and caveolae-independent, 
depends on dynamin and is slightly cholesterol depletion sensitive. 
- Attachment and internalization of FIPV serotype II occurs in most cells, while genome 
release appears to be restricted to a fraction of the cells which might explain why 
most cells are not susceptible to FIPV infection. 
 
Fundamental research, like described in this thesis, is extremely important in the search for 
targets that can be used in the development of new antiviral compounds. Especially in the 
battle against incurable diseases like feline infectious peritonitis. The studies described in this 
thesis already provide some ideas on how to fight this disease. For example, FIPV infection 
of monocytes can be prevented by blocking dynamin. However, blocking dynamin function in 
an organism will probably have numerous adverse effects. 
 
A lot of questions remain to be studied in the future. First of all, several experiments can be 
performed to evaluate the relevance of the hypothetical models depicted in Figures 1 and 2. 
Further, signalling during internalization can be studied in order to find specific regulators for 
the independent internalization pathway that could be used as targets for treatment of FIP. 
And finally, it would be of interest to identify the unknown FIPV binding and internalizing 
receptor. 
What is known now about the entry of type II FIPV, also puts us in an ideal position to start 
analysing the entry of type I FIPV. Knowing more about the entry of type I FIPV is of major 
interest because most natural infections are serotype I infections. Therefore, if a treatment is 
developed that targets FIPV entry, it should also be able to reduce type I FIPV entry.  
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SUMMARY 
 
Feline coronaviruses occur in two virulence variants of which the feline infectious peritonitis 
virus (FIPV) is the most threatening. It causes a monocyte-derived viremia that leads to a 
progressive vasculitis and is mostly fatal for the infected cat. There is no effective treatment 
available. To address this matter, an improved knowledge of the pathogenesis of FIPV is 
needed. The process of viral entry is an attractive target for the development of new 
therapeutic agents. However, little is known about the entry of FIPV. It is even questioned if 
the virus enters cells via direct fusion with the plasma membrane or after receptor-mediated 
internalization.  
In this thesis, the entry process of FIPV is studied to add upon the knowledge in FIPV 
pathogenesis and to evaluate the presence of possible targets for antiviral therapy. 
 
In chapter 1, an introduction is given about FIPV and virus entry in general. In the first 
section of chapter 1, the taxonomy and pathogenesis of FIPV are described. Further, insights 
are provided in the structure of a FIP virion and the production of new virions upon infection 
of a cell. In the second section of chapter 1, the process of viral entry is discussed. The 
different receptors that can be used by group 1 coronaviruses are listed and their use by the 
different coronaviruses is described. An overview of possible internalization pathways for 
viruses is given. And finally, different coronaviruses are linked to their internalization 
pathways.  
 
In chapter 2, the outline of the aims is given. 
 
In chapter 3, a quantitative analysis of the different steps in viral entry, i.e. attachment and 
internalization, was performed. Kinetics of attachment and internalization were determined 
by evaluating the number of attached virions and the percentage of internalized virions at 
different time points after inoculation. Kinetics were determined in both the in vivo target 
cells, feline primary monocytes and in Crandell feline kidney (CrFK) cells, cells from a 
continuous cell line. This was done to evaluate if this cell line could be used as a model cell 
line for FIPV entry studies. Unfortunately, attachment and internalization were less efficient 
in CrFK cells, so entry experiments in CrFK cells cannot predict interactions of FIPV with 
monocytes during virus entry.  
Two virus strains were included in the study, namely the serotype I strain Black and the 
serotype II strain 79-1146, to evaluate differences between both serotypes. Virus binding to 
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monocytes differed between the serotype I and II strain. This might suggest that both 
serotypes use different receptors in monocytes, like was shown previously in cell lines. 
Further, for the serotype II strain, virus binding was different between monocytes of two 
cats. This could be due to differences in expression levels of receptor protein(s) involved in 
FIPV entry. It is clear that these hypotheses should be verified by evaluating virus binding 
for more virus strains and more cats.  
Virus internalization was very efficient in monocytes. Besides the fact that the majority of 
bound virions was internalized within 1 minute, internalization also occurred in the majority 
of cells. This was in contrast to the restricted number of cells that is susceptible to infection. 
It was also shown that this internalization process proceeded via receptor-mediated 
endocytosis and not via direct fusion at the plasma membrane. 
 
In chapter 4, the role of feline aminopeptidase N (fAPN) and dendritic cell-specific 
intercellular adhesion molecule grabbing non-integrin (DC-SIGN), as receptors for FIPV 
serotype II strain 79-1146, has been studied in both monocytes and cells from continuous 
cell lines. First, the effect of blocking the potential receptor(s) was evaluated and secondly, 
the level of co-localization of FIPV and the receptors was determined.  
It was found that blocking fAPN inhibited binding and infection in CrFKs completely and that 
FIPV co-localized with fAPN. In contrast, on monocytes, binding and infection were only 
reduced by 53 % and 44 %, respectively, and only 60 % of bound FIPV co-localized with 
fAPN. Thus, APN is capable of binding and internalizing FIPV in monocytes and APN-
mediated entry leads to infection in monocytes. However, this is not the exclusive receptor 
for FIPV on monocytes, like it appears to be in CrFK cells.  
To evaluate the FIPV binding and internalizing capacities of human DC-SIGN (hDC-SIGN), 
CHO cells were transduced with hDC-SIGN. Transduction rendered the cells susceptible to 
binding and internalization of FIPV but not to infection. In monocytes, blocking fDC-SIGN did 
not influence binding and infection and there was no co-localization. It is clear that fDC-SIGN 
is not the second receptor next to fAPN on monocytes. However, blocking fDC-SIGN caused 
a further inhibition of infection from 56 % up to 18 % infection in APN-blocked monocytes. It 
seems that DC-SIGN is not directly required for attachment or internalization in monocytes, 
but might be necessary for infection via an alternative pathway independent of APN.  
In conclusion, it was clear that virus-receptor interactions on CrFK cells are not 
representative for the interactions on in vivo target cells. The results obtained in this chapter 
also led to a model for receptor interactions upon FIPV type II entry in monocytes.   
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In chapter 5, the mechanism of internalization of FIPV serotype II strain 79-1146 in 
monocytes was studied. In chapter 3, it was shown that FIPV enters cells via endocytosis 
and not via direct fusion at the plasma membrane. This study aimed to specify which 
endocytic pathway was used by FIPV in monocytes. There are two main categories of 
endocytic pathways: phagocytosis and pinocytosis. Pinocytosis can be divided in 
macropinocytosis, clathrin-mediated internalization, caveolae-mediated internalization and 
several clathrin- and caveolae-independent internalization pathways. To identify the pathway 
that was used by FIPV, three strategies were applied: internalization pathways were blocked 
with inhibitors or by expressing dominant-negative internalization proteins in monocytes, and 
double stainings were performed to analyse co-localization between FIPV and internalization 
proteins. Phagocytosis, macropinocytosis and clathrin-mediated internalization were clearly 
not involved in FIPV entry. Caveolae-mediated internalization was not involved either but 
sterol-binding drugs, applied to block this pathway non specifically, had a slight but 
significant reducing effect on FIPV uptake. Further, blocking the function of dynamin by an 
inhibitory peptide and expression of dominant-negative dynamin significantly reduced both 
the internalization and infection with FIPV in monocytes. Rho-GTPases were not involved in 
internalization. It was concluded that the entry of FIPV II in monocytes proceeded via a 
clathrin- and caveolae-independent pathway that depends on dynamin and is slightly 
cholesterol-depletion sensitive.  
 
In chapter 6, the step after internalization, the release of the genome of FIPV type II strain 
79-1146 from endosomes into the cytosol, was studied. This process was analysed by 
visualizing released nucleocapsids in the cytosol at different time points after the start of 
internalization. At 35 minutes after this starting point, the maximum number of cells with 
released genomes was observed. Compared to the percentage of cells with internalization, 
the percentage of cells with genome release was low. It appears that there is a restriction to 
infection at this level. This might explain why only a small fraction of the cells is susceptible 
to infection.  
The release of nucleocapsids from endosomes occurs via fusion between viral envelopes and 
endosomal membranes. This process can be triggered by a number of factors such as the pH 
drop in late endosomes, protease activity, a receptor-induced conformational change or 
other unknown factors. By using inhibitors, it was shown that genome release of FIPV is not 
induced by low pH. Preliminary data suggest a role for serine and/or cysteine protease(s). In 
the future, the involvement of proteases will be further studied to identify the exact 
protease(s) that are involved in FIPV entry.  
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As a general conclusion, it can be stated that the process of FIPV entry in monocytes does 
not resemble FIPV entry in CrFK cells. However, serotype I and serotype II strains probably 
use different receptors in both cell types.  
FIPV serotype II entry in monocytes occurs in a large majority of cells and proceeds 
exclusively via endocytosis. Based on the results obtained in chapters 3 to 6, a model for 
FIPV type II entry in monocytes was proposed. This is shown in Figure 1. The first pathway 
of internalization (pathway 1) results from binding to APN in the plasma membrane. Possibly 
APN resides in or is transported to lipid rafts. After binding, most likely, dynamin is recruited 
and a vesicle containing the virus-receptor complex is internalized via a clathrin- and 
caveolae-independent pathway. To release the viral genome from the vesicle into the 
cytosol, cysteine and/or serine protease activity might be necessary. Another, yet unknown 
receptor can also bind and internalize FIPV (pathway 2). It is not known if this receptor (rec 
X) is present in lipid rafts. The internalization also occurs via a clathrin- and caveolae-
independent pathway, that probably also depends on dynamin. After internalization, the 
internalized vesicle might fuse with a DC-SIGN- or an APN-containing vesicle (this association 
between rec X and DC-SIGN or APN may also occur at the plasma membrane). How genome 
release is mediated, is not known but possibly cysteine and/or serine proteases induce 
fusion.  
It seems like only a fraction of the cells that internalize virus, release free nucleocapsids from 
endosomes. This might explain - at least in part - the discrepancy between the fraction of 
cells that internalize virus and the fraction that is susceptible to infection.  
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Figure 1: Hypothetical model for the entry of FIPV type II in feline blood monocytes based on the 
data obtained in this thesis.  
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The main conclusions that can be drawn from this thesis are: 
- Crandell feline kidney cells can not be used as a model cell line to study FIPV entry. 
- Serotype I and II FIPV strains might use different receptors on monocytes as they do 
in CrFK cells. 
- FIPV serotype I and II internalization in monocytes is extremely efficient and occurs 
exclusively via endocytosis. 
- fAPN is a virus binding and internalizing receptor for serotype II FIPV on monocytes, 
while DC-SIGN is not. 
- fAPN is not the only receptor for serotype II FIPV on monocytes. 
- FIPV serotype II internalization in monocytes is clathrin- and caveolae-independent, 
depends on dynamin and is slightly cholesterol depletion sensitive. 
- Attachment and internalization of FIPV serotype II occurs in most cells, while genome 
release appears to be restricted to a fraction of the cells which might explain why 
most cells are not susceptible to FIPV infection. 
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SAMENVATTING 
 
Binnen de feliene coronavirussen bestaan er twee virulentie varianten. Het feliene infectieuze 
peritonitis virus (FIPV) is de meest bedreigende. Het virus veroorzaakt een monocyt-
geassocieerde viremie die leidt tot een progressieve vasculitis. De infectie kent meestal een 
fatale afloop en er is geen effectieve behandeling beschikbaar. Om hierin verandering te 
brengen, is er een verbeterde kennis van de pathogenese van FIPV nodig. Vele nieuwe 
antivirale middelen zijn gericht tegen virusopname. Voor FIPV, is er echter weinig gekend 
over dit proces. Het is zelfs niet duidelijk of FIPV zijn doelwitcel, de monocyt, binnendringt 
via directe membraanfusie of via receptor-gemedieerde endocytose.  
In deze thesis, is de opname van FIPV bestudeerd met als doel een deeltje van de 
pathogenese op te helderen en zo een stap dichter te komen bij een effectieve behandeling. 
 
In hoofdstuk 1, worden het FIP virus en het proces van virus opname beschreven. Het 
eerste deel van hoofdstuk 1 handelt over de taxonomie en pathogenese van FIPV. Verder 
worden de structuur van het virion en de productie van virale partikels bij infectie van een 
cel, beschreven. Het tweede deel van hoofdstuk 1 handelt over virus opname. De 
verschillende receptoren van coronavirussen in groep 1 worden opgesomd en de binding aan 
deze receptoren wordt besproken. Daarnaast worden alle mogelijke opnamewegen 
beschreven en worden verschillende coronavirussen gelinkt aan de opnameweg die hen in 
hun doelwitcel brengt.  
 
In hoofdstuk 2 wordt de doelstelling van deze thesis toegelicht.  
 
In hoofdstuk 3, werd een kwantitatieve analyse gemaakt van de verschillende stappen in 
het proces van virusopname, namelijk binding en internalisatie. De kinetieken van binding en 
internalisatie werden bepaald door het aantal viruspartikels dat gebonden is aan een cel en 
het percentage van partikels die opgenomen zijn per cel, te kwantificeren op verschillende 
tijdstippen na inoculatie met virus. Deze kinetieken werden bepaald in de in vivo doelwitcel 
van het virus, feliene bloedmonocyten, en in cellen van een continue cellijn, ‘Crandell feline 
kidney’ (CrFK) cellen. Deze cellijn werd ingesloten in de studie om te evalueren of ze 
gebruikt kon worden als model cellijn voor de studie van opname van FIPV in monocyten. 
Binding en internalisatie bleken helaas minder efficiënt te verlopen in de CrFK cellijn dan in 
monocyten, dus kunnen opname experimenten met deze cellen niet voorspellen hoe het 
virus met monocyten zal interageren.  
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Er werden twee virusstammen gebruikt in deze studie, een serotype I stam Black en een 
serotype II stam 79-1146, om zo eventuele verschillen tussen serotypes te bekijken. Virus 
binding was verschillend voor beide stammen, dit zou kunnen betekenen dat beide serotypes 
verschillende receptoren gebruiken in monocyten, zoals ze doen in CrFK cellen. Voor binding 
van het serotype II virus, werden ook verschillen opgemerkt tussen monocyten afkomstig 
van twee verschillende katten. Dit zou het gevolg kunnen zijn van verschillende expressie 
van een receptor die betrokken is bij virus opname. Deze hypothesen moeten nog verder 
onderzocht worden door meer stammen en meer katten in te sluiten in de studie.  
Virus internalisatie was een zeer efficiënt proces in monocyten. Niet alleen werd de 
meerderheid van de gebonden partikels binnen 1 minuut geïnternaliseerd, dit proces voltrok 
zich ook in de meerderheid van de cellen. Dit staat in contrast met het beperkte aantal cellen 
dat gevoelig is voor infectie. Er werd ook aangetoond dat internalisatie gebeurde via 
receptor-gemedieerde endocytose en niet via directe fusie met de plasma membraan. 
 
In hoofdstuk 4, werd de rol van felien aminopeptidase N (fAPN) en ‘dendritic cell-specific 
intercellular adhesion molecule grabbing non-integrin’ (DC-SIGN), als receptoren voor de 
serotype II FIPV stam 79-1146, bestudeerd in monocyten en in cellen van continue cellijnen. 
Eerst werd het effect bepaald van het blokkeren van deze proteïnen, en vervolgens werd de 
colokalisatie van FIPV en de receptoren bepaald.   
Er werd vastgesteld dat het blokkeren van fAPN, binding en infectie in CrFK cellen verhindert 
en dat het virus volledig colokaliseert met deze receptor. In monocyten werden binding en 
infectie ‘slechts’ gereduceerd met respectievelijk 53 % en 44 %. Colokalisatie tussen FIPV en 
fAPN was beperkt tot 60 % van de viruspartikels. Virus kan dus via fAPN binden en 
opgenomen worden in monocyten en opname langs deze weg kan tot infectie leiden. Toch is 
er naast fAPN nog een receptor voor binding en internalisatie, wat niet het geval is in CrFK 
cellen.  
Om te evalueren of humaan DC-SIGN (hDC-SIGN) FIPV kon binden en internaliseren, 
werden CHO cellen met hDC-SIGN getransduceerd. De transductie zorgde ervoor dat deze 
cellen virus konden binden en opnemen, maar de cellen konden niet geïnfecteerd worden. 
Het blokkeren van fDC-SIGN in monocyten had geen effect op virus binding en infectie. 
Verder was er ook geen colokalisatie tussen FIPV en fDC-SIGN. fDC-SIGN bleek duidelijk niet 
de tweede receptor, naast fAPN, op monocyten te zijn. Het blokkeren van fDC-SIGN in cellen 
waarin fAPN ook geblokkeerd is, veroorzaakte echter wel een bijkomende inhibitie van 
infectie van 56 naar 18 %. Het lijkt alsof fDC-SIGN niet nodig is voor binding en internalisatie 
in monocyten, maar wel een rol speelt in infectie onafhankelijk van fAPN. 
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Uit deze studie bleek dat virus-receptor interacties in CrFK cellen niet representatief zijn voor 
interacties in in vivo doelwit cellen. Verder kon ook een model opgesteld worden van de 
receptor interacties bij opname van serotype II FIPV in monocyten.  
 
In hoofdstuk 5, werd het mechanisme van internalisatie van FIPV serotype II stam 79-1146 
in monocyten bepaald. In hoofdstuk 3 werd aangetoond dat FIPV monocyten binnendringt 
via receptor-gemedieerde endocytose en niet via directe fusie met de plasma membraan. 
Deze studie had als doel te bepalen langs welke weg internalisatie van FIPV in monocyten 
gebeurt. Endocytose kan opgedeeld worden in twee klassen: fagocytose en pinocytose. 
Pinocytose omvat macropinocytose, clathrine-gemedieerde internalisatie, caveolae-
gemedieerde internalisatie en verschillende clathrine- en caveolae-onafhankelijke 
internalisatie wegen. Om de opnameweg van FIPV te bepalen, werden drie strategieën 
toegepast: internalisatie wegen werden geblokkeerd met inhibitoren of door expressie van 
dominant-negatieve internalisatie proteïnen in monocyten, en dubbelkleuringen werden 
uitgevoerd om de colokalisatie tussen virus en internalisatie proteïnen te bekijken. 
Fagocytose, macropinocytose en clathrine-gemedieerde internalisatie bleken duidelijk niet 
betrokken bij de opname van FIPV. Caveolae-gemedieerde internalisatie was ook niet 
betrokken maar de sterol-bindende middelen die gebruikt werden om caveolae-gemedieerde 
internalisatie aspecifiek te inhiberen, hadden een klein, maar significant reducerend effect op 
de opname van FIPV. Het inhiberen van de functie van dynamine, met een dynamine 
inhiberend peptide en expressie van dominant-negatief dynamine, reduceerde opname en 
infectie met FIPV significant. Rho-GTPasen bleken niet betrokken bij opname van FIPV. Er 
werd geconcludeerd dat de opname van FIPV serotype II in monocyten gebeurt via een 
clathrine- en caveolae-onafhankelijke weg die afhankelijk is van dynamine en licht gevoelig is 
voor het onttrekken van cholesterol. 
 
In hoofdstuk 6, werd de stap bestudeerd die volgt op internalisatie via endocytose, 
namelijk de vrijstelling van het genoom in het cytosol. Dit proces werd geanalyseerd door 
vrije nucleokapsieds in het cytosol te visualiseren op verschillende tijdstippen na de start van 
internalisatie. Op 35 minuten na de start van internalisatie, werd het maximaal percentage 
cellen met vrijgestelde nucleokapsieds gedetecteerd. In vergelijking met het aantal cellen die 
virus internaliseren, was het aantal cellen met vrijstelling laag. Het lijkt alsof 
genoomvrijstelling een stap is in de replicatiecyclus die niet in alle cellen kan doorgaan. Dit 
zou kunnen verklaren dat slechts een laag percentage cellen geïnfecteerd kan worden.  
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De vrijstelling van nucleokapsieds uit endosomen resulteert uit fusie van de virale envelop 
met de membraan van endosomen. Deze fusie kan geïnduceerd worden door verschillende 
factoren zoals de verlaagde pH in late endosomen, protease activiteit, een receptor-
geïnduceerde conformatie verandering of andere onbekende factoren. Aan de hand van 
inhibitoren werd aangetoond dat de verlaagde pH in endosomen niet noodzakelijk is voor de 
vrijstelling van FIPV. Volgens preliminaire experimenten, zouden serine en/of cysteïne 
proteasen echter wel betrokken zijn bij de genoomvrijstelling van FIPV. In de toekomst zal 
de rol van proteasen in de genoomvrijstelling van FIPV verder onderzocht worden zodat de 
proteasen geïdentificeerd kunnen worden die de vereiste membraanfusie induceren.    
 
Als algemene conclusie, kan gesteld worden dat de opname van FIPV in monocyten niet 
vergelijkbaar is met opname in CrFK cellen. Toch gebruiken serotype I en II stammen 
waarschijnlijk verschillende receptoren in beide celtypes.  
FIPV serotype II opname in monocyten vindt plaats in de meeste monocyten en gebeurt via 
endocytose. Op basis van de resultaten die bekomen zijn in de hoofdstukken 3 tot 6, werd 
een hypothetisch model voorgesteld voor de opname van serotype II FIPV in monocyten. Dit 
is weergegeven in figuur 1. De eerste opnameweg (opnameweg 1) wordt gevolgd na binding 
aan APN in de plasma membraan. Het is mogelijk dat APN gelokaliseerd is in of 
getransporteerd wordt naar lipid rafts. Na binding, wordt dynamine waarschijnlijk 
gerecruteerd naar het internaliserend vesikel dat uiteindelijk opgenomen wordt via clathrine- 
en caveolae-onafhankelijke internalisatie. Serine en/of cysteïne protease activiteit zou nodig 
kunnen zijn om genoomvrijstelling uit de endosomen te induceren. FIPV zou ook kunnen 
binden aan en internaliseren via een tweede, nog onbekende receptor (opnameweg 2). 
Uiteraard is niet bekend of deze receptor (rec X) zich in lipid rafts bevindt. Waarschijnlijk is 
deze opnameweg ook onafhankelijk van clathrine en caveolae, maar afhankelijk van 
dynamine. Na internalisatie, zou het vesikel kunnen fusioneren met een DC-SIGN- of APN-
bevattend vesikel (tenzij de associatie tussen rec X en DC-SIGN of APN reeds ter hoogte van 
de plasma membraan plaats vindt). Hoe de daaropvolgende genoomvrijstelling gebeurt, is 
niet gekend, maar mogelijks zijn serine en/of cysteïne proteasen hierbij betrokken.   
Het lijkt alsof slechts een fractie van de cellen met virus opname, in staat zijn om 
nucleokapsieds vrij te stellen uit endosomen. Dit zou - allerminst gedeeltelijk - het verschil 
tussen de fractie cellen die virus internaliseren en de fractie die gevoelig is voor infectie, 
kunnen verklaren.  
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Figuur 1: Hypothetisch model voor de opname van serotype II FIPV in feliene bloed monocyten op 
basis van de data bekomen in deze thesis.  
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De belangrijkste conclusies van deze studie zijn: 
- De ‘Crandell feline kidney’ cellijn kan niet gebruikt worden als model cellijn om de 
opname van FIPV te bestuderen. 
- Er zijn indicaties dat serotype I en II stammen in monocyten verschillende receptoren 
gebruiken zoals aangetoond in CrFK cellen. 
- Internalisatie van serotype I en II FIPV in monocyten is uiterst efficiënt en vindt 
uitsluitend plaats via endocytose. 
- fAPN is een virus bindende en internaliserende receptor voor serotype II FIPV, maar 
DC-SIGN niet. 
- fAPN is niet de enige receptor voor serotype II FIPV op monocyten. 
- Internalisatie van serotype II FIPV in monocyten is clathrine- en caveoline-
onafhankelijk, afhankelijk van dynamine en licht gevoelig voor het onttrekken van 
cholesterol. 
- Binding en internalisatie van serotype II FIPV komt voor in de meerderheid van de 
cellen, terwijl genoomvrijstelling beperkt lijkt te zijn tot een fractie van cellen. Dit zou 
kunnen verklaren waarom de meeste cellen niet gevoelig zijn voor infectie.     
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FIPpers Leslie en Ben. Leslie, je vond al snel je draai binnen de groep en binnen het labo. 
Bedankt om bloed te gaan nemen voor mij, de liftjes naar Gent en om cellen te fixeren 
tijdens mijn zwangerschap. Je bent een aanwinst voor de groep! Hetzelfde geldt voor jou, 
Ben. De enige man in ons gezelschap. We maken graag gebruik van je gestalte en 
spierkracht wanneer die van ons tekort schiet ☺. Ik wens jullie allebei veel succes in het 
onderzoek! Sjouke en Gerlinde, jullie waren de laatste aanwinsten van de ‘oude’ 1ste bureau. 
Sjouke, 1x deed je me enorm schrikken toen ik je op een zaterdag ochtend om 8h in je 
slaapzak aantrof op de grond van de 1ste bureau! Maar meestal was je verschijning minder 
schrikwekkend, en werkte je enthousiasme aanstekelijk. Gerlinde, in de eerste plaats 
bedankt voor het lezen van de eerste versie van deze thesis. Bedankt ook voor het delen van 
je ervaringen in de States. Ik wens je veel succes in je verdere carrière.  
 
Een paar maand geleden brak er een nieuwe periode aan. De verhuis naar een nieuwe 
bureau! Mijn nieuwe bureaugenootjes Hanne, Miet, Karen en Inge zorgen opnieuw voor een 
opperbeste sfeer in den bureau zoals dat enkel op de virologie kan ☺!! Hanne wil ik in het 
bijzonder nog eens bedanken om chaperonne te spelen in het L3 labo van het UZ. Ik wens je 
veel succes in de komende maanden en ben er zeker van dat je een schitterend doctoraat 
zal afleggen. En Miet bedank ik graag voor het occasionele gezelschap op de bus en niet te 
vergeten, om me op te volgen als ‘voorzitster’ van de JC. Je doet het echt schitterend ☺! 
Karen en Inge, jullie ken ik eigenlijk nog maar pas, toch weet ik zeker dat er in de toekomst 
nog veel gelachen zal worden in de 1ste bureau van de para.  
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Heel recent traden nog 2 nieuwe leden tot de FIP groep toe, namelijk Dominique en 
Annelike. Dominique, jou ken ik al een beetje. Bedankt voor de leuke babbels en het 
bewaren van mijn geheimpje! Ik wens je een goede start toe met je onderzoek en veel 
succes op het IWT! Hetzelfde voor jou, Annelike!  
 
Buiten mijn bureaugenoten zijn er nog een heel aantal mensen die me nauw aan het hart 
liggen. Lennert en Annelies, jullie heb ik pas het laatste jaar beter leren kennen maar die 
korte tijd leverde wel al veel leuke momenten op! Ik hoop dat er ook nog heel veel komen. 
Lennert, veel succes op het komende IWT van die van de para ☺! Ik weet zeker dat je veel 
in je mars hebt. Ik vind het ook super dat er eindelijk iemand is die even snel geëmotioneerd 
is als ik. Ik hoop dat we nog vele traantjes mogen wegpinken ☺! Annelies, bedankt voor het 
meermaals fixeren van celletjes voor mij de laatste maanden en om mee te gaan bloed 
nemen in het verlof, je was een natuurtalent! Veel succes met de verbouwingen. Mark, 
bedankt voor het gezelschap bij de wekelijkse afspraak met Filip op de fiets, de fatburning 
en/of de bodysculpt! Ik vond het fantastisch dat je steeds op de afspraak was en hoop snel 
terug met je aan de slag te kunnen gaan. Ook bedankt voor de hulp met de varkens voor 
Sebastiaan, als ‘kattenmadam’ was dat me niet alleen gelukt, vrees ik. Je had je plaatsje in 
mijn dankwoord dus al lang verdiend vóór je mijn chocomelkske in de pmd zak gooide ☺. 
Ook Wander wens ik heel hard te bedanken voor de interesse in mijn onderzoek en de vele 
babbels. Ook jij fixeerde mijn celletjes. Ik vind het ongelooflijk hoe je geëvolueerd bent van 
losbol student tot een rasecht onderzoeker! Ik wens je veel succes in de toekomst en ben 
ervan overtuigd dat je een mooie carrière wacht. Bedankt voor alle hulp en… voor het heel 
goed bewaren van een oud geheim ☺.  
 
Ik ben niet de eerste en zal ook zeker niet de laatste zijn die de sfeer op de ‘Viro’ looft. De 
collegialiteit is uniek en de vriendschap helpt iedereen door de onvermijdelijke dipjes. Merijn, 
Iris, Peter D, Annick, Sabrina, Annebel, Kalina, Filip, Uladzimir, Dipo, Matthias C, Joao, … 
Thanks to all of you for contributing to the pleasant atmosphere in the lab! Iris, bedankt voor 
de gezellige babbels ‘onder de middag’. Ik wens je veel succes de komende maanden met 
het afronden van je doctoraat en een spetterend huwelijksfeest in 2010! Annick, bedankt 
voor de leuke babbels en de occasionele lift naar Gent!  
En ook al delen ze een verdieping met ‘de immuno’, het blijven toch echte viro-collega’s en 
mogen zeker niet ontbreken in dit dankwoord: Nick, Céline, Nina en Matthias D. Nick, 
bedankt voor de interesse in leven en werk ☺. Ik wens je veel succes in de toekomst! Céline, 
bedankt voor het gezelschap bij de looptochtjes in het Zuidpark en veel succes met je 
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doctoraat! Matthias, bedankt voor de babbeltjes ’s avonds, en vooral voor het aanbieden van 
je printer in tijden van crisis. Je bent altijd bereid anderen te helpen. Ik wens je veel succes 
bij het beëindigen van je doctoraat!  
 
Verder heb ik ook altijd kunnen rekenen op de laboranten. Chantal, bedankt voor het maken 
en titreren van virusstocks (ondanks de vaak tegenvallende titers bij minder frequent 
gebruikte stammen). Nele, bedankt voor het experimenteel werk dat je de laatste maanden 
voor mij gedaan hebt. Ik heb je hulp enorm geapprecieerd. Verder ook een bedankje voor 
de tip over The Mission! Melanie, bedankt voor de titraties die je voor me deed en de leuke 
gesprekjes ‘s middags. Lieve en Carine, bedankt voor de bereidheid om alle vragen te 
beantwoorden en jullie ervaring te delen. Vooral wat betreft de aard van contaminaties, hé 
Lieve ☺. Dries, bedankt voor de blotjes die je voor me deed, ik ben blij dat je ons binnenkort 
vergezelt op het eerste verdiep. Chris, je bent er nu wel niet meer bij maar ik wens je toch 
zeker te bedanken voor het maken van de lysevloeistof ed, maar vooral voor de leuke 
gesprekjes tijdens de kleuringen. Geniet maar van je pensioen met echtgenoot en kleinkind! 
Geert en Fernand, het onafscheidelijke duo. Geert, bedankt voor de boodschappen voor de 
katten en de hulp met het varken, je vriendelijke ‘goeiemorgen’, je goed humeur op 
vrijdagmiddag ☺, en om ervoor te zorgen dat we altijd zorgeloos verder kunnen werken. 
Fernand, bedankt voor het herstellen van kapotte pompen en de hulp bij andere technische 
problemen. Zottegem heeft al jullie hulp enorm geapprecieerd! Gert(je) en Mieke, jullie 
stonden dan weer in voor steun op administratief gebied. Bedankt voor alle hulp, steeds 
weer met de glimlach! Marijke, bedankt voor het proper houden van mijn bureautje, het 
leegmaken van de prullenmand van ‘de snoepers’ en zoveel meer. Ik heb ook genoten van 
de gesprekjes tussendoor! Dirk, bedankt voor de assistentie bij computerprobleempjes. Jullie 
vormen allen samen het kloppend hart van het laboratorium voor virologie.  
 
An D, je hebt het labo reeds verlaten maar toch bedankt voor het gezelschap op allerlei 
activiteiten buiten het labo en de leuke gesprekken bij de boterhammetjes ’s middags. Ons 
uitstapje naar Parijs was onvergetelijk! Veel succes in je nieuwe job en veel plezier met je 2 
mannen!  
 
Ik wil ook een woordje richten aan Sebastiaan en Lowiese. Met Sebastiaan heb ik vorig jaar 
al veel plezier gehad in de varkensstallen, met Lowiese wordt het dit jaar vast even plezant 
als we beginnen worstelen met kattendarmen! Ik weet dat jullie de laatste weken niet veel 
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aan mij gehad hebben, hopelijk kan ik dat de komende weken goed maken vooraleer ik weer 
even verdwijn… ☺ 
 
Regelmatig eens stoom aflaten bij outsiders kan enorm deugd doen. Daarvoor kon ik altijd 
terecht bij mijn vriendinnen Evy, Ine en Valéry. Ik vind het super dat we na al die jaren nog 
steeds contact hebben. Al onze bijeenkomsten - vooral die zonder de mannen ☺ - werken 
echt therapeutisch! Dat blijven we doen hé! Ook Koker en Liesbeth en VB en Heidi, bedankt 
voor de interesse en de geruststellende woorden! Leentje en Eva, ook al zie ik jullie niet zo 
vaak, toch weet ik dat jullie er altijd zijn voor me en dat is vaak al genoeg!  
 
Ook op het thuisfront heb ik altijd al de onvoorwaardelijke steun gekregen van mijn familie. 
Pepe André en al zijn nakomelingen ☺ (Christine en Ivan, Wouter en Brecht, Claudine en 
Johan, Ruben en Laure, Jan, Jo en Barbara met de kleine Emma) informeerden regelmatig 
hoe het nu ging. Ik vind het fantastisch dat er zo een sterke band tussen ons allen bestaat 
en hoop dat we - ondanks het steeds toenemende aantal - elke gelegenheid blijven 
aangrijpen om samen te komen om te vieren. Mijn broer Dieter en Lotte dank ik voor de 
interesse en de vele vragen - vooral van Lotte -  om toch maar een beeld te krijgen van waar 
ik me nu eigenlijk mee bezig hou ☺. Maar belangrijker, zorgden ze altijd voor welkome 
afleiding en ontspanning met onze petekindjes June en Jade. Last maar allesbehalve least 
dank ik mijn mama. Eerst en vooral voor het strijken van tientallen hemden in de laatste 
maanden, en voor de spaghettisaus en andere spijzen, de afgelopen jaren. Maar vooral 
bedankt voor al het niet-praktische dat je voor mij gedaan hebt, te veel om met woorden te 
omvatten en alles behalve vanzelfsprekend. Bedankt voor alle kansen die je me gegeven 
hebt, de vrijheid ook om te doen wat ik wilde, zoals ik het wilde. Ik hoop dezelfde mama te 
kunnen zijn voor mijn kindjes. 
Ook mijn ‘schoonouders’ Marcel en Monique wens ik te bedanken voor hun interesse en 
steun en hun geloof in mij. Bedankt dat we regelmatig de beentjes onder tafel mochten 
steken en bedankt voor alles wat jullie al voor mij gedaan hebben! Thomas en An, bedank ik 
voor het delen van hun werkervaringen en voor het luisteren naar de evoluties in mijn 
onderzoek op zondagmiddag.  
 
Mijn laatste woorden wijd ik aan jou, mijn schatteke. Want zoals je vaak gezegd hebt, is dit 
ook een beetje jouw doctoraat, meer dan een beetje zelfs… De avonden dat ik er niet was, 
er geen eten was en dat je me in de late uurtjes of midden in een spannende voetbalmatch 
☺ kwam halen, het weekendwerk, de crisismomenten, mijn spullen op vrijdag gaan halen en 
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op zondag terug brengen naar het labo, … niets was je te veel! Zelfs niet het voederen van 
de dieren en ruimen van maden in de zomervakantie ☺. Bij het schrijven van de thesis werd 
je zonder morren even huisman en zorgde je ervoor dat ons huisje proper was, de ‘waskes’ 
gedaan werden, dat er eten in huis was en de afwas gedaan werd. Dit alles terwijl je het zelf 
op het werk ook super-druk had. Al die tijd heb je me gesteund en verbaasd met je niet 
aflatende geloof in mij! Zonder jou was dit niet mogelijk geweest! Bedankt voor alles! Ik kijk 
uit naar al wat komen zal samen met jou! Later in ons eigen huis, maar vooral heel 
binnenkort, met ons drietjes…  
 
Evelien 
